Processing 00000000.tx.1: The Rockefeller University Press, 0021-9525/2001/11/661 $5.00 The Journal of Cell Biology, Volume 155, Number 4, November 12, 2001 661-674 Article Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins Sabine Mechtersheimer1, Paul Gutwein1, Nancy Agmon-Levin1, Alexander Stoeck1, Matthias Oleszewski1, Svenja Riedle1, Rolf Postina4, Falk Fahrenholz4, Mina Fogel2, Vance Lemmon3 and Peter Altevogt1 1 Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany 2 Department of Pathology, Kaplan Hospital, Rehovot 76100, Israel 3 Department of Neurosciences, Case Western Reserve University, Cleveland, Ohio 44106 4 Institute of Biochemistry, University of Mainz, D-55128 Mainz, Germany Address correspondence to Peter Altevogt, Tumor Immunology Program, G0100, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. 

Phrase: "The Rockefeller University Press,"

Phrase: "0021-9525/2001/11/661 $5.00"

Phrase: "The Journal of Cell Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "Volume 155,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "November 12,"

Phrase: "2001 661-674 Article Ectodomain shedding of L1 adhesion molecule"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell migration by autocrine binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1622501:Migration, Cell [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to integrins Sabine Mechtersheimer1,"

Phrase: "Paul Gutwein1,"

Phrase: "Nancy Agmon-Levin1,"

Phrase: "Alexander Stoeck1,"

Phrase: "Matthias Oleszewski1,"

Phrase: "Svenja Riedle1,"

Phrase: "Rolf Postina4,"

Phrase: "Falk Fahrenholz4,"

Phrase: "Mina Fogel2,"

Phrase: "Vance Lemmon3"

Phrase: "and"

Phrase: "Peter Altevogt1 1 Tumor Immunology Program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1709697:Program [Conceptual Entity]
   799   C2728259:Program [Pharmacologic Substance]
   799   C3484370:Program [Functional Concept]

Phrase: "G0100,"

Phrase: "German Cancer Research Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1513817:Cancer Center [Health Care Related Organization]
   861   C0683939:research center [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "D-"

Phrase: "69120 Heidelberg,"

Phrase: "Germany 2 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587487:Pathology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Kaplan Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Rehovot 76100,"

Phrase: "Israel 3 Department of Neurosciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44106 4 Institute of Biochemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "University of Mainz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "D-"

Phrase: "55128 Mainz,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "correspondence to Peter Altevogt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282413:Correspondence [Intellectual Product]

Phrase: "Tumor Immunology Program,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
   734   C0920608:Tumor Immunology [Biologic Function]

Phrase: "G0100,"

Phrase: "German Cancer Research Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1513817:Cancer Center [Health Care Related Organization]
   861   C0683939:research center [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: "Im Neuenheimer Feld 280,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3539078:IM [Idea or Concept]

Phrase: "D-"

Phrase: "69120 Heidelberg,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.2: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.3: 49-6221-423-714. 

Phrase: "49-6221-423-714."
Processing 00000000.tx.4: Fax: 49-6221-423-702. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "49-6221-423-702."
Processing 00000000.tx.5: E-mail: p.altevogt{at}dkfz-heidelberg.de  Abstract Top Abstract Introduction Results Discussion Materials and methods References  The L1 adhesion molecule plays an important role in axon guidance and cell migration in the nervous system. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "p.altevogt{at}dkfz-heidelberg.de  Abstract Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The L1 adhesion molecule"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in axon guidance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "cell migration in the nervous system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1622501:Migration, Cell [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.6: L1 is also expressed by many human carcinomas. 

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "expressed by many human carcinomas."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0007097:Carcinomas [Neoplastic Process]
   760   C0086418:Human [Human]
Processing 00000000.tx.7: In addition to cell surface expression, the L1 ectodomain can be released by a metalloproteinase, but the biological function of this process is unknown. 

Phrase: "In addition to cell surface expression,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0205148:Surface [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "the L1 ectodomain"

Phrase: "can"

Phrase: "be"

Phrase: "released by a metalloproteinase,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "the biological function of this process"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0031845:Biological function, NOS [Physiologic Function]
           Biological Process
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0031843:function [Physiologic Function]
   753   C0205460:biological [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.8: Here we demonstrate that membrane-proximal cleavage of L1 can be detected in tumors and in the developing mouse brain. 

Phrase: "Here"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that membrane-proximal cleavage of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "can"

Phrase: "be"

Phrase: "detected in tumors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0027651:Tumors [Neoplastic Process]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]

Phrase: "and in the developing mouse brain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1521713:Mouse Brain [Tissue]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1515981:And [Idea or Concept]
Processing 00000000.tx.9: The shedding of L1 involved a disintegrin and metalloproteinase (ADAM)10, as transfection with dominant-negative ADAM10 completely abolishes L1 release. 

Phrase: "The shedding of L1"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "a disintegrin and metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(ADAM)10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "as"

Phrase: "transfection with dominant-negative ADAM10 completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "abolishes"

Phrase: "L1 release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.10: L1-transfected CHO cells (L1-CHO) showed enhanced haptotactic migration on fibronectin and laminin, which was blocked by antibodies to v5 and L1. 

Phrase: "L1-transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(L1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "CHO)"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "enhanced haptotactic migration on fibronectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "was"

Phrase: "blocked by antibodies"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   824   C0282682:antibody block [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "to v5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "L1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]
Processing 00000000.tx.11: Migration of L1-CHO cells, but not the basal migration of CHO cells, was blocked by a metalloproteinase inhibitor, indicating a role for L1 shedding in the migration process. 

Phrase: "Migration of L1-CHO cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the basal migration of CHO cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1622501:cells migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "blocked by a metalloproteinase inhibitor,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C1999216:Inhibitor [Qualitative Concept]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "indicating"

Phrase: "a role for L1 shedding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the migration process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.12: CHO and metalloproteinase-inhibited L1-CHO cells were stimulated to migrate by soluble L1-Fc protein. 

Phrase: "CHO"

Phrase: "and"

Phrase: "metalloproteinase-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "L1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "migrate by soluble L1-Fc protein."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0232902:migrate [Functional Concept]
   753   C0441918:L1 [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   753   C2983605:FC [Activity]
Processing 00000000.tx.13: The induction of migration was blocked by v5-specific antibodies and required Arg-Gly-Asp sites in L1. 

Phrase: "The induction of migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "blocked by v5-specific antibodies"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C0282682:antibody block [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0028778:Blocked [Pathologic Function]
   760   C0205369:Specific [Qualitative Concept]
   760   C0332206:Blocked [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   760   C2349105:V5+ [Element, Ion, or Isotope]
   760   C2983591:BLOCKED [Research Activity]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "required Arg-Gly-Asp sites in L1."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.14: A 150-kD L1 fragment released by plasmin could also stimulate CHO cell migration. 

Phrase: "A 150-kD L1 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "released by plasmin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "also"

Phrase: "stimulate"

Phrase: "CHO cell migration."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1622501:Migration, Cell [Cell Function]
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]
   734   C0085080:CHO cell [Cell]
Processing 00000000.tx.15: We propose that ectodomain-released L1 promotes migration by autocrine/paracrine stimulation via v5. 

Phrase: "We"

Phrase: "propose"

Phrase: "that ectodomain-released L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "migration by autocrine/paracrine stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "via v5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]
Processing 00000000.tx.16: This regulatory loop could be relevant for migratory processes under physiological and pathophysiological conditions. 

Phrase: "This regulatory loop"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678662:regulatory loop [Physiologic Function]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "relevant for migratory processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "under physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathophysiological conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.17: Key Words: L1; 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.18: shedding; 

Phrase: "shedding"

Phrase: ";"
Processing 00000000.tx.19: ADAM10; 

Phrase: "ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.20: cell migration; 

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.21: integrins  Introduction Top Abstract Introduction Results Discussion Materials and methods References  The regulation of cell migration is of paramount importance for many cellular processes. 

Phrase: "integrins  Introduction Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The regulation of cell migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C1155915:regulation of cell migration [Cell Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "is of paramount importance"

Phrase: "for many cellular processes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0007613:Cellular Process [Cell Function]
   983   C1325880:cellular process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.22: During embryogenesis, cells migrate long distances before reaching their destination. 

Phrase: "During embryogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "migrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrate [Functional Concept]

Phrase: "long distances before reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012751:distances [Quantitative Concept]

Phrase: "their destination."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079220:Destination [Spatial Concept]
  1000   C1521840:Destination [Functional Concept]
Processing 00000000.tx.23: A well-studied example is the formation of the nervous system. 

Phrase: "A well-studied example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707959:Example [Conceptual Entity]

Phrase: "is"

Phrase: "the formation of the nervous system."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.24: The cerebral cortex extends axons long distances to various cortical and subcortical structures. 

Phrase: "The cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "axons long distances to various cortical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012751:distances [Quantitative Concept]

Phrase: "and"

Phrase: "subcortical structures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678594:structures [Spatial Concept]
   861   C0815275:subcortical [Body Location or Region]
Processing 00000000.tx.25: Cell surface receptors that transduce signals from environmental cues direct the guidance of these axons. 

Phrase: "Cell surface receptors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "transduce"

Phrase: "signals from environmental cues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "the guidance of these axons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C2984268:Axon guidance [Cell Function]
   760   C0150600:Guidance [Health Care Activity]
   760   C1959633:Guidance [Clinical Attribute]
   756 E C0598948:axonal guidance [Cell Function]
Processing 00000000.tx.26: Environmental cues include diffusible and nondiffusible molecules that can be attractant and/or repellent. 

Phrase: "Environmental cues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010439:Cues [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "diffusible"

Phrase: "and"

Phrase: "nondiffusible molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "attractant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1622714:attractant [Molecular Function]

Phrase: "and/or"

Phrase: "repellent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544309:Repellent [Hazardous or Poisonous Substance]
Processing 00000000.tx.27: Examples include growth factors, semaphorins, netrins, cell adhesion molecules, and extracellular matrix molecules (Tessier-Lavigne and Goodman, 1996). 

Phrase: "Examples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707959:Example [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "growth factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "semaphorins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136340:Semaphorins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "netrins,"

Phrase: "cell adhesion molecules,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:molecules [Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "extracellular matrix molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "(Tessier-Lavigne"

Phrase: "and"

Phrase: "Goodman,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.28: Cell migration remains important in the adult organism in a variety of organ systems. 

Phrase: "Cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "remains"

Phrase: "important in the adult organism"

Phrase: "in a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of organ systems."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0460002:organ systems [Body System]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.29: During tumor metastasis, for example, released tumor cells migrate from the primary tumor into the circulatory system, and then invade a new site (Fidler, 1990). 

Phrase: "During tumor metastasis,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0027627:tumor metastasis [Neoplastic Process]
           Metastasis
  1000   C2939419:Tumor metastasis [Neoplastic Process]
   861   C2939420:metastasis [Neoplastic Process]
   789 E C0036525:Metastatic [Functional Concept]
   789 E C1522484:metastatic [Quantitative Concept]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "released tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "migrate from the primary tumor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0677930:Primary Tumor [Neoplastic Process]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0205225:Primary [Qualitative Concept]
   760   C0232902:migrate [Functional Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "into the circulatory system,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0007226:Circulatory system [Body System]
  1000   C0497231:circulatory system [Functional Concept]
           Circulatory
   861   C0005775:Circulatory [Physiologic Function]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "invade"

Phrase: "a new site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(Fidler,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.30: Cell adhesion and migration are mediated in many instances by cell surface integrins that link interactions with the substratum to the cytoskeleton inside the cell. 

Phrase: "Cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "are"

Phrase: "mediated in many instances"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   737   C1550608:Instance [Idea or Concept]

Phrase: "by cell surface integrins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   734   C0699040:Cell surface [Cell Component]

Phrase: "that"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "interactions with the substratum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "to the cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010853:Cytoskeleton [Cell Component]
  1000   C1748451:Cytoskeleton [Cell Component]

Phrase: "inside the cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.31: Integrins are heterodimeric cell adhesion molecules that were initially found to mediate the interaction of cells to components of the extracellular matrix like laminin, fibronectin, vitronectin, etc. 

Phrase: "Integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "are"

Phrase: "heterodimeric cell adhesion molecules"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   923   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:molecules [Substance]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the interaction of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0007582:Cell Interaction [Cell Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "to components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of the extracellular matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015350:Extracellular Matrix [Tissue]
   861   C0521119:Extracellular [Cell Component]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "like laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vitronectin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]
Processing 00000000.tx.32: (Hynes, 1992). 

Phrase: "(Hynes,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.33: Integrin binding and clustering initiates not only adhesion, but also activates many intracellular signaling events that regulate diverse cell functions such as cell migration, polarity, survival, or cell growth (for review see Giancotti and Ruoslahti, 1999; Schwartz and Shattil, 2000) L1 is a 200220-kD type I membrane glycoprotein of the immunoglobulin family, consisting of 6 Ig-like domains and five fibronectin-type III repeats, followed by a transmembrane region and a highly conserved cytoplasmic tail. 

Phrase: "Integrin binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149503:Integrin Binding [Molecular Function]
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "clustering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009085:Clustering [Research Activity]

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "not only adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "also"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "many intracellular signaling events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "that"

Phrase: "regulate"

Phrase: "diverse cell functions such as cell migration,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0007613:cell functions [Cell Function]
   774   C1622501:Migration, Cell [Cell Function]
   757   C1533574:Migration, function [Physiologic Function]
   748   C0007634:Cell [Cell]
   748   C0542341:Functions [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "polarity,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0596963:Polarity [Quantitative Concept]
   928 E C0813983:polar [Quantitative Concept]
   900 E C0337815:Poles [Population Group]
   900 E C0935623:Pole [Body Location or Region]
   900 E C1418729:POLE [Gene or Genome]

Phrase: "survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "or"

Phrase: "cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Giancotti"

Phrase: "and"

Phrase: "Ruoslahti,"

Phrase: "1999"

Phrase: "; Schwartz"

Phrase: "and"

Phrase: "Shattil,"

Phrase: "2000"

Phrase: ")"

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "is"

Phrase: "a 200220-kD type I membrane glycoprotein of the immunoglobulin family,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0025248:Membrane Glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   738   C0025255:Membrane [Tissue]
   738   C0596901:Membrane [Cell Component]
   738   C1706182:Membrane [Manufactured Object]

Phrase: "consisting of 6 Ig-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C3541296:IG [Idea or Concept]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "like domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "five fibronectin-type III repeats,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0205341:repeats [Functional Concept]
   804   C1705914:Repeats [Conceptual Entity]
   771 E C1547730:Repeat [Temporal Concept]

Phrase: "followed by a transmembrane region"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C1519623:Transmembrane Region [Amino Acid Sequence]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C1167322:transmembrane [Cell Component]
   760   C2752508:transmembrane [Cell Component]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "a highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved"

Phrase: "cytoplasmic tail."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Tail [Cell Component]
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0039259:Tail [Body Part, Organ, or Organ Component]
   861   C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.34: In neuronal cells, L1 is involved in several morphogenic events, such as neuronneuron adhesion, neurite fasciculation, synaptogenesis, neurite outgrowth on Schwann cells and neuronal cell migration (for review see Hortsch, 1996; Schachner, 1997, Brmmendorf et al., 1998). 

Phrase: "In neuronal cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "is"

Phrase: "involved in several morphogenic events,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441471:Events [Event]
   760   C1314939:Involved [Functional Concept]
   760   C3541888:Events [Classification]

Phrase: "such as neuronneuron adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "neurite fasciculation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015644:Fasciculation [Sign or Symptom]

Phrase: "synaptogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597545:synaptogenesis [Organ or Tissue Function]

Phrase: "neurite outgrowth on Schwann cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C3158384:neurite outgrowth [Cell Function]
   760   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "neuronal cell migration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1326504:neuronal migration [Cell Function]
   901   C1622501:Migration, Cell [Cell Function]
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Hortsch,"

Phrase: "1996"

Phrase: "; Schachner,"

Phrase: "1997,"

Phrase: "Brmmendorf et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.35: Although initially characterized and most extensively studied in the nervous system, L1 is expressed also by hematopoietic and certain epithelial cells (Kowitz et al., 1992; Ebeling et al., 1996, Pancook et al., 1997; Debiec et al., 1998) and a variety of human tumor cell lines such as neuroblastomas, melanomas, and lung carcinomas (Linnemann et al., 1989; Patel et al., 1991; Reid and Hemperly, 1992; Katayama et al., 1997), suggesting a potential role of the molecule in other adhesion and migration events. 

Phrase: "Although"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "most extensively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "studied in the nervous system,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0027763:Nervous System [Body System]
   806   C0422837:NERVOUS SYSTEM [Finding]
   806   C1269560:Nervous system [Body System]
   760   C0027769:Nervous [Sign or Symptom]
   760   C0449913:System [Functional Concept]
   760   C0599851:Nervous [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   751 E C0205494:Neurologic [Qualitative Concept]
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]
   714 E C0027855:Neurology [Biomedical Occupation or Discipline]

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "is"

Phrase: "expressed"

Phrase: "also by hematopoietic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018957:Haematopoietic [Body System]
   790   C0229601:Hematopoietic [Functional Concept]
   718 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "and"

Phrase: "certain epithelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0014597:Epithelial Cells [Cell]
   901   C1273342:Epithelial Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Kowitz et al.,"

Phrase: "1992"

Phrase: "; Ebeling et al.,"

Phrase: "1996,"

Phrase: "Pancook et al.,"

Phrase: "1997"

Phrase: "; Debiec et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "and"

Phrase: "a variety of human tumor cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "such as neuroblastomas,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027819:Neuroblastomas [Neoplastic Process]
   966 E C0700095:neuroblastoma [Neoplastic Process]
   966 E C3540583:Neuroblastoma [Intellectual Product]

Phrase: "melanomas,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025202:Melanomas [Neoplastic Process]
   966 E C2984289:Melanoma [Functional Concept]
   966 E C3539018:Melanoma [Intellectual Product]

Phrase: "and"

Phrase: "lung carcinomas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0684249:Lung Carcinoma [Neoplastic Process]
   861   C0007097:Carcinomas [Neoplastic Process]

Phrase: "(Linnemann et al.,"

Phrase: "1989"

Phrase: "; Patel et al.,"

Phrase: "1991"

Phrase: "; Reid"

Phrase: "and"

Phrase: "Hemperly,"

Phrase: "1992"

Phrase: "; Katayama et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a potential role of the molecule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in other adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "migration events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]
Processing 00000000.tx.36: L1 supports cellular processes through interaction with extracellular ligands and transduction of a variety of signaling events through associated proteins (Kamiguchi and Lemmon, 1997; Brmmendorf et al., 1998; Doherty et al., 2000). 

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "cellular processes through interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0007613:Cellular Process [Cell Function]
   816   C1325880:cellular process [Cell Function]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "with extracellular ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "and"

Phrase: "transduction of a variety of signaling events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0037083:Signal Transduction [Cell Function]
   748   C1160185:transduction [Organism Function]

Phrase: "through associated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Kamiguchi"

Phrase: "and"

Phrase: "Lemmon,"

Phrase: "1997"

Phrase: "; Brmmendorf et al.,"

Phrase: "1998"

Phrase: "; Doherty et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.37: L1 can undergo homophilic L1-L1 binding involving several Ig domains (De Angelis et al., 1999), and can interact via Ig domain 1 with the proteoglycan neurocan (Oleszewski et al., 1999). 

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "undergo"

Phrase: "homophilic L1-L1 binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "several Ig domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "(De Angelis et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "can"

Phrase: "interact via Ig domain 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541296:IG [Idea or Concept]
   760   C3541951:Domain [Intellectual Product]

Phrase: "with the proteoglycan neurocan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1413764:NEUROCAN [Gene or Genome]
   861   C2326566:Neurocan [Amino Acid, Peptide, or Protein]

Phrase: "(Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.38: The Arg-Gly-Asp (RGD)* sites in Ig domain 6 of L1 support heterophilic binding to integrins including 51, v1, and v3, as well as the platelet integrin IIb3 (Ruppert et al., 1995; Ebeling et al., 1996; Montgomery et al., 1996; Felding-Habermann et al., 1997; Oleszewski et al., 1999). 

Phrase: "The Arg-Gly-Asp (RGD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Arg-Gly-Asp
   812   C2699006:RGD [Intellectual Product]

Phrase: ")"

Phrase: "* sites in Ig domain 6 of L1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   757   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "heterophilic binding to integrins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1149503:Integrin Binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "51,"

Phrase: "v1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0457422:V1 [Finding]
  1000   C0507238:V1 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "v3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0507236:V3 [Body Part, Organ, or Organ Component]

Phrase: "as well as"

Phrase: "the platelet integrin IIb3"

Phrase: "(Ruppert et al.,"

Phrase: "1995"

Phrase: "; Ebeling et al.,"

Phrase: "1996"

Phrase: "; Montgomery et al.,"

Phrase: "1996"

Phrase: "; Felding-Habermann et al.,"

Phrase: "1997"

Phrase: "; Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.39: Recently, an RGD-independent binding site for 91 was identified in the third fibronectin (FN)III domain (Silletti et al., 2000). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "an RGD-independent binding site for 91"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "identified in the third fibronectin (FN)III domain"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205396:Identified [Qualitative Concept]
   748   C0205437:Third [Quantitative Concept]
   748   C0439070:III [Intellectual Product]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1705160:III [Qualitative Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "(Silletti et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.40: In addition to the cell surface localization, L1 can be released as a soluble molecule from mouse cerebellar cells in culture (Sadoul et al., 1988) and from mouse and human tumor cells (Montgomery et al., 1996; Beer et al., 1999; Gutwein et al., 2000). 

Phrase: "In addition to the cell surface localization,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1660153:cell localization [Biologic Function]
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]
   734   C0699040:Cell surface [Cell Component]

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "released as a soluble molecule"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0391871:Released [Functional Concept]
   760   C0567416:Molecule [Substance]
   760   C1283071:Released [Functional Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from mouse cerebellar cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(Sadoul et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: "and from mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "human tumor cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Montgomery et al.,"

Phrase: "1996"

Phrase: "; Beer et al.,"

Phrase: "1999"

Phrase: "; Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.41: We have shown before that L1 release involves membrane-proximal cleavage by an unknown metalloproteinase, most likely of the a disintegrin and metalloproteinase (ADAM) family (Gutwein et al., 2000). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "that L1 release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "involves"

Phrase: "membrane-proximal cleavage by an unknown metalloproteinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "most likely of the a disintegrin and metalloproteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0750501:most likely [Idea or Concept]
   744   C0332148:Likely [Qualitative Concept]
   744   C0750492:Likely [Idea or Concept]

Phrase: "(ADAM) family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "(Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.42: An increasing number of soluble proteins are now recognized as being derived from integral plasma membrane proteins (for review see Schlndorff and Blobel, 1999; Turner and Hooper, 1999; Blobel, 2000). 

Phrase: "An increasing number of soluble proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "recognized"

Phrase: "as"

Phrase: "being"

Phrase: "derived from integral plasma membrane proteins"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   820   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   816   C1179841:Plasma membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0007603:Plasma membrane [Cell Component]
   790   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C1168405:protein plasma [Laboratory Procedure]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0443238:Integral [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1441547:Derived [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245521:derived [Idea or Concept]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Schlndorff"

Phrase: "and"

Phrase: "Blobel,"

Phrase: "1999"

Phrase: "; Turner"

Phrase: "and"

Phrase: "Hooper,"

Phrase: "1999"

Phrase: "; Blobel,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.43: These proteins are diverse in structure and function, and comprise molecules such as TNF-, FasL, IL-6 receptor, L-selectin, proTGF-, and amyloid precursor protein (APP) (for review see Turner and Hooper, 1999). 

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "diverse in structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880371:Diverse [Qualitative Concept]

Phrase: "and"

Phrase: "function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "molecules such as TNF-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:molecules [Substance]

Phrase: "FasL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0253023:Fas-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas-L [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "IL-6 receptor,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0063717:IL-6 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   913   C1149183:IL receptor [Molecular Function]
   901   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1334122:IL6 [Gene or Genome]
   901   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0020898:IL [Geographic Area]
   827   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0022271:IL [Geographic Area]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "L-selectin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1335808:L-SELECTIN [Gene or Genome]
   861   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325391:selectin [Molecular Function]

Phrase: "proTGF-,"

Phrase: "and"

Phrase: "amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Turner"

Phrase: "and"

Phrase: "Hooper,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.44: Members of the ADAM family (membrane proteins composed of a disintegrin and metalloproteinase domain) were shown to be important in ectodomain release (for review see Black and White, 1998; Schlndorff and Blobel, 1999). 

Phrase: "Members of the ADAM family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0086282:Family Members [Family Group]
   781 E C1611821:Family Member [Intellectual Product]
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "(membrane proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0025255:Membrane [Tissue]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "composed of a disintegrin and metalloproteinase domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1511990:Disintegrin Domain [Amino Acid Sequence]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in ectodomain release"

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Black and White, 1998"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1609177:Black and White [Organic Chemical,Pharmacologic Substance]
   812   C0005680:Black [Population Group]
   812   C0007457:White [Population Group]
   812   C0027567:Black [Population Group]
   812   C0043157:White [Population Group]
   812   C0085756:Black [Population Group]
   812   C0220938:White [Qualitative Concept]
   812   C0439541:Black [Qualitative Concept]

Phrase: "; Schlndorff"

Phrase: "and"

Phrase: "Blobel,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.45: ADAM17/TACE mediates the membrane release of TNF-, L-selectin, and TGF- (Peschon et al., 1998). 

Phrase: "ADAM17/TACE"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0723595:Tace [Hormone,Pharmacologic Substance,Steroid]
   861   C0796679:TACE [Therapeutic or Preventive Procedure]
   861   C1412186:TACE [Gene or Genome]
   861   C1706640:TACE [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539919:TACE [Therapeutic or Preventive Procedure]
   805 E C0008275:Chlorotrianisene [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the membrane release of TNF-,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "L-selectin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1335808:L-SELECTIN [Gene or Genome]
   861   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325391:selectin [Molecular Function]

Phrase: "and"

Phrase: "TGF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Peschon et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.46: ADAM10/Kuz has been described as -secretase for the cleavage of APP (Lammich et al., 1999), and ADAM9 is involved in the phorbolester-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) (Izumi et al., 1998, Gechtman et al., 1999). 

Phrase: "ADAM10/Kuz"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412181:KUZ [Gene or Genome]
   861   C2984596:KUZ [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "as -secretase for the cleavage of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   810   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   810   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Lammich et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ADAM9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412207:ADAM9 [Gene or Genome]

Phrase: "is"

Phrase: "involved in the phorbolester-induced ectodomain shedding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0031586:Phorbol Ester [Hazardous or Poisonous Substance,Organic Chemical]
   748   C0205263:Induced [Functional Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "of membrane-anchored heparin-binding EGF-like growth factor"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   923   C0058402:Heparin-Binding EGF-Like Growth Factor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   923   C0166825:heparin-binding EGF-like growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1539630:HEPARIN-BINDING EGF-LIKE GROWTH FACTOR [Gene or Genome]
           HEPARIN-BINDING EGF
   875   C0599765:Heparin Binding Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1522455:Heparin Binding Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1148608:Heparin Binding [Molecular Function]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C0220844:growth [Physiologic Function]
   793   C0243122:binding [Functional Concept]
   793   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1521761:Factor [Functional Concept]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]

Phrase: "(HB-EGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019046:Hb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(Izumi et al.,"

Phrase: "1998,"

Phrase: "Gechtman et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.47: Recent reports have established an important link between ectodomain cleavage by metalloproteinases and the regulation of migratory processes. 

Phrase: "Recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "an important link between ectodomain cleavage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "by metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the regulation of migratory processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.48: The function of the axonal chemoattractant Netrin-1 is regulated by cleavage of its receptor, deleted in colorectal cancer (DCC). 

Phrase: "The function of the axonal chemoattractant Netrin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
   731   C0234573:Axon function [Cell Function]

Phrase: "is"

Phrase: "regulated by cleavage of its receptor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1330957:cleavage [Cell Function]

Phrase: "deleted in colorectal cancer (DCC)."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0009402:Colorectal Cancer [Neoplastic Process]
   833   C1527249:Colo-rectal cancer [Neoplastic Process]
   833   C2984278:Colorectal cancer [Functional Concept]
   833   C3542412:Colorectal Cancer [Intellectual Product]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0555952:Colorectal [Spatial Concept]
   770   C0998265:Cancer [Eukaryote]
   770   C1306459:Cancer [Finding]
   770   C1880274:Deleted [Activity]
Processing 00000000.tx.49: Blocking of cleavage by a metalloproteinase inhibitor potentiated axon outgrowth (Galko and Tessier-Lavigne, 2000). 

Phrase: "Blocking of cleavage"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0010813:cleavage [Cell Function]
   790   C0233660:Blocking [Mental or Behavioral Dysfunction]
   790   C0332206:Blocking [Functional Concept]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]
   756 E C0028778:Block [Pathologic Function]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "by a metalloproteinase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "potentiated"

Phrase: "axon outgrowth"

Phrase: "(Galko"

Phrase: "and"

Phrase: "Tessier-Lavigne,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.50: The contact-mediated axon repulsion by ephrin-A2 involves cleavage by Kuz, which is triggered by binding of the A2 ligand Eph receptor (Hattori et al., 2000). 

Phrase: "The contact-mediated axon repulsion by ephrin-A2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0683283:repulsion [Mental Process]

Phrase: "involves"

Phrase: "cleavage by Kuz,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "which"

Phrase: "is"

Phrase: "triggered by binding of the A2 ligand Eph receptor"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   784   C1323366:Eph receptor binding [Molecular Function]
   784   C1333337:EPH receptor A2 [Gene or Genome]
   781   C0597358:receptor ligand binding [Molecular Function]
           Receptor Binding
   764   C0916831:Eph Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   764   C1444748:Triggered by [Qualitative Concept]
           Trigger
   762   C1517880:Ligand Binding [Molecular Function]
   762   C1621296:receptor ligand [Molecular Function]
   742   C0023688:Ligand [Chemical]
   742   C0243122:binding [Functional Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0812262:EPH [Gene or Genome]
   742   C0908506:EPH [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   708   C0032930:Trigger [Clinical Attribute]

Phrase: "(Hattori et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.51: This proteolytic process allows efficient axon detachment and withdrawal. 

Phrase: "This proteolytic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "efficient axon detachment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0541879:detachment [Mental Process]
   827   C0595950:Detachment [Pathologic Function]
   755 E C0687118:Detached [Functional Concept]
   755 E C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "withdrawal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2349954:Withdrawal [Activity]
  1000   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
Processing 00000000.tx.52: Finally, a recent study has shown that ectodomain shedding of EGF receptor ligands is required for keratinocyte migration in cutaneous wound healing (Tokumaru et al., 2000). 

Phrase: "Finally,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ectodomain shedding of EGF receptor ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C1621321:receptor shedding [Molecular Function]

Phrase: "is"

Phrase: "required for keratinocyte migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1656945:keratinocyte migration [Cell Function]
   770   C0022567:keratinocyte [Cell]
   770   C0600210:Migration [Social Behavior]
   770   C1514873:Required [Functional Concept]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "in cutaneous wound healing"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0043240:Wound Healing [Organism Function]
           Healing
   873   C0564444:skin wound [Injury or Poisoning]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0205249:Healing [Functional Concept]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "(Tokumaru et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.53: It was hypothesized that the inhibition of EGF receptor ligand shedding abrogated the auto/paracrine stimulation of soluble EGF receptor ligands, which is critical for keratinocyte migration. 

Phrase: "It"

Phrase: "was"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the inhibition of EGF receptor ligand shedding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C3269587:inhibition of receptor ligand [Molecular Function]
   774   C1514761:Receptor Inhibition [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "abrogated"

Phrase: "the auto/paracrine stimulation of soluble EGF receptor ligands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "critical for keratinocyte migration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.54: In the light of these published results, we have examined the possible biological role of L1 ectodomain shedding. 

Phrase: "In the light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "of these published results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "we"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the possible biological role of L1 ectodomain shedding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.55: Given the known involvement of L1 in cell migratory processes, we have specifically addressed the question whether the ectodomain release of L1 might have a decisive part in such events. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the known involvement of L1 in cell migratory processes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1314939:Involvement [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "specifically"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "the ectodomain release of L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "might"

Phrase: "have"

Phrase: "a decisive part in such events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.56: In the present report, we provide evidence that membrane-proximal cleavage of L1 can be detected in tumor cell lines and in the developing mouse brain. 

Phrase: "In the present report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that membrane-proximal cleavage of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "can"

Phrase: "be"

Phrase: "detected in tumor cell lines"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   862   C0085983:Tumor Cell Lines [Cell]
   806   C0007600:Cell lines [Cell]
   806   C0431085:Tumor cell [Cell]
   806   C0597032:Tumor Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0205132:lines [Spatial Concept]
   760   C0442726:Detected [Finding]
   760   C1269647:Cell [Cell]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1578706:Tumor [Intellectual Product]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3273930:Tumor [Finding]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "and in the developing mouse brain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1521713:Mouse Brain [Tissue]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1515981:And [Idea or Concept]
Processing 00000000.tx.57: In androgen receptor (AR) breast tumor cells, the shedding of L1 involves ADAM10, as transfection with dominant-negative ADAM10 completely abolishes L1 release. 

Phrase: "In androgen receptor (AR) breast tumor cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   858   C1514760:Receptor Cell [Cell]
   840   C0431085:Tumor cells [Cell]
   806 E C0597032:Tumor Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "the shedding of L1"

Phrase: "involves"

Phrase: "ADAM10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "as"

Phrase: "transfection with dominant-negative ADAM10 completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "abolishes"

Phrase: "L1 release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.58: We also demonstrate that cleavage of L1 stimulates cell migration on fibronectin and laminin by autocrine binding of soluble L1 to v5 integrins. 

Phrase: "We also"

Phrase: "demonstrate"

Phrase: "that cleavage of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "stimulates"

Phrase: "cell migration on fibronectin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1622501:Migration, Cell [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "laminin by autocrine binding of soluble L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1523874:laminin binding [Molecular Function]
   748   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to v5 integrins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.59: These observations have important implications for understanding how L1 can function to promote cell migration in the nervous system, as well as how L1 expression in tumors could contribute to dissemination and metastasis.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "important implications for understanding how L1"

Phrase: "can"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell migration in the nervous system,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1622501:Migration, Cell [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "as well as"

Phrase: "how L1 expression in tumors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "contribute to dissemination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205221:Dissemination [Spatial Concept]
   790   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "metastasis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.60: Results Top Abstract Introduction Results Discussion Materials and methods References  A 32-kD cytoplasmic fragment of L1 is retained in the membrane after release of the L1 ectodomain Soluble L1 is present in the culture medium of various L1-positive mouse and human carcinoma cell lines (Beer et al., 1999; Gutwein et al., 2000). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A 32-kD cytoplasmic fragment of L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "retained in the membrane"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0349462:Retained membrane [Disease or Syndrome]
   770   C0025255:Membrane [Tissue]
   770   C0333118:Retained [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]

Phrase: "after release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of the L1 ectodomain Soluble L1"

Phrase: "is"

Phrase: "present in the culture medium of various L1-positive mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0150312:Present [Quantitative Concept]
   739   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "human carcinoma cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   906   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell lines [Cell]
   861   C1518174:Carcinoma Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "(Beer et al.,"

Phrase: "1999"

Phrase: "; Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.61: The release from the cell surface requires proteolytic cleavage of the ectodomain, which in adherent cells is induced by detachment with EDTA and incubation at 37C (Gutwein et al., 2000). 

Phrase: "The release from the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "requires"

Phrase: "proteolytic cleavage of the ectodomain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1157978:ectodomain cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "which in adherent cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0334154:Adherent [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "induced by detachment"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   790   C0541879:detachment [Mental Process]
   790   C0595950:Detachment [Pathologic Function]
   718 E C0687118:Detached [Functional Concept]
   718 E C1561504:detached [Idea or Concept]

Phrase: "with EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubation at 37C"

Phrase: "(Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.62: To identify the COOH-terminal cleavage product and to further investigate the cleavage process, a polyclonal antibody against the cytoplasmic tail of L1 (pcytL1) was used. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the COOH-terminal cleavage product"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the cleavage process,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "a polyclonal antibody against the cytoplasmic tail of L1 (pcytL1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0312620:Cytoplasmic antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.63: L1-transfected CHO cells (CHO-L1) were incubated in suspension at 37C for 1 h, and the cell pellets were lysed and analyzed by Western blotting. 

Phrase: "L1-transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(CHO-L1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "were"

Phrase: "incubated in suspension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0038960:Suspension [Biomedical or Dental Material]
   790   C1382107:Suspension [Substance]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1705537:Suspension [Functional Concept]

Phrase: "at 37C"

Phrase: "for 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "analyzed by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.64: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.65: 1 A, pcytL1 detected protein bands at 220, 85, and 32 kD in CHO-L1 cells, but not in untransfected CHO cells. 

Phrase: "1 A,"

Phrase: "pcytL1"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "protein bands at 220,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0175723:Bands [Medical Device]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "85,"

Phrase: "and"

Phrase: "32 kD in CHO-L1 cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026691:KD [Disease or Syndrome]
   753   C1705240:KD [Gene or Genome]
   753   C1839259:KD [Disease or Syndrome]

Phrase: "but"

Phrase: "not in untransfected CHO cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1518422:Not [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.66: A mAb against the ectodomain of human L1 (UJ 127.11) reacted with the 220- and the 85-kD fragment, but not with the 32-kD fragment (Fig. 1 A). 

Phrase: "A mAb against the ectodomain of human L1 (UJ 127.11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "reacted with the 220-"

Phrase: "and"

Phrase: "the 85-kD fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "not with the 32-kD fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0026691:KD [Disease or Syndrome]
   753   C0332255:fragment [Functional Concept]
   753   C1518422:Not [Functional Concept]
   753   C1705240:KD [Gene or Genome]
   753   C1708096:Fragment [Qualitative Concept]
   753   C1839259:KD [Disease or Syndrome]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.67: The latter band was also not detected by pcytL1 in CHO cells transfected with mouse L1 carrying a deletion of the cytoplasmic portion (unpublished data). 

Phrase: "The latter band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected by pcytL1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with mouse L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0441918:L1 [Finding]
   770   C1179698:L1 [Body Location or Region]
   770   C1416177:L1 [Gene or Genome]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a deletion of the cytoplasmic portion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.68: This suggested that a 32-kD fragment comprising the COOH-terminal portion of L1 remained associated with the membrane after cleavage. 

Phrase: "This"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a 32-kD fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "comprising"

Phrase: "the COOH-terminal portion of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "remained"

Phrase: "associated with the membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "after cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]
Processing 00000000.tx.69: The protein bands at 220 kD represents full-length L1. 

Phrase: "The protein bands at 220 kD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0175723:Bands [Medical Device]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "full-length L1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]
Processing 00000000.tx.70: The 85-kD L1 fragment represents the COOH-terminal fragment after proteolytic cleavage of L1 in the third FNIII repeat which contains the dibasic sequence QRKHSKRHIH (Fig. 1 B). 

Phrase: "The 85-kD L1 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the COOH-terminal fragment after proteolytic cleavage of L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "in the third FNIII repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the dibasic sequence QRKHSKRHIH"

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.71: Serine proteases like plasmin (Nayeem et al., 1999) can cleave at this site and release a soluble 140150-kD fragment into the supernatant (see below). 

Phrase: "Serine proteases like plasmin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0036734:serine proteases [Amino Acid, Peptide, or Protein,Enzyme]
   833   C2717971:Serine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1947941:Proteases [Enzyme]

Phrase: "(Nayeem et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "can"

Phrase: "cleave at this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a soluble 140150-kD fragment into the supernatant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.72: View larger version (16K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.73: L1 is shed without cytoplasmic tail. 

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "is"

Phrase: "shed without cytoplasmic tail."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1511625:Cytoplasmic Tail [Cell Component]
   770   C0010834:Cytoplasmic [Cell Component]
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.74: (A) CHO or L1-transfected CHO cells were incubated at 37C in suspension in medium without FCS for 1 h. 

Phrase: "(A) CHO"

Phrase: "or"

Phrase: "L1-transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "in medium without FCS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0150312:In [Quantitative Concept]
   770   C0332285:In [Spatial Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.75: The cell pellet was lysed and analyzed by Western blot with mAb UJ127.11 to the ectodomain or pcytL1 to the cytoplasmic domain of L1. 

Phrase: "The cell pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "analyzed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with mAb UJ127.11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to the ectodomain"

Phrase: "or"

Phrase: "pcytL1 to the cytoplasmic domain of L1."
Processing 00000000.tx.76: (B) Schematic representation of L1 cleavage fragments and their relative localization. 

Phrase: "(B) Schematic representation of L1 cleavage fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "and"

Phrase: "their relative localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]
Processing 00000000.tx.77: The location of antibody recognition sites are indicated. 

Phrase: "The location of antibody recognition sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.78: (1), mAb 5G3; 

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "mAb 5G3"

Phrase: ";"
Processing 00000000.tx.79: (2), mAb UJ 127.11; 

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "mAb UJ 127.11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.80: (3) pcytL1.  

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "pcytL1."
Processing 00000000.tx.81: L1-positive tumor cell lines were tested for the presence of the 32-kD cleavage fragment. 

Phrase: "L1-positive tumor cell lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0085983:Tumor Cell Lines [Cell]
   840   C0007600:Cell lines [Cell]
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "tested for the presence of the 32-kD cleavage fragment."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   739   C0010813:cleavage [Cell Function]
   739   C0026691:KD [Disease or Syndrome]
   739   C0332255:fragment [Functional Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0392366:tested [Intellectual Product]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C1330957:cleavage [Cell Function]
   739   C1705240:KD [Gene or Genome]
   739   C1708096:Fragment [Qualitative Concept]
   739   C1839259:KD [Disease or Syndrome]
   706 E C0022885:Test [Laboratory Procedure]
   706 E C0039593:Test [Functional Concept]
Processing 00000000.tx.82: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.83: 2 A, the 32-kD fragment was clearly detected in lysates from the breast carcinoma lines AR and SKBR3, but only minor amounts were detected in MDA-231, MDA-435, or SKOV3 cell lysates. 

Phrase: "2 A,"

Phrase: "the 32-kD fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "clearly"

Phrase: "detected in lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C1881488:Lysate [Physical Object]

Phrase: "from the breast carcinoma lines AR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0002844:Androgen [Hormone,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "SKBR3,"

Phrase: "but"

Phrase: "only minor amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "detected in MDA-231,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   770   C0026374:MDA [Geographic Area]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "MDA-435,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   861   C0026374:MDA [Geographic Area]

Phrase: "or"

Phrase: "SKOV3 cell lysates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.84: As shown by Western blot analysis in Fig. 

Phrase: "As"

Phrase: "shown by Western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.85: 2 B and by capture ELISA in Fig. 

Phrase: "2 B"

Phrase: "and by capture ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014441:ELISA [Laboratory Procedure]
   770   C1515981:And [Idea or Concept]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.86: 2 C, the level of shed L1 in the supernatants paralleled the presence of L1-32 in the cell lysate. 

Phrase: "2 C,"

Phrase: "the level of shed L1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0446432:L1 level [Body Location or Region]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "paralleled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C2348042:Parallel [Qualitative Concept]
   966   C2826345:PARALLEL [Research Activity]

Phrase: "the presence of L1-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the cell lysate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.87: A close correlation between the amount of L1 in the supernatant and the level of L1 expression was noted, suggesting that the release of L1 is an intrinsic property of many human tumor lines. 

Phrase: "A close correlation between the amount of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "the level of L1 expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0446432:L1 level [Body Location or Region]
   797   C3244092:expression level [Idea or Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the release of L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "an intrinsic property of many human tumor lines."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0871161:Property [Qualitative Concept]
   744   C1882134:Property [Conceptual Entity]
   744   C2347695:Property [Entity]
Processing 00000000.tx.88: View larger version (38K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.89: Presence of a L1-32 indicates membrane-proximal cleavage. 

Phrase: "Presence of a L1-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "indicates"

Phrase: "membrane-proximal cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
Processing 00000000.tx.90: Cells were incubated at 37C in suspension in medium without FCS for 1 h (A) Cell pellets were lysed and blotted with pcytL1 followed by ECL detection. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "in medium without FCS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0150312:In [Quantitative Concept]
   770   C0332285:In [Spatial Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "for 1 h (A) Cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0993610:pellets [Biomedical or Dental Material]
   771 E C0441436:Pellet [Manufactured Object]
   771 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "blotted with pcytL1"

Phrase: "followed by ECL detection."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C1332684:ECL [Gene or Genome]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.91: Note that a parallel blot using the secondary antibody only was negative. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "a parallel blot"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the secondary antibody only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "negative."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.92: (B) Supernatants were analyzed for the presence of shed L1 using blotting with mAb UJ127.11 to the ectodomain of human L1 followed by ECL detection. 

Phrase: "(B) Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "analyzed for the presence of shed L1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0441918:L1 [Finding]
   748   C0936012:Analyzed [Research Activity]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "blotting with mAb UJ127.11"

Phrase: "to the ectodomain"

Phrase: "of human L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "followed by ECL detection."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C1332684:ECL [Gene or Genome]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.93: (C) Supernatants were also probed for the presence of soluble L1 using a capture ELISA.  

Phrase: "(C) Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "also"

Phrase: "probed for the presence of soluble L1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   748   C1749467:soluble [Cell Component]
   748   C1948047:Soluble [Qualitative Concept]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a capture ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.94: Treatment of attached cells with PMA or pervanadate also induced shedding of L1 that can be blocked by hydroxamate-based metalloproteinase inhibitors (Gutwein et al., 2000). 

Phrase: "Treatment of attached cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "or"

Phrase: "pervanadate also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "shedding of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441918:L1 [Finding]
   790   C1179698:L1 [Body Location or Region]
   790   C1416177:L1 [Gene or Genome]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "blocked by hydroxamate-based metalloproteinase inhibitors"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   773   C1152589:metalloproteinase inhibitor [Molecular Function]
   753   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0028778:Blocked [Pathologic Function]
   753   C0178696:hydroxamate [Organic Chemical]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0332206:Blocked [Functional Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C1880279:Base [Biomedical or Dental Material]
   719 E C1999216:Inhibitor [Qualitative Concept]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "(Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.95: We examined the presence of L1-32 in AR cells after induction of cleavage in the absence or presence of BB-3103 metalloproteinase inhibitor. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the presence of L1-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in AR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C1514760:Receptor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "after induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of BB-3103 metalloproteinase inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.96: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.97: 3 A, dramatically increased levels of soluble L1 were detected in the supernatant after PMA (lane 2) or pervanadate treatment (lane 4) that were reduced to background levels in the presence of BB-3103 (lanes 3 and 5). 

Phrase: "3 A,"

Phrase: "dramatically increased levels of soluble L1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0446432:L1 level [Body Location or Region]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detected in the supernatant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1550101:Supernatant [Body Substance]

Phrase: "after PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "pervanadate treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "that"

Phrase: "were"

Phrase: "reduced to background levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0392756:Reduced [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1706907:Background [Conceptual Entity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of BB-3103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "(lanes 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.98: Surprisingly, enhanced L1 release was observed by treatment of cells with methyl--cyclodextrin (MCD) (lane 6), a drug known to interfere with membrane cholesterol levels. 

Phrase: "Surprisingly,"

Phrase: "enhanced L1 release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed by treatment of cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0007634:Cells [Cell]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3282337:Cells [Cell]
   760   C3538994:TREATMENT [Research Activity]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with methyl--cyclodextrin (MCD)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   827   C0332287:With [Qualitative Concept]
   827   C1705690:With [Intellectual Product]

Phrase: "(lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "a drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interfere with membrane cholesterol levels."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0201950:cholesterol levels [Laboratory Procedure]
   806   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   760   C0025255:Membrane [Tissue]
   760   C0441889:Levels [Qualitative Concept]
   760   C0521102:Interfere [Qualitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.99: Also, the MCD-induced release of L1 was inhibited by BB-3103 (lane 7). 

Phrase: "Also,"

Phrase: "the MCD-induced release"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   804   C0030685:Release [Health Care Activity]
   804   C0205263:Induced [Functional Concept]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "was"

Phrase: "inhibited by BB-3103"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   770   C0004739:BB [Geographic Area]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0332297:BB [Spatial Concept]

Phrase: "(lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.100: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.101: 3 B, the induction of L1 cleavage by PMA, pervanadate, or MCD clearly augmented the presence of L1-32 from a basal level in untreated cells. 

Phrase: "3 B,"

Phrase: "the induction of L1 cleavage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "pervanadate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "MCD clearly"

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "the presence of L1-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "from a basal level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "in untreated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.102: Collectively, the data suggested that L1-32 represents the portion of L1 remaining associated with the cells after shedding of the ectodomain. 

Phrase: "Collectively,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that L1-32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the portion of L1 remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "associated with the cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   802   C0699040:cell associated [Cell Component]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706221:Associate [Professional or Occupational Group]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "after shedding"

Phrase: "of the ectodomain."
Processing 00000000.tx.103: View larger version (24K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.104: Regulated cleavage of L1 is blocked by metalloproteinase inhibitor. 

Phrase: "Regulated cleavage of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "blocked by metalloproteinase inhibitor."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C1152589:metalloproteinase inhibitor [Molecular Function]
   770   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C1999216:Inhibitor [Qualitative Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.105: Attached AR cells were treated with PMA (100 ng/ml), pervanadate (200 mmolar), or MCD for 1 h at 37C in the absence or presence of BB-3103 inhibitor. 

Phrase: "Attached AR cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C1514760:Receptor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with PMA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C2825188:PMA [Intellectual Product]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(100 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(200 mmolar"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "MCD"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of BB-3103 inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.106: (A) Supernatants were immunoprecipitated with mAb to L1 coupled to Sepharose and analyzed for shed L1 using blotting with mAb UJ127.11 followed by ECL detection. 

Phrase: "(A) Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "immunoprecipitated with mAb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "to L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "coupled to Sepharose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0036681:Sepharose [Carbohydrate]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "analyzed for shed L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441918:L1 [Finding]
   770   C0936012:Analyzed [Research Activity]
   770   C1179698:L1 [Body Location or Region]
   770   C1416177:L1 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "blotting with mAb UJ127.11"

Phrase: "followed by ECL detection."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C1332684:ECL [Gene or Genome]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.107: (B) Cell pellets were lysed and blotted with pcytL1 followed by ECL detection.  

Phrase: "(B) Cell pellets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0993610:pellets [Biomedical or Dental Material]
   793 E C0441436:Pellet [Manufactured Object]
   793 E C1998480:Pellet [Quantitative Concept]
   734   C0004561:B-cell [Cell]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "blotted with pcytL1"

Phrase: "followed by ECL detection."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C1332684:ECL [Gene or Genome]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.108: Ectodomain cleavage of L1 occurs in the developing mouse brain L1 plays an important role in brain development. 

Phrase: "Ectodomain cleavage of L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1157978:ectodomain cleavage [Molecular Function]
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "occurs in the developing mouse brain L1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1521713:Mouse Brain [Tissue]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1416177:L1 [Gene or Genome]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in brain development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.109: We examined the possibility that ectodomain cleavage of L1 occurred in vivo. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the possibility"

Phrase: "that ectodomain cleavage of L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1157978:ectodomain cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.110: Mouse brains of different ages were lysed, and equal amounts of protein were analyzed by Western blotting using pcytL1. 

Phrase: "Mouse brains of different ages"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1521713:Mouse Brain [Tissue]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pcytL1."
Processing 00000000.tx.111: To avoid post-lysis cleavage of L1, the lysates were prepared in the presence of 10 mM EDTA and 2 mM 1,10 phenanthroline, conditions that are known to block metalloproteinase activity. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "post-lysis cleavage of L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "the lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared in the presence of 10 mM EDTA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   711   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "2 mM 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1418486:MM-1 [Gene or Genome]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "10 phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "metalloproteinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150224:metalloproteinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.112: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.113: 4, L1-32 was most prominent in newborn P1 mice but declined at later stages. 

Phrase: "4,"

Phrase: "L1-32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "was"

Phrase: "most prominent in newborn P1 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205402:Prominent [Qualitative Concept]

Phrase: "but"

Phrase: "declined at later stages."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   816   C1279941:late stages [Temporal Concept]
   770   C1306673:Stages [Qualitative Concept]
   737   C0205087:Late [Temporal Concept]
   737 E C0205390:Stage [Temporal Concept]
   737 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.114: The low level of L1-220 and the absence of L1-85 in E15 brain is in agreement with earlier studies using rat brain (Liljelund et al., 1994). 

Phrase: "The low level of L1-220"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0446432:L1 level [Body Location or Region]
   753   C0205251:low [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299352:Low [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C1550472:low [Idea or Concept]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the absence of L1-85"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in E15 brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with earlier studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Liljelund et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.115: Densitometric analysis of band intensities revealed a L1-220/L1-32 ratio of approximately 4:1 in P1 brain that changed at later ages. 

Phrase: "Densitometric analysis of band intensities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a L1-220/L1-32 ratio of approximately 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1 in P1 brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0445159:P1.1 [Intellectual Product]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "that"

Phrase: "changed at later ages."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0001779:Age [Organism Attribute]
   770   C0392747:Changed [Functional Concept]
   770   C0443172:Changed [Quantitative Concept]
   737   C0205087:Late [Temporal Concept]
   737 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.116: This suggests that the level of L1-32 cleavage is highest in P1 brain, but the onset of cleavage probably occurred earlier. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the level of L1-32 cleavage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0446432:L1 level [Body Location or Region]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "highest in P1 brain,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1522410:Highest [Qualitative Concept]
   737 E C0205250:High [Qualitative Concept]
   737 E C1299351:High [Qualitative Concept]
   737 E C2700149:HIGH [Intellectual Product]

Phrase: "but"

Phrase: "the onset of cleavage probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.117: These data confirm and extend the results of Liljelund, showing that the expression of L1 and the proteolytic cleavage are developmentally regulated. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the results of Liljelund,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the proteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "are"

Phrase: "developmentally"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.118: View larger version (37K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.119: L1-32 can be detected in the developing mouse brain. 

Phrase: "L1-32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "detected in the developing mouse brain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1521713:Mouse Brain [Tissue]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0442726:Detected [Finding]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.120: Mouse brains of different ages were homogenized in lysis buffer, and equal amounts of protein were analyzed by SDS-PAGE and Western blotting using pcytL1 followed by peroxidase-conjugated secondary antibodies and ECL detection.  

Phrase: "Mouse brains of different ages"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1521713:Mouse Brain [Tissue]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "homogenized in lysis buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]

Phrase: "and"

Phrase: "equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pcytL1"

Phrase: "followed by peroxidase-conjugated secondary antibodies"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0027627:secondary [Neoplastic Process]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "ECL detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.121: Expression of L1 augments cell migration Having established that ectodomain cleavage of L1 occurs in human tumor cells and during mouse brain development, we set out to explore the physiological role of the shedding process. 

Phrase: "Expression of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "Having"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that ectodomain cleavage of L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1157978:ectodomain cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "occurs in human tumor cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   806   C0431085:Tumor cells [Cell]
   797   C0427861:Human cells [Laboratory or Test Result]
   773 E C0597032:Tumor Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0086418:Human [Human]
   760   C1578706:Tumor [Intellectual Product]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3273930:Tumor [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and during mouse brain development,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1160340:brain development [Organ or Tissue Function]
   806   C1521713:Mouse Brain [Tissue]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C1527148:Development [Functional Concept]

Phrase: "we"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "explore"

Phrase: "the physiological role of the shedding process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.122: In the brain, L1 plays an important role in the migration of neural cells. 

Phrase: "In the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the migration of neural cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.123: Therefore, we examined the role of L1 and its ectodomain cleavage process in cell migration. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the role of L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "its ectodomain cleavage process in cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1622501:Migration, Cell [Cell Function]
   799   C0600210:Migration [Social Behavior]
   799   C1533574:Migration [Physiologic Function]
   799   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.124: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.125: 5 A, we observed that CHO cells stably transfected with mouse or human L1 (mL1-CHO or hL1-CHO cells) showed a three- to fivefold increase in haptotactic migration on fibronectin compared with CHO cells. 

Phrase: "5 A,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that CHO cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "human L1 (mL1-CHO"

Phrase: "or"

Phrase: "hL1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a three-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "to fivefold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in haptotactic migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "on fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compared with CHO cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: In contrast, CHO cells expressing L1 in which both RGD sites were mutated to RGE (mL1-mutIII-CHO) or those expressing mutant forms of L1 containing either the cytoplasmic and transmembrane portion of L-selectin (L1/L-selectin) or the ectodomain of L-selectin (L-selectin/L1) did not show increased migration (Fig. 5 A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "L1 in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441918:L1 [Finding]
   790   C1179698:L1 [Body Location or Region]
   790   C1416177:L1 [Gene or Genome]

Phrase: "both RGD sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "mutated to RGE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "(mL1-mutIII-CHO)"

Phrase: "or"

Phrase: "those expressing mutant forms of L1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either"

Phrase: "the cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "transmembrane portion of L-selectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "(L1/L-selectin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C1335808:L-SELECTIN [Gene or Genome]
   827   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1325391:selectin [Molecular Function]

Phrase: ")"

Phrase: "or"

Phrase: "the ectodomain of L-selectin"

Phrase: "(L-selectin/L1)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]
   734   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   734   C1335808:L-SELECTIN [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "increased migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "(Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.127: The transfected CHO cells expressed L1 or the chimeric forms of L1 at comparable level as detected by FACS analysis (Fig. 5 B). 

Phrase: "The transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "or"

Phrase: "the chimeric forms of L1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "at comparable level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "detected by FACS analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 5 B"

Phrase: ")."
Processing 00000000.tx.128: View larger version (141K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(141K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.129: Expression of L1 enhances haptotactic migration of CHO cells. 

Phrase: "Expression of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "haptotactic migration of CHO cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.130: (A) FN at 10 mg/ml or BSA for control were coated on the backside of Transwell chambers. 

Phrase: "(A) FN at 10 mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "BSA for control"

Phrase: "were"

Phrase: "coated on the backside of Transwell chambers."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0179874:chambers [Medical Device]
   748   C1522408:Coated [Qualitative Concept]
   714 E C0453946:Coat [Manufactured Object]
   714 E C0935616:Chamber [Body Part, Organ, or Organ Component]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.131: CHO, h/mL1-CHO or mL1-mutIII-CHO cells stably expressing L1 devoid of RGDs were seeded into the top chamber and allowed to transmigrate for 16 h at 37C. 

Phrase: "CHO,"

Phrase: "h/mL1-CHO"

Phrase: "or"

Phrase: "mL1-mutIII-CHO cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "devoid of RGDs"

Phrase: "were"

Phrase: "seeded into the top chamber"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1704458:Top [Spatial Concept]
   726   C0036563:Seed [Plant]
   726   C1705192:Seed [Laboratory Procedure]
   726   C1882540:{Seed} [Quantitative Concept]
   726   C2346495:Seed [Conceptual Entity]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transmigrate for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.132: Each determination was done in quadruplicate and transmigrated cells were stained from the back of the filter. 

Phrase: "Each determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "done in quadruplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205175:Quadruplicate [Quantitative Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]

Phrase: "and"

Phrase: "transmigrated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained from the back of the filter."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0205095:Back of [Spatial Concept]
           Back
   748   C0004600:Back [Body Location or Region]
   748   C0180860:Filter [Manufactured Object]
   748   C0460009:Back [Body Location or Region]
   748   C0581406:Filter [Medical Device]
   748   C1522664:Filter [Intellectual Product]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]
   748   C1995000:Back [Body Location or Region]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.133: The dye was eluted from the filter and measured at 595 nm. 

Phrase: "The dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "eluted from the filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0180860:Filter [Manufactured Object]
   770   C0581406:Filter [Medical Device]
   770   C1522664:Filter [Intellectual Product]
   770   C1704449:Filter [Conceptual Entity]
   770   C1704684:Filter [Medical Device]
   770   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "measured at 595 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.134: The amount of dye is proportional to the number of transmigrated cells. 

Phrase: "The amount of dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "is"

Phrase: "proportional to the number of transmigrated cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205351:Proportional [Qualitative Concept]
Processing 00000000.tx.135: Values for the migration on BSA were below 0.25 OD units for each cell type. 

Phrase: "Values for the migration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "on BSA"

Phrase: "were below 0.25 OD units"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0439164:OD units [Quantitative Concept]
           OD
   753   C0029421:OD [Disease or Syndrome]
   753   C0439148:Units [Quantitative Concept]
   753   C1512019:OD [Intellectual Product]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "for each cell type."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.136: (B) Staining of CHO-transfected cells used in (A) with mAbs to human or mouse L1, respectively. 

Phrase: "(B) Staining of CHO-transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in (A) with mAbs"

Phrase: "to human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "or"

Phrase: "mouse L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.137: (C) Analysis of CHO and mL1-CHO cell migration on vitronectin or laminin (each coated at 10 mg/ml). 

Phrase: "(C) Analysis of CHO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "mL1-CHO cell migration on vitronectin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1622501:Migration, Cell [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "or"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "each"

Phrase: "coated at 10 mg/ml"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0439294:mg ml [Quantitative Concept]
   760   C0439269:mg% [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]
   760   C1522408:Coated [Qualitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.138: Analysis of migrated cells was done as described in A. 

Phrase: "Analysis of migrated cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "done"

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.139: (D) Doseresponse curve for the migration of CHO and mL1-CHO cells. 

Phrase: "("

Phrase: "D)"

Phrase: "Doseresponse curve for the migration of CHO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0683162:dose-response curve [Quantitative Concept]
   748   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "mL1-CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.140: The assay was done as described in A. 

Phrase: "The assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "done"

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.141: (E) FN or BSA for control were coated on LABTEK chamber slides, and the adhesion of CHO cells and transfectants was determined in the presence of 2 mM Ca 21 and 2 mM Mg21. 

Phrase: "(E) FN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "BSA for control"

Phrase: "were"

Phrase: "coated on LABTEK chamber slides,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0444330:slides [Research Device]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C1705201:Slide [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the adhesion of CHO cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007577:Cell Adhesion [Cell Function]
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "transfectants"

Phrase: "was"

Phrase: "determined in the presence of 2 mM Ca 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0596235:CA+2 [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "2 mM Mg21."
Processing 00000000.tx.142: Binding to BSA was below 50 cells/area. 

Phrase: "Binding to BSA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "was below 50 cells/area."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0017446:Area [Geographic Area]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0205146:Area [Spatial Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.143: (F) Cells were grown on coverslips, stained with mAb 324 to mouse L1, and analyzed by fluorescence microscopy. 

Phrase: "(F) Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on coverslips,"

Phrase: "stained with mAb 324"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to mouse L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "analyzed by fluorescence microscopy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.144: (G) Cells were cultivated for 24 h and TCA-precipitated supernatants and cell lysates were analyzed. 

Phrase: "(G) Cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0524983:G Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0439267:g% [Quantitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultivated for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "TCA-precipitated supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.145: After SDS-PAGE, L1 was detected by Western blotting and ECL detection using anti L1 antibodies.  

Phrase: "After SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "was"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "ECL detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti L1 antibodies."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.146: A similar difference in cell migration between mL1-CHO or CHO cells was also observed on vitronectin or laminin as the migration substrate (Fig. 5 C and see below). 

Phrase: "A similar difference in cell migration between mL1-CHO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1622501:Migration, Cell [Cell Function]
   742   C0600210:Migration [Social Behavior]
   742   C1533574:Migration [Physiologic Function]
   742   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "or"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "observed on vitronectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1336937:VITRONECTIN [Gene or Genome]
   790   C1441672:Observed [Functional Concept]

Phrase: "or"

Phrase: "laminin as the migration substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 5 C"

Phrase: "and"

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.147: As shown in the doseresponse curve in Fig. 

Phrase: "As"

Phrase: "shown in the doseresponse curve"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0683162:dose-response curve [Quantitative Concept]
   760   C0205134:Curve [Spatial Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.148: 5 D, the difference in migration between CHO and mL1-CHO cells was detectable over a wide range of input cell numbers (between 104 and 5 x 105). 

Phrase: "5 D,"

Phrase: "the difference in migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between CHO"

Phrase: "and"

Phrase: "mL1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "detectable over a wide range of input cell numbers"

Phrase: "("

Phrase: "between 104"

Phrase: "and"

Phrase: "5 x 105"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.149: To exclude the possibility that the transfection had altered the integrin profiles, the static adhesion to fibronectin was examined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "had"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the integrin profiles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "the static adhesion to fibronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.150: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.151: 5 E, there was no difference in the adhesion to fibronectin between CHO cells and transfected sublines. 

Phrase: "5 E,"

Phrase: "there"

Phrase: "was"

Phrase: "no difference in the adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "to fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "between CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "transfected sublines."
Processing 00000000.tx.152: Similar observations were made with vitronectin as substrate (unpublished data). 

Phrase: "Similar observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "were"

Phrase: "made with vitronectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1336937:VITRONECTIN [Gene or Genome]
   756   C1881534:Make [Functional Concept]

Phrase: "as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.153: The adhesion of CHO and mL1-CHO cells to fibronectin was blocked in both cases with mAb SAM-1 to the 5 integrin that is highly expressed by CHO cells (unpublished data). 

Phrase: "The adhesion of CHO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "mL1-CHO cells to fibronectin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "blocked in both cases"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "with mAb SAM-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0036002:SAM [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0279268:SAM [Therapeutic or Preventive Procedure]
   827   C1563296:SAM [Pathologic Function]

Phrase: "to the 5 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "that"

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed by CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.154: To analyze whether the structural changes introduced into L1 had affected the membrane localization, cells were also analyzed by fluorescent microscopy (Fig. 5 F). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "whether"

Phrase: "the structural changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0678594:Structural [Spatial Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "introduced into L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0441918:L1 [Finding]
   790   C1179698:L1 [Body Location or Region]
   790   C1416177:L1 [Gene or Genome]
   756   C1292748:introduce [Functional Concept]

Phrase: "had"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the membrane localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "analyzed by fluorescent microscopy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:FLUORESCENT MICROSCOPY [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0936012:Analyzed [Research Activity]

Phrase: "(Fig. 5 F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.155: The membrane localization of mL1-mutIII was not different from wild-type L1. 

Phrase: "The membrane localization of mL1-mutIII"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "not different from wild-type L1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.156: In contrast, CHO-62 cells carrying the cytoplasmic tail of L-selectin showed a different L1 distribution. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "CHO-62 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the cytoplasmic tail of L-selectin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1511625:Cytoplasmic Tail [Cell Component]
   753   C0010834:Cytoplasmic [Cell Component]
   753   C0039259:Tail [Body Part, Organ, or Organ Component]
   753   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a different L1 distribution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.157: In addition to surface staining (Fig. 5 B), L1 was localized in a region close to the nucleus. 

Phrase: "In addition to surface staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "(Fig. 5 B"

Phrase: ")"

Phrase: ","

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "was"

Phrase: "localized in a region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C0392752:Localized [Spatial Concept]

Phrase: "close to the nucleus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C0587267:Close [Functional Concept]
Processing 00000000.tx.158: The cells appeared also larger in morphology with a more rounded-up appearance. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "also larger in morphology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443228:larger [Quantitative Concept]
   770   C0549177:Larger [Quantitative Concept]
   770   C1704243:Larger [Quantitative Concept]

Phrase: "with a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "rounded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Rounded [Spatial Concept]

Phrase: "-"

Phrase: "up appearance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]
Processing 00000000.tx.159: Despite their inability to migrate, CHO-62 cells released significantly more L1 into the supernatant than wild-type CHO-L1 cells (Fig. 5 G). 

Phrase: "Despite their inability to"

Phrase: "migrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrate [Functional Concept]

Phrase: ","

Phrase: "CHO-62 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "significantly more L1 into the supernatant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441918:L1 [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]

Phrase: "than wild-type CHO-L1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0449475:type cell [Intellectual Product]
   853   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5 G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.160: The v5 integrin is involved in enhanced cell migration We investigated the difference in migration between mL1-CHO cells and CHO cells in more detail using blocking mAbs. 

Phrase: "The v5 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "is"

Phrase: "involved in enhanced cell migration"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1622501:Migration, Cell [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0600210:Migration [Social Behavior]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1533574:Migration [Physiologic Function]
   760   C1704653:Cell [Medical Device]
   760   C1881827:MIGRATION [Phenomenon or Process]
   760   C1948049:Cell [Spatial Concept]
   760   C2349975:Enhanced [Activity]

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the difference in migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between mL1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CHO cells in more detail"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "blocking mAbs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.161: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.162: 6 A, mAb P1F6 to human v5 crossreacted with hamster integrins and could inhibit the migration of mL1-CHO cells to the level of CHO cells. 

Phrase: "6 A,"

Phrase: "mAb P1F6 to human v5"

Phrase: "crossreacted with hamster integrins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018557:Hamster [Mammal]
   770   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "could"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the migration of mL1-CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1622501:cells migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.163: Importantly, there was no effect of the v5-specific mAb on the migration of CHO cells. 

Phrase: "Importantly,"

Phrase: "there"

Phrase: "was"

Phrase: "no effect of the v5-specific mAb"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "of CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: Additional FACS analysis with mAb P1F6 showed no difference in the expression level of the v5 integrin (Fig. 6 B). 

Phrase: "Additional FACS analysis with mAb P1F6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no difference in the expression level of the v5 integrin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "(Fig. 6 B"

Phrase: ")."
Processing 00000000.tx.165: The migration of mL1-CHO was also efficiently blocked in the presence of mAb 324 against mouse L1, but not by the isotype-matched control mAb 79 (Fig. 6 A). 

Phrase: "The migration of mL1-CHO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "also efficiently"

Phrase: "blocked in the presence of mAb 324"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0028778:Blocked [Pathologic Function]
   748   C0332206:Blocked [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "against mouse L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "but"

Phrase: "not by the isotype-matched control mAb 79"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0150103:matched [Research Activity]
   744   C0243148:control [Qualitative Concept]
   744   C1518422:Not [Functional Concept]
   744   C1550141:Control [Substance]
   744   C1708943:Matched [Qualitative Concept]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 6 A"

Phrase: ")."
Processing 00000000.tx.166: View larger version (81K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.167: Inhibition of cell migration by antibodies and metalloproteinase inhibitor. 

Phrase: "Inhibition of cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1524058:inhibition of cell migration [Cell Function]
           Cell Migration Inhibition
   881   C0007607:Cell Migration Inhibition [Laboratory Procedure]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "metalloproteinase inhibitor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.168: (A) ML1-CHO cells or CHO cells were preincubated with the indicated mAbs at 10 mg/ml and added to the upper compartment of the Transwell chamber coated with FN from the backside. 

Phrase: "(A) ML1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with the indicated mAbs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444656:Indicated [Finding]
   726   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at 10 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "added to the upper compartment of the Transwell chamber"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0935616:Chamber [Body Part, Organ, or Organ Component]
   742   C1185625:Compartment [Body Space or Junction]
   742   C1282910:Upper [Spatial Concept]
   742   C1524062:Added [Functional Concept]
   742   C2986730:Compartment [Spatial Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "coated with FN"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "from the backside."
Processing 00000000.tx.169: Note that antibody was present during the assay time. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "present during the assay time."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.170: (B) Staining of CHO and mL1-CHO cells with a mAb to v5 integrin. 

Phrase: "(B) Staining of CHO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "mL1-CHO cells with a mAb"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0085080:CHO Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "to v5 integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.171: (C) ML1-CHO cells or CHO cells were preincubated with the indicated amount of BB-3103 inhibitor for 2 h and then transferred to the upper compartment of the Transwell chamber. 

Phrase: "(C) ML1-CHO cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   886   C0229579:C-Cell [Cell]
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with the indicated amount of BB-3103 inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   742   C0004739:BB [Geographic Area]
   742   C0332297:BB [Spatial Concept]
   742   C1265611:Amount [Quantitative Concept]
   742   C1444656:Indicated [Finding]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred to the upper compartment of the Transwell chamber."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   742   C0348011:transferred [Functional Concept]
   742   C0935616:Chamber [Body Part, Organ, or Organ Component]
   742   C1185625:Compartment [Body Space or Junction]
   742   C1282910:Upper [Spatial Concept]
   742   C2986730:Compartment [Spatial Concept]
   708 E C0040671:Transfer [Mental Process]
   708 E C1705822:Transfer [Activity]
Processing 00000000.tx.172: Each determination was done in quadruplicate and transmigrated cells were stained from the backside of the filter as described in Fig. 

Phrase: "Each determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "done in quadruplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205175:Quadruplicate [Quantitative Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]

Phrase: "and"

Phrase: "transmigrated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained from the backside of the filter"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0180860:Filter [Manufactured Object]
   748   C0581406:Filter [Medical Device]
   748   C1522664:Filter [Intellectual Product]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.173: 5 A. 

Phrase: "5 A."
Processing 00000000.tx.174: (D) Inhibition of cell migration by a mAb to the 5 integrin. 

Phrase: "("

Phrase: "D)"

Phrase: "Inhibition of cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1524058:inhibition of cell migration [Cell Function]
           Cell Migration Inhibition
   881   C0007607:Cell Migration Inhibition [Laboratory Procedure]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by a mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to the 5 integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.175: ML1-CHO or CHO cells were preincubated with the mAbs at 10 mg/ml and added to the upper compartment of the Transwell chamber coated with FN.  

Phrase: "ML1-CHO"

Phrase: "or"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with the mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at 10 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "added to the upper compartment of the Transwell chamber"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0935616:Chamber [Body Part, Organ, or Organ Component]
   742   C1185625:Compartment [Body Space or Junction]
   742   C1282910:Upper [Spatial Concept]
   742   C1524062:Added [Functional Concept]
   742   C2986730:Compartment [Spatial Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "coated with FN."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.176: To rule out the possibility that CHO and mL1-CHO cells used different integrins to migrate on fibronectin, additional blocking experiments were carried out. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that CHO"

Phrase: "and"

Phrase: "mL1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different integrins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "migrate on fibronectin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0232902:migrate [Functional Concept]

Phrase: "additional blocking experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.177: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.178: 6 D, mAb SAM-1 to the 5 integrin also could efficiently block the transmigration. 

Phrase: "6 D,"

Phrase: "mAb SAM-1 to the 5 integrin also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0036002:SAM [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0279268:SAM [Therapeutic or Preventive Procedure]
   744   C1563296:SAM [Pathologic Function]

Phrase: "could"

Phrase: "efficiently"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the transmigration."
Processing 00000000.tx.179: Most importantly, both CHO and mL1-CHO cells were equally well blocked by the mAb. 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "both CHO"

Phrase: "and"

Phrase: "mL1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "equally well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "blocked by the mAb."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.180: These results indicated that altered integrin levels or altered integrin usage were not the reason for the improved cell migration of L1-CHO cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that altered integrin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "altered integrin usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0457083:Usage [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the reason for the improved cell migration of L1-CHO cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0392360:Reason [Idea or Concept]
Processing 00000000.tx.181: We also reinvestigated the migration of CHO and mL1-CHO cells on laminin. 

Phrase: "We also"

Phrase: "reinvestigated"

Phrase: "the migration of CHO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "mL1-CHO cells on laminin."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.182: The migration of both type of cells was nearly completely blocked by mAb GoH3 against CD49f. 

Phrase: "The migration of both type of cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1622501:cells migration [Cell Function]
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "nearly completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by mAb GoH3"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "against CD49f."
Processing 00000000.tx.183: Similar to fibronectin, mAb P1F6 to the v5 integrin did not affect the migration of CHO cells, but the enhanced migration of mL1-CHO cells was reduced again to the level of CHO cells (unpublished data). 

Phrase: "Similar to fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "mAb P1F6 to the v5 integrin"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the migration of CHO cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "but"

Phrase: "the enhanced migration of mL1-CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1622501:cells migration [Cell Function]
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "again to the level of CHO cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0085080:CHO Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.184: We concluded that in transfected cells the presence of L1 led to an enhanced cell migration on different substrates that specifically involved the v5 integrin, and that the elimination of RGDs in L1 abolished the augmenting effect on cell migration (Figs. 5 A and 6 A). 

Phrase: "We"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the presence of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "led to an enhanced cell migration"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   790   C1622501:Migration, Cell [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0600210:Migration [Social Behavior]
   753   C1269647:Cell [Cell]
   753   C1533574:Migration [Physiologic Function]
   753   C1704653:Cell [Medical Device]
   753   C1708698:LED [Manufactured Object]
   753   C1881827:MIGRATION [Phenomenon or Process]
   753   C1948049:Cell [Spatial Concept]
   753   C2349975:Enhanced [Activity]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "on different substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "that specifically"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "the v5 integrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "that"

Phrase: "the elimination of RGDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0221102:Elimination [Physiologic Function]

Phrase: "in L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "abolished"

Phrase: "the augmenting effect on cell migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(Figs. 5 A"

Phrase: "and"

Phrase: "6 A"

Phrase: ")."
Processing 00000000.tx.185: Inhibition of L1 ectodomain shedding blocks enhanced cell migration We investigated the possibility that L1 shedding was crucial for the enhanced migration of L1-CHO cells. 

Phrase: "Inhibition of L1 ectodomain shedding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "enhanced cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1622501:Migration, Cell [Cell Function]
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the possibility"

Phrase: "that L1 shedding"

Phrase: "was"

Phrase: "crucial for the enhanced migration of L1-CHO cells."
Processing 00000000.tx.186: Cells were pretreated with BB-3103 and the haptotactic migration on FN was analyzed. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with BB-3103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   770   C0004739:BB [Geographic Area]
   770   C0332297:BB [Spatial Concept]

Phrase: "and"

Phrase: "the haptotactic migration on FN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.187: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.188: 6 C, the metalloproteinase inhibitor reduced the migration of mL1-CHO cells back to the level of CHO cells in a dose-dependent manner. 

Phrase: "6 C,"

Phrase: "the metalloproteinase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the migration of mL1-CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1622501:cells migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "back to the level of CHO cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   789   C1621432:back of cell [Cell Component]
   774   C0205095:Back of [Spatial Concept]
           Back
   748   C0004600:Back [Body Location or Region]
   748   C0460009:Back [Body Location or Region]
   748   C1995000:Back [Body Location or Region]

Phrase: "in a dose-dependent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]
Processing 00000000.tx.189: The inhibitor did not effect the migration of CHO cells, although a slight reduction might have been undetected due to the low level of migration of these cells. 

Phrase: "The inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "the migration of CHO cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "although"

Phrase: "a slight reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "might"

Phrase: "have"

Phrase: "been"

Phrase: "undetected due to the low level of migration of these cells."
Processing 00000000.tx.190: Similar results were obtained with the Ro 31-9790 inhibitor (unpublished data). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with the Ro 31-9790 inhibitor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   814   C0385836:Ro 31-9790 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0035826:RO [Geographic Area]
   748   C0450355:31 [Intellectual Product]
   748   C1301820:Obtained [Functional Concept]
   748   C1413096:RO [Gene or Genome]
   748   C1999216:Inhibitor [Qualitative Concept]
   748   C2987048:RO [Gene or Genome]
   714 E C1706701:Obtain [Activity]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.191: We concluded that for L1-CHO cells, the metalloproteinase inhibitors exerted a similar effect on the haptotactic migration as the mAb to the v5 integrin. 

Phrase: "We"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that for L1-CHO cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the metalloproteinase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "a similar effect on the haptotactic migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "as the mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to the v5 integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.192: Both compounds did not block the migration of the cells completely but rather selectively effected the enhanced cell migration caused by the presence of L1. 

Phrase: "Both compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the migration of the cells completely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1622501:cells migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "but"

Phrase: "rather selectively"

Phrase: "effected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1280500:Effect [Qualitative Concept]
   966   C2348382:Effect [Qualitative Concept]

Phrase: "the enhanced cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1622501:Migration, Cell [Cell Function]
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "caused by the presence of L1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0441918:L1 [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.193: Soluble L1 can stimulate migration of CHO cells We hypothesized that cleaved L1 might deliver an autocrine signal to the cells and thereby promote enhanced migration. 

Phrase: "Soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "stimulate"

Phrase: "migration of CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1622501:cells migration [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that cleaved L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "might"

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "an autocrine signal to the cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0037083:signal cell [Cell Function]
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "thereby"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "enhanced migration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.194: According to this hypothesis, the addition of soluble L1 should enhance the migration of CHO cells. 

Phrase: "According to this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "the addition of soluble L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "should"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the migration of CHO cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.195: To test this assumption, CHO cells were first exposed to conditioned medium from L1-positive cells, and the effect on the haptotactic migration was analyzed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this assumption,"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "exposed to conditioned medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0009458:Medium [Intellectual Product]
   770   C0009647:Conditioned [Mental Process]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "from L1-positive cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the effect on the haptotactic migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.196: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.197: 7 A, the medium from L1-CHO but not CHO cells could stimulate cell migration that was of similar magnitude as L1-CHO cells. 

Phrase: "7 A,"

Phrase: "the medium from L1-CHO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "but"

Phrase: "not CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "stimulate"

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "that"

Phrase: "was of similar magnitude"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0449286:magnitude [Quantitative Concept]
   770   C1421478:WAS [Gene or Genome]
   770   C1704240:Magnitude [Quantitative Concept]
   770   C2348205:Similar [Qualitative Concept]

Phrase: "as L1-CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.198: The stimulatory activity was also present in the conditioned medium of AR tumor cells but was absent when AR cells or L1-CHO cells were cultivated in the presence of BB-3103 in order to block shedding. 

Phrase: "The stimulatory activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "present in the conditioned medium of AR tumor cells"
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
   760   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0431085:Tumor cells [Cell]
   760   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   741   C1514760:Receptor Cell [Cell]
   739   C0002844:Androgen [Hormone,Pharmacologic Substance]
   739   C0007634:Cells [Cell]
   739   C0009458:Medium [Intellectual Product]
   739   C0009647:Conditioned [Mental Process]
   739   C0027651:Tumor [Neoplastic Process]
   739   C0150312:Present [Quantitative Concept]
   739   C0439536:Medium [Quantitative Concept]
   739   C0449450:Present [Idea or Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1578706:Tumor [Intellectual Product]
   739   C1705217:Medium [Substance]
   739   C3244283:medium [Intellectual Product]
   739   C3273930:Tumor [Finding]
   739   C3282337:Cells [Cell]
   739   C3536949:Androgen [Pharmacologic Substance]
   726 E C0597032:Tumor Cell [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "was"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "when"

Phrase: "AR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C1514760:Receptor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "L1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultivated in the presence of BB-3103"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   748   C0004739:BB [Geographic Area]
   748   C0332297:BB [Spatial Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "shedding."
Processing 00000000.tx.199: To further prove that the activity was mediated by soluble L1, we used a recombinant L1-Fc protein (Fig. 7 B). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "prove"

Phrase: "that"

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "mediated by soluble L1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0441918:L1 [Finding]
   770   C1179698:L1 [Body Location or Region]
   770   C1416177:L1 [Gene or Genome]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a recombinant L1-Fc protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 7 B"

Phrase: ")."
Processing 00000000.tx.200: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.201: 7 C, the L1-Fc protein but not a control protein (SART-1-Fc) could stimulate CHO migration like conditioned medium containing native L1. 

Phrase: "7 C,"

Phrase: "the L1-Fc protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a control protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(SART-1-Fc)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2983605:FC [Activity]

Phrase: "could"

Phrase: "stimulate"

Phrase: "CHO migration like conditioned medium containing native L1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0600210:Migration [Social Behavior]
   744   C1533574:Migration [Physiologic Function]
   744   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.202: We concluded that soluble L1 can stimulate cell migration. 

Phrase: "We"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "stimulate"

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.203: View larger version (61K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(61K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.204: Exogenous addition of soluble L1 enhances migration of CHO cells. 

Phrase: "Exogenous addition of soluble L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "migration of CHO cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1622501:cells migration [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.205: (A) CHO cells in the presence of the indicated conditioned media (1:10 final dilution) were seeded into the upper compartment of the Transwell chamber coated with FN from the backside and allowed to transmigrate for 16 h at 37C. 

Phrase: "(A) CHO cells in the presence of the indicated conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   772   C0427850:Presence of cells [Laboratory or Test Result]
   756   C0085080:CHO Cells [Cell]
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10 final dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "seeded into the upper compartment of the Transwell chamber"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0935616:Chamber [Body Part, Organ, or Organ Component]
   742   C1185625:Compartment [Body Space or Junction]
   742   C1282910:Upper [Spatial Concept]
   742   C2986730:Compartment [Spatial Concept]
   708   C0036563:Seed [Plant]
   708   C1705192:Seed [Laboratory Procedure]
   708   C1882540:{Seed} [Quantitative Concept]
   708   C2346495:Seed [Conceptual Entity]

Phrase: "coated with FN"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "from the backside"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transmigrate for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.206: (B) Schematic representation of the L1-Fc and L1-Fc mut III fusion proteins. 

Phrase: "(B) Schematic representation of the L1-Fc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "and"

Phrase: "L1-Fc mut III fusion proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C2945616:iii protein [Amino Acid, Peptide, or Protein]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.207: (C) CHO cells in the presence of the indicated Fc fusion protein (final concentration 0.67 mg/ml) were seeded into the upper compartment of the Transwell chamber. 

Phrase: "(C) CHO cells in the presence of the indicated Fc fusion protein"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   767   C0427850:Presence of cells [Laboratory or Test Result]
   753   C0085080:CHO Cells [Cell]
   736   C0007634:Cells [Cell]
   736   C3282337:Cells [Cell]
   734   C0007594:Cell Fusion [Laboratory Procedure]
   734   C0229579:C-Cell [Cell]
   734   C1261468:Cell fusion [Cell Function]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "(final concentration 0.67 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "seeded into the upper compartment of the Transwell chamber."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0935616:Chamber [Body Part, Organ, or Organ Component]
   742   C1185625:Compartment [Body Space or Junction]
   742   C1282910:Upper [Spatial Concept]
   742   C2986730:Compartment [Spatial Concept]
   708   C0036563:Seed [Plant]
   708   C1705192:Seed [Laboratory Procedure]
   708   C1882540:{Seed} [Quantitative Concept]
   708   C2346495:Seed [Conceptual Entity]
Processing 00000000.tx.208: (D) ML1-CHO cells were pretreated with BB-3103 to prevent L1 shedding and haptotactic migration. 

Phrase: "("

Phrase: "D)"

Phrase: "ML1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with BB-3103 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   760   C0004739:BB [Geographic Area]
   760   C0332297:BB [Spatial Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "L1 shedding"

Phrase: "and"

Phrase: "haptotactic migration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.209: Cells were then seeded together with the indicated Fc fusion proteins into the upper compartment of the Transwell chamber. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "seeded together with the indicated Fc fusion proteins"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]
   744   C1444656:Indicated [Finding]
   744   C1883357:Together [Qualitative Concept]
   744   C2983605:FC [Activity]
   737   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   711   C0036563:Seed [Plant]
   711   C1705192:Seed [Laboratory Procedure]
   711   C1882540:{Seed} [Quantitative Concept]
   711   C2346495:Seed [Conceptual Entity]

Phrase: "into the upper compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "of the Transwell chamber."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.210: Each determination was done in quadruplicates and transmigrated cells were stained from the backside of the filter as described in Fig. 

Phrase: "Each determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "done in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1272695:Done [Qualitative Concept]
   833   C2746065:Done [Temporal Concept]

Phrase: "quadruplicates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205175:Quadruplicate [Quantitative Concept]

Phrase: "and"

Phrase: "transmigrated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained from the backside of the filter"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0180860:Filter [Manufactured Object]
   748   C0581406:Filter [Medical Device]
   748   C1522664:Filter [Intellectual Product]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.211: 5 A.  

Phrase: "5 A."
Processing 00000000.tx.212: The effect of soluble L1 is blocked by a mAb to v5 and requires RGDs in L1 To determine whether the migration promoting effect of soluble L1 required a direct binding to v5 integrin, antibody blocking experiments were performed. 

Phrase: "The effect of soluble L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "blocked by a mAb"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "to v5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "requires"

Phrase: "RGDs in L1 To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1335588:RGDS [Gene or Genome]

Phrase: "determine"

Phrase: "whether"

Phrase: "the migration promoting effect of soluble L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "a direct binding to v5 integrin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1149503:Integrin Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "antibody blocking experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   717   C0282682:antibody block [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.213: Indeed, as shown in Fig. 

Phrase: "Indeed,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.214: 7 C, the migration-promoting effect of soluble L1 was efficiently blocked in the presence of the antibody to v5. 

Phrase: "7 C,"

Phrase: "the migration-promoting effect of soluble L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "efficiently"

Phrase: "blocked in the presence of the antibody"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   757   C0282682:antibody block [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0332206:Blocked [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "to v5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]
Processing 00000000.tx.215: Previously, it has been shown that conserved RGD sites in Ig domain 6 of L1 can support binding to integrins (Ruppert et al., 1995; Ebeling et al., 1996; Montgomery et al., 1996; Felding-Habermann et al., 1997; Oleszewski et al., 1999). 

Phrase: "Previously,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that conserved RGD sites in Ig domain 6 of L1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   741   C2945843:Site of [Qualitative Concept]
   739   C0205145:Sites [Spatial Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]

Phrase: "can"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "binding to integrins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C1149503:Integrin Binding [Molecular Function]
   790   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "(Ruppert et al.,"

Phrase: "1995"

Phrase: "; Ebeling et al.,"

Phrase: "1996"

Phrase: "; Montgomery et al.,"

Phrase: "1996"

Phrase: "; Felding-Habermann et al.,"

Phrase: "1997"

Phrase: "; Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.216: To analyze whether the RGD sites were necessary for the migration-promoting effect of soluble L1, we used an L1-Fc protein in which the RGDs were mutated to RGE (L1-Fc mut III). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "whether"

Phrase: "the RGD sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "necessary for the migration-promoting effect of soluble L1,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an L1-Fc protein in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the RGDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335588:RGDS [Gene or Genome]

Phrase: "were"

Phrase: "mutated to RGE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "(L1-Fc mut III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.217: We have reported before that L1-Fc mut III does not support integrin-mediated cell binding of mouse B16F10 or IH3 cells (Oleszewski et al., 1999). 

Phrase: "We"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "that L1-Fc mut III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "integrin-mediated cell binding of mouse B16F10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1149503:Integrin Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "IH3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.218: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.219: 7 C, the L1-Fc mut III proteins were unable to stimulate CHO migration. 

Phrase: "7 C,"

Phrase: "the L1-Fc mut III proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   823   C2945616:iii protein [Amino Acid, Peptide, or Protein]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "stimulate"

Phrase: "CHO migration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.220: Additional controls revealed that similar amounts of L1-Fc and L1-Fc mut III fusion proteins were present in the assay and that both Fc proteins could efficiently bind to immobilized neurocan (unpublished data). 

Phrase: "Additional controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that similar amounts of L1-Fc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "L1-Fc mut III fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C2945616:iii protein [Amino Acid, Peptide, or Protein]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "present in the assay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "that"

Phrase: "both Fc proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "efficiently"

Phrase: "bind to immobilized neurocan"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1413764:NEUROCAN [Gene or Genome]
   770   C2326566:Neurocan [Amino Acid, Peptide, or Protein]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.221: Like CHO cells, ML1mutIII CHO cells were able to migrate in response to soluble L1-Fc (unpublished data). 

Phrase: "Like CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "ML1mutIII CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "migrate in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0232902:migrate [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to soluble L1-Fc (unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.222: We next investigated whether the metalloproteinase-inhibiting effect on L1-CHO migration could be overcome by the addition of exogenous L1. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the metalloproteinase-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "effect on L1-CHO migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "overcome by the addition of exogenous L1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2983310:Overcome [Activity]
Processing 00000000.tx.223: Indeed, as shown in Fig. 

Phrase: "Indeed,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.224: 7 D, BB-3103 pretreated L1-CHO cells migrated well on fibronectin in response to L1-Fc protein. 

Phrase: "7 D,"

Phrase: "BB-3103 pretreated L1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0085080:CHO Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "well on fibronectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205170:Well [Qualitative Concept]
   790   C3146287:Well [Manufactured Object]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to L1-Fc protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.225: Collectively, these results suggested that one effect of the metalloproteinase inhibitor was to prevent the shedding of L1 and the subsequent autocrine/paracrine signaling via v5 integrins. 

Phrase: "Collectively,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that one effect of the metalloproteinase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the shedding of L1"

Phrase: "and"

Phrase: "the subsequent autocrine/paracrine signaling via v5 integrins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0525011:Paracrine Signaling [Cell Function]
   767   C0525010:Autocrine Signaling [Cell Function]
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]
Processing 00000000.tx.226: This inhibition was overcome by exogenous addition of soluble L1. 

Phrase: "This inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "overcome by exogenous addition of soluble L1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2983310:Overcome [Activity]
Processing 00000000.tx.227: L1 cell surface expression levels affect cell migration We examined whether the expression level of L1 could influence the rate of cell migration. 

Phrase: "L1 cell surface expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   881   C0446432:L1 level [Body Location or Region]
   806   C3244092:expression level [Idea or Concept]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the expression level of L1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C3244092:expression level [Idea or Concept]
   797   C0446432:L1 level [Body Location or Region]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "influence"

Phrase: "the rate of cell migration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.228: SKOV3 cells were subjected to several rounds of cell sorting and stable cell populations with elevated or reduced expression of L1 were established. 

Phrase: "SKOV3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to several rounds of cell sorting"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0007616:Cell Sorting [Laboratory Procedure]
   757   C0487470:round cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0237886:Sorting [Mental Process]
   748   C0700314:sorting [Cell Function]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1947906:Sorting [Activity]
   748   C1948049:Cell [Spatial Concept]
   714   C0332490:Round [Spatial Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "stable cell populations with elevated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0038116:Stable Population [Quantitative Concept]
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "or"

Phrase: "reduced expression of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.229: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.230: 8 A, SKOV3hi expressed approximately threefold higher levels of L1 as compared with SKOV3lo cells (mean fluorescence 2458). 

Phrase: "8 A,"

Phrase: "SKOV3hi"

Phrase: "expressed"

Phrase: "approximately threefold higher levels of L1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0446432:L1 level [Body Location or Region]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "compared with SKOV3lo cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(mean fluorescence 2458"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   827   C0444504:Mean [Quantitative Concept]
   827   C2347634:Mean [Quantitative Concept]
   827   C2348143:Mean [Quantitative Concept]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.231: As established by ELISA, SKOV3hi, and SKOV3lo cells also released different amounts of soluble L1 into the medium (unpublished data). 

Phrase: "As"

Phrase: "established by ELISA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0443211:Established [Qualitative Concept]
   790   C1272684:Established [Qualitative Concept]

Phrase: "SKOV3hi,"

Phrase: "and"

Phrase: "SKOV3lo cells also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "different amounts of soluble L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "into the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.232: View larger version (47K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.233: The level of L1 expression affects cell migration. 

Phrase: "The level of L1 expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0446432:L1 level [Body Location or Region]
   797   C3244092:expression level [Idea or Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.234: SKOV3 cell variants differing in the expression levels of L1 (SKOV3hi or SKOV3lo) were established by repeated FACS sorting. 

Phrase: "SKOV3 cell variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "differing in the expression levels of L1 (SKOV3hi"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   750   C0446432:L1 level [Body Location or Region]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   744   C0441918:L1 [Finding]
   744   C1179698:L1 [Body Location or Region]
   744   C1416177:L1 [Gene or Genome]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "SKOV3lo"

Phrase: ")"

Phrase: "were"

Phrase: "established by repeated FACS sorting."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205341:Repeated [Functional Concept]
   760   C0237886:Sorting [Mental Process]
   760   C0443211:Established [Qualitative Concept]
   760   C0700314:sorting [Cell Function]
   760   C1272684:Established [Qualitative Concept]
   760   C1947906:Sorting [Activity]
Processing 00000000.tx.235: (A) Cytofluorographic staining of SKOV3hi or SKOV3lo cells with mAb UJ 127.11. 

Phrase: "(A) Cytofluorographic staining of SKOV3hi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "or"

Phrase: "SKOV3lo cells with mAb UJ 127.11."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.236: (B) Analysis of cell adhesion and haptotactic cell migration of SKOV3hi or SKOV3lo cells. 

Phrase: "(B) Analysis of cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "haptotactic cell migration of SKOV3hi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1622501:Migration, Cell [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "or"

Phrase: "SKOV3lo cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.237: The assays were done as described in Figs. 

Phrase: "The assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "done"

Phrase: "as"

Phrase: "described in Figs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349966:Figs [Food]
   790   C1552738:described [Idea or Concept]
   756 E C1337208:FIG [Food]
Processing 00000000.tx.238: 5 E and 7 C, respectively. 

Phrase: "5 E"

Phrase: "and"

Phrase: "7 C,"

Phrase: "respectively."
Processing 00000000.tx.239: (C) Cells were preincubated with the indicated mAbs at 10 mg/ml and transmigration on FN was tested as described in Fig. 

Phrase: "(C) Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0229579:C-Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with the indicated mAbs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444656:Indicated [Finding]
   726   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at 10 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "transmigration on FN"

Phrase: "was"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.240: 6 A. 

Phrase: "6 A."
Processing 00000000.tx.241: (D) Cells were preincubated with the indicated mAbs at 10 mg/ml and transmigration on laminin was tested as described in Fig. 

Phrase: "(D) Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with the indicated mAbs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444656:Indicated [Finding]
   726   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "at 10 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "transmigration on laminin"

Phrase: "was"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.242: 6 A.  

Phrase: "6 A."
Processing 00000000.tx.243: Neither type of cell differed in their adhesion to fibronectin (Fig. 8 B). 

Phrase: "Neither type of cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C0449475:Type of cell [Intellectual Product]
           cell type
   819   C0007634:Cell Type [Cell]
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "differed in their adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "to fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 8 B"

Phrase: ")."
Processing 00000000.tx.244: However, the haptotaptic migration on fibronectin was different. 

Phrase: "However,"

Phrase: "the haptotaptic migration on fibronectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.245: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.246: 8 B shows that SKOV3hi cells migrated much better compared with SKOV3lo cells, but this difference was no longer detectable when L1Fc fusion protein was added to the cells before the assay. 

Phrase: "8 B"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that SKOV3hi cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "much better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332272:Better [Qualitative Concept]

Phrase: "compared with SKOV3lo cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "this difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "no longer detectable"

Phrase: "when"

Phrase: "L1Fc fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "added to the cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1524062:Added [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "before the assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.247: The migration was blocked in the presence of metalloproteinase inhibitors (unpublished data). 

Phrase: "The migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "blocked in the presence of metalloproteinase inhibitors"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   762   C1152589:metalloproteinase inhibitor [Molecular Function]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0028778:Blocked [Pathologic Function]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332206:Blocked [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C1999216:Inhibitor [Qualitative Concept]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.248: Additional mAb inhibition experiments revealed that on fibronectin the migration of SKOV3hi and SKOV3lo cells was inhibited mAb SAM-1 to the 5 integrin and on laminin by mAb GoH3 to the 6 integrin, respectively (Fig. 8, C and D). 

Phrase: "Additional mAb inhibition experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that on fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the migration of SKOV3hi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "SKOV3lo cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "mAb SAM-1 to the 5 integrin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0036002:SAM [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0279268:SAM [Therapeutic or Preventive Procedure]
   748   C1563296:SAM [Pathologic Function]

Phrase: "and on laminin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1515981:And [Idea or Concept]

Phrase: "by mAb GoH3"

Phrase: "to the 6 integrin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "respectively"

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.249: Most importantly, and in agreement with the results obtained with CHO cells, a partial inhibition by mAb P1F6 to the v5 integrin was seen on both substrates (Fig.8, C and D). 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "and in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1515981:And [Idea or Concept]

Phrase: "with the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained with CHO cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "a partial inhibition by mAb P1F6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "to the v5 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "was"

Phrase: "seen on both substrates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737   C1710236:Substrate [Manufactured Object]
   737 E C1947903:See [Activity]

Phrase: "(Fig.8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.250: Results similar to those presented here for SKOV3 cells were obtained with high and low L1-expressing variants of the ovarian tumor line OAW 42 (unpublished data). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "similar to those presented here"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "for SKOV3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "obtained with high"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205250:High [Qualitative Concept]
   790   C1299351:High [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C2700149:HIGH [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "low L1-expressing variants of the ovarian tumor line OAW 42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205419:variants [Qualitative Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.251: Thus, the level of cell surface expression of L1 and hence the amount of L1 released by the cells affected the haptotactic migration on two different substrates. 

Phrase: "Thus,"

Phrase: "the level of cell surface expression of L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0446432:L1 level [Body Location or Region]
   767   C3244092:expression level [Idea or Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "hence"

Phrase: "the amount of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "released by the cells"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the haptotactic migration on two different substrates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.252: L1 shedding in AR cells involves ADAM10 ADAM10 has been identified as the principal -secretase for APP, and ADAM10 activity can be upregulated by treatment of cells with MCD or the hydroxymethyl glutaryl-CoA reductase inhibitor lovastatin (Lammich et al., 1999; Kojiro et al., 2001). 

Phrase: "L1 shedding in AR cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C1621321:receptor shedding [Molecular Function]

Phrase: "involves"

Phrase: "ADAM10 ADAM10"

Phrase: "has"

Phrase: "been"

Phrase: "identified as the principal -secretase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205225:Principal [Qualitative Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C0401925:Principal [Professional or Occupational Group]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "for APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "ADAM10 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "upregulated by treatment of cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0007634:Cells [Cell]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3282337:Cells [Cell]
   760   C3538994:TREATMENT [Research Activity]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with MCD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   827   C0332287:With [Qualitative Concept]
   827   C1705690:With [Intellectual Product]

Phrase: "or"

Phrase: "the hydroxymethyl glutaryl-CoA reductase inhibitor lovastatin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]
   780   C3536932:Hydroxymethylglutaryl-CoA Reductase Inhibitor [Pharmacologic Substance]
   734   C0020374:Hydroxymethylglutaryl-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1415615:hydroxymethylglutaryl-CoA reductase [Gene or Genome]

Phrase: "(Lammich et al.,"

Phrase: "1999"

Phrase: "; Kojiro et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.253: Given the observation that MCD treatment of AR cells also drastically enhanced L1 shedding, we investigated whether ADAM10 was a candidate sheddase for L1 release. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that MCD treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "of AR cells also drastically enhanced L1 shedding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   878   C1621321:receptor shedding [Molecular Function]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "a candidate sheddase for L1 release."
Processing 00000000.tx.254: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.255: 9 A shows that transient expression of a dominant-negative form of ADAM10 (ADAM10 DN) could nearly completely abolish the pervanadate or PMA-induced release of L1 from AR cells. 

Phrase: "9 A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that transient expression of a dominant-negative form of ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   722   C1554102:Formal Expression [Idea or Concept]

Phrase: "(ADAM10 DN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]

Phrase: "could"

Phrase: "nearly completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "abolish"

Phrase: "the pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "PMA-induced release of L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from AR cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C1514760:Receptor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.256: Overexpression of ADAM10 only marginally enhanced L1 release, suggesting that the shedding of L1 was controlled by additional factors beyond the expression level of shedding enzyme. 

Phrase: "Overexpression of ADAM10 only marginally enhanced L1 release,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514559:Overexpression [Genetic Function]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the shedding of L1"

Phrase: "was"

Phrase: "controlled by additional factors"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0332298:Controlled by [Functional Concept]
   802   C0683951:control factors [Quantitative Concept]
   770   C1524062:Additional [Functional Concept]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737   C2827422:Factor [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "beyond the expression level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of shedding enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.257: Additional experiments using antibodies to hemagglutinin and Flag epitopes confirmed that ADAM10 and ADAM10 DN were expressed by the transfected cells (Fig. 9 B). 

Phrase: "Additional experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies to hemagglutinin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "Flag epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "ADAM10 DN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]

Phrase: "were"

Phrase: "expressed by the transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 9 B"

Phrase: ")."
Processing 00000000.tx.258: Further studies using mL1-CHO cells showed a similar downregulation of L1 release by the ADAM10 DN construct (unpublished data). 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mL1-CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar downregulation of L1 release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "by the ADAM10 DN construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.259: Collectively, these results strongly imply that in both AR and CHO cells the L1 release involved ADAM10. 

Phrase: "Collectively,"

Phrase: "these results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "imply"

Phrase: "that in both AR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0002844:Androgen [Hormone,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the L1 release involved ADAM10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1412181:ADAM10 [Gene or Genome]
   812   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.260: View larger version (22K): [in this window] [in a new window]  Figure 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 9."
Processing 00000000.tx.261: ADAM10 is involved in L1 shedding. 

Phrase: "ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "involved in L1 shedding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441918:L1 [Finding]
   770   C1179698:L1 [Body Location or Region]
   770   C1314939:Involved [Functional Concept]
   770   C1416177:L1 [Gene or Genome]
Processing 00000000.tx.262: (A) AR cells were transiently transfected with 10 mg plasmid DNA encoding HA-tagged ADAM10 or Flag-tagged dominant-negative ADAM10 (ADAM10 DN). 

Phrase: "(A) AR cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C1514760:Receptor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with 10 mg plasmid DNA encoding HA-tagged ADAM10"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0439269:mg% [Quantitative Concept]
   739   C1412181:ADAM10 [Gene or Genome]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1547699:Encoding [Idea or Concept]
   739   C1708632:Tagged [Qualitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C2700640:Encoding [Activity]
   739   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "Flag-tagged dominant-negative ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1412181:ADAM10 [Gene or Genome]
   804   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "(ADAM10 DN)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]
Processing 00000000.tx.263: 48 h after transfection, cells were stimulated with PMA or pervanadate to induce shedding. 

Phrase: "48 h after transfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with PMA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   790   C2825188:PMA [Intellectual Product]

Phrase: "or"

Phrase: "pervanadate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "shedding."
Processing 00000000.tx.264: After 2 h, the supernatants were harvested and the cells lysed in lysis buffer. 

Phrase: "After 2 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "lysed in lysis buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
           lysed
   770   C1536403:lysis [Cell Function]
Processing 00000000.tx.265: Cell lysates and conditioned media were analysed by ELISA for soluble L1. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "and"

Phrase: "conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "analysed by ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0014441:ELISA [Laboratory Procedure]

Phrase: "for soluble L1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]
Processing 00000000.tx.266: (B) Detection of HA-tagged ADAM10 or FLAG-tagged ADAM10 DN in the lysate of transfected cells.  

Phrase: "(B) Detection of HA-tagged ADAM10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "FLAG-tagged ADAM10 DN in the lysate of transfected cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1333964:DN [Disease or Syndrome]
   739   C1707618:DN [Intellectual Product]
Processing 00000000.tx.267: The L1150 plasmin fragment augments migration of CHO cells It has been shown recently that the addition of plasmin to L1-positive cells results in a dose-dependent loss of surface L1 expression with the concomitant appearance of a 140150-kD soluble L1 species (L1150) into the supernatant (Nayeem et al., 1999). 

Phrase: "The L1150 plasmin fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "migration of CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1622501:cells migration [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that"

Phrase: "the addition of plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "to L1-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "results in a dose-dependent loss of surface L1 expression"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C1512045:Dose-dependent [Quantitative Concept]
   739   C0178602:Dose [Quantitative Concept]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205148:Surface [Spatial Concept]
   739   C0441918:L1 [Finding]
   739   C0851827:Dependent [Qualitative Concept]
   739   C0869039:Dose [Quantitative Concept]
   739   C1114758:Dose # [Clinical Attribute]
   739   C1179698:L1 [Body Location or Region]
   739   C1274040:Result [Functional Concept]
   739   C1416177:L1 [Gene or Genome]
   739   C1517945:Loss [Quantitative Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1701901:Dependent [Qualitative Concept]
   739   C2825142:Result [Finding]
   739   C3244310:dependent [Functional Concept]

Phrase: "with the concomitant appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233426:Appearance [Organism Attribute]
   861   C0700364:Appearance [Qualitative Concept]

Phrase: "of a 140150-kD soluble L1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "(L1150"

Phrase: ")"

Phrase: "into the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(Nayeem et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.268: Cleavage occurs at a dibasic site in the middle of the third FNIII repeat, thus, the released fragment contains the RGD site(s) in the 6.Ig-domain. 

Phrase: "Cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "occurs at a dibasic site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2825164:Site [Spatial Concept]

Phrase: "in the middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: "of the third FNIII repeat,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "thus,"

Phrase: "the released fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the RGD site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s) in the 6.Ig-domain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C2603362:S' [Clinical Attribute]
   753   C3541296:IG [Idea or Concept]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.269: We asked whether the plasmin fragment could substitute for the metalloproteinase-released ectodomain of L1. 

Phrase: "We"

Phrase: "asked"

Phrase: "whether"

Phrase: "the plasmin fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "could"

Phrase: "substitute for the metalloproteinase-released ectodomain of L1."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   744   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0391871:Released [Functional Concept]
   744   C0441918:L1 [Finding]
   744   C1179698:L1 [Body Location or Region]
   744   C1283071:Released [Functional Concept]
   744   C1416177:L1 [Gene or Genome]
   711 E C0030685:Release [Health Care Activity]
   711 E C0439180:% release [Quantitative Concept]
   711 E C0680255:release [Health Care Activity]
   711 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.270: AR cells in serum-free medium were treated with a predetermined concentration of plasmin or plasmin plus the specific inhibitor 2-antiplasmin, and supernatants and cell pellets were taken for biochemical and functional analysis. 

Phrase: "AR cells in serum-free medium"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C1514760:Receptor Cell [Cell]
   757   C1183428:Free cell [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with a predetermined concentration of plasmin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "plasmin plus the specific inhibitor 2-antiplasmin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0032139:Plasmin Inhibitor [Pharmacologic Substance]
   748   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "taken for biochemical"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205474:Biochemical [Functional Concept]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "functional analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0558024:Functional analysis [Health Care Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.271: To suppress the metalloproteinase-mediated L1 release, all supernatants were generated in the presence of Ro 31-9790 inhibitor. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the metalloproteinase-mediated L1 release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "all supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "generated in the presence of Ro 31-9790 inhibitor."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0385836:Ro 31-9790 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0035826:RO [Geographic Area]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0450355:31 [Intellectual Product]
   742   C1413096:RO [Gene or Genome]
   742   C1999216:Inhibitor [Qualitative Concept]
   742   C2987048:RO [Gene or Genome]
   742   C3146294:Generated [Activity]
Processing 00000000.tx.272: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.273: 10 A shows that in the presence of Ro1plasmin, a substantial loss of L1 from the cell pellet was observed which could be detected with both L1 mAbs 5G3 and UJ 127.11. 

Phrase: "10 A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in the presence of Ro1plasmin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "a substantial loss of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "from the cell pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "detected with both L1 mAbs 5G3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441918:L1 [Finding]
   753   C0442726:Detected [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "UJ 127.11."
Processing 00000000.tx.274: The latter mAb also detected the L1-85 fragment remaining associated with the cell pellet after plasmin cleavage. 

Phrase: "The latter mAb also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the L1-85 fragment remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1527428:Remaining [Qualitative Concept]

Phrase: "associated with the cell pellet"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0699040:cell associated [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0441436:Pellet [Manufactured Object]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1998480:Pellet [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "after plasmin cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
Processing 00000000.tx.275: This is in agreement with the notion that mAb UJ 127.11 recognizes an epitope between the dibasic cleavage site and the plasma membrane (Fig. 1 B), whereas mAb 5G3 reportedly binds to the NH2 terminus of L1 (Silletti et al., 2000). 

Phrase: "This"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the notion"

Phrase: "that mAb UJ 127.11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "recognizes"

Phrase: "an epitope between the dibasic cleavage site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003316:Epitope [Immunologic Factor]

Phrase: "and"

Phrase: "the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Fig. 1 B"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "mAb 5G3 reportedly"

Phrase: "binds to the NH2 terminus of L1 (Silletti et al.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0002508:NH2 [Organic Chemical]
   739   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   739   C0441918:L1 [Finding]
   739   C1145667:Bind [Activity]
   739   C1167622:bind [Molecular Function]
   739   C1179698:L1 [Body Location or Region]
   739   C1416177:L1 [Gene or Genome]

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.276: Analysis of the supernatant from treated cultures indicated that in the presence of the metalloproteinase inhibitor, the formation of soluble L1-200 was drastically reduced, and that plasmin addition resulted in the appearance of an expected 150-kD L1 fragment (Fig. 10 A). 

Phrase: "Analysis of the supernatant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "from treated cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that in the presence of the metalloproteinase inhibitor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1152589:metalloproteinase inhibitor [Molecular Function]
   744   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "the formation of soluble L1-200"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "drastically"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "that plasmin addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]

Phrase: "resulted in the appearance of an expected 150-kD L1 fragment"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   738   C0026691:KD [Disease or Syndrome]
   738   C0233426:Appearance [Organism Attribute]
   738   C0332255:fragment [Functional Concept]
   738   C0441918:L1 [Finding]
   738   C0700364:Appearance [Qualitative Concept]
   738   C1179698:L1 [Body Location or Region]
   738   C1416177:L1 [Gene or Genome]
   738   C1517001:Expected [Idea or Concept]
   738   C1705240:KD [Gene or Genome]
   738   C1708096:Fragment [Qualitative Concept]
   738   C1839259:KD [Disease or Syndrome]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "(Fig. 10 A"

Phrase: ")."
Processing 00000000.tx.277: The formation of the 150-kD plasmin fragment was blocked in the presence of 2-antiplasmin. 

Phrase: "The formation of the 150-kD plasmin fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "blocked in the presence of 2-antiplasmin."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0003410:Antiplasmin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0332206:Blocked [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.278: View larger version (19K): [in this window] [in a new window]  Figure 10. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 10."
Processing 00000000.tx.279: The L1150-kD plasmin fragment can also stimulate cell migration. 

Phrase: "The L1150-kD plasmin fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "can"

Phrase: "also"

Phrase: "stimulate"

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.280: AR cell were treated with Ro 31-9790 inhibitor (Ro) in combination with plasmin and 2-antiplasmin for 6 h at 37C. 

Phrase: "AR cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1514760:Receptor Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "treated with Ro 31-9790 inhibitor"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0385836:Ro 31-9790 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0035826:RO [Geographic Area]
   753   C0450355:31 [Intellectual Product]
   753   C1413096:RO [Gene or Genome]
   753   C1522326:Treated [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   753   C2987048:RO [Gene or Genome]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(Ro) in combination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035826:RO [Geographic Area]
   790   C1413096:RO [Gene or Genome]
   790   C2987048:RO [Gene or Genome]

Phrase: "with plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "2-antiplasmin for 6 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003410:Antiplasmin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at 37C."
Processing 00000000.tx.281: (A) Cells and supernatants were collected and analyzed by Western blotting using the indicated antibodies. 

Phrase: "(A) Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.282: (B) Supernatants of treated cultures were investigated for the ability to induce haptotactic migration of CHO cells as described in Fig. 

Phrase: "(B) Supernatants of treated cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "investigated for the ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C1292732:investigated [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "haptotactic migration of CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.283: 7 A.  

Phrase: "7 A."
Processing 00000000.tx.284: To analyze whether the plasmin fragment also could trigger cell migration, the supernatants of treated cultures were tested for the ability to induce haptotactic migration of CHO cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "whether"

Phrase: "the plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "also"

Phrase: "could"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "cell migration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "the supernatants of treated cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "tested for the ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "haptotactic migration of CHO cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.285: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.286: 10 B, supernatants containing L1-200 or the plasmin fragment L1-150 could indeed induce migration whereas control supernatants containing no cleaved L1 could not. 

Phrase: "10 B,"

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "L1-200"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "or"

Phrase: "the plasmin fragment L1-150"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0332255:fragment [Functional Concept]
   812   C0441918:L1 [Finding]
   812   C1179698:L1 [Body Location or Region]
   812   C1416177:L1 [Gene or Genome]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "could"

Phrase: "indeed"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "whereas"

Phrase: "control supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "no cleaved L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "could"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.287: It should be noted that the L1-150 fragment was derived directly from the cell surface, and that there was apparently more L1 protein present than in the L1-200containing supernatant. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the L1-150 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "directly from the cell surface,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1947931:Directly [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that there"

Phrase: "was"

Phrase: "apparently more L1 protein present than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "in the L1-200containing supernatant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.288: Therefore, it is possible that on a molar basis, the L1-200 fragment is more potent in the induction of migration than the L1-150 fragment.  

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that on a molar basis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026367:Molar [Body Part, Organ, or Organ Component]
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "the L1-200 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "more potent in the induction of migration"

Phrase: "than the L1-150 fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.289: Discussion Top Abstract Introduction Results Discussion Materials and methods References  This report presents the first evidence that ectodomain cleavage of L1 has a biological role by providing soluble L1, which in turn can trigger cell migration. 

Phrase: "Discussion Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that ectodomain cleavage of L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1157978:ectodomain cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "has"

Phrase: "a biological role by providing soluble L1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "can"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.290: We find that L1-32, a fragment comprising the transmembrane and cytoplasmic region of L1, remains associated with the membrane. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that L1-32,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "a fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "comprising"

Phrase: "the transmembrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167322:transmembrane [Cell Component]
  1000   C2752508:transmembrane [Cell Component]

Phrase: "and"

Phrase: "cytoplasmic region of L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1183489:Cytoplasmic region [Cell Component]
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "remains"

Phrase: "associated with the membrane."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.291: Not only is the fragment detected in varying amounts in human L1-positive carcinoma cell lines, but it is also in mouse brain of stage P1. 

Phrase: "Not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "is"

Phrase: "the fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "detected in varying amounts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C1265611:amounts [Quantitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in human L1-positive carcinoma cell lines,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   887   C0682523:Human Cell Line [Cell]
   876   C0427861:human cell [Laboratory or Test Result]
   839   C0439178:positive cell [Quantitative Concept]
   827   C0007600:Cell lines [Cell]
   827   C1518174:Carcinoma Cell [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "also in mouse brain of stage P1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1521713:Mouse Brain [Tissue]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0205390:Stage [Temporal Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
Processing 00000000.tx.292: The presence of L1-32 declines with advancing age of the mice. 

Phrase: "The presence of L1-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "declines with advancing age of the mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001779:Age [Organism Attribute]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   714   C0725066:Advance [Medical Device]
Processing 00000000.tx.293: Therefore, ectodomain cleavage of L1 is not only a property of tumor cells, but it occurs in vivo during brain development. 

Phrase: "Therefore,"

Phrase: "ectodomain cleavage of L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1157978:ectodomain cleavage [Molecular Function]
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "a property of tumor cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0871161:Property [Qualitative Concept]
   760   C1882134:Property [Conceptual Entity]
   760   C2347695:Property [Entity]

Phrase: "but"

Phrase: "it"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in vivo during brain development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.294: In cultured cells, the cleavage could be augmented by treatment with PMA and pervanadate and was blocked by hydroxamate based metalloproteinase inhibitors, suggesting that a metalloproteinase was involved. 

Phrase: "In cultured cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "the cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "could"

Phrase: "be"

Phrase: "augmented by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0205217:Augmented [Quantitative Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "and"

Phrase: "pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "was"

Phrase: "blocked by hydroxamate based metalloproteinase inhibitors,"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   773   C1152589:metalloproteinase inhibitor [Molecular Function]
   753   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0028778:Blocked [Pathologic Function]
   753   C0178696:hydroxamate [Organic Chemical]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0332206:Blocked [Functional Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C1880279:Base [Biomedical or Dental Material]
   719 E C1999216:Inhibitor [Qualitative Concept]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.295: Transfection studies indicated that in established cell lines the shedding of L1 required ADAM10. 

Phrase: "Transfection studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that in established cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   828   C0598089:established cell line [Cell]
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C0443211:Established [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1272684:Established [Qualitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "the shedding of L1"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "ADAM10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.296: The starting point of our study was the observation that L1-transfected CHO cells showed a three- to fivefold better migration on fibronectin than CHO cells, and that this enhanced migration was blocked by the BB-3103 metalloproteinase inhibitor, suggesting a role of L1 shedding in the migration process. 

Phrase: "The starting point of our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552961:Point [Quantitative Concept]
   753   C2347617:point [Quantitative Concept]

Phrase: "was"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that L1-transfected CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085080:CHO Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a three-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "to fivefold better migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "on fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "than CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this enhanced migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "blocked by the BB-3103 metalloproteinase inhibitor,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   778   C1152589:metalloproteinase inhibitor [Molecular Function]
   748   C0004739:BB [Geographic Area]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0028778:Blocked [Pathologic Function]
   748   C0332206:Blocked [Functional Concept]
   748   C0332297:BB [Spatial Concept]
   748   C1999216:Inhibitor [Qualitative Concept]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role of L1 shedding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the migration process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.297: It was possible that metalloproteinase inhibitors of the hydroxamate family might cause effects beyond the inhibition of ectodomain shedding. 

Phrase: "It"

Phrase: "was"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that metalloproteinase inhibitors of the hydroxamate family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1152589:metalloproteinase inhibitor [Molecular Function]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "might"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "effects beyond the inhibition of ectodomain shedding."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.298: A recent study has shown that batimastat (BB-94) can alter gene expression levels in vivo (Krger et al., 2001). 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that batimastat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215791:batimastat [Organic Chemical,Pharmacologic Substance]

Phrase: "(BB-94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1608879:BB 94 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ")"

Phrase: "can"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "gene expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Krger et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.299: Additional data revealed that mAbs to v5 and L1 also inhibited migration of L1-CHO cells to control levels. 

Phrase: "Additional data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that mAbs to v5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "L1 also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "migration of L1-CHO cells to control levels."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1622501:cells migration [Cell Function]
   744   C0600210:Migration [Social Behavior]
   744   C1533574:Migration [Physiologic Function]
   744   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.300: CHO cells are low in v5, but express high levels of 51 which are used for migration on fibronectin. 

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "low in v5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205251:low [Qualitative Concept]
   790   C1299352:Low [Qualitative Concept]
   790   C1550472:low [Idea or Concept]

Phrase: "but"

Phrase: "express"

Phrase: "high levels of 51"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "are"

Phrase: "used for migration"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0600210:Migration [Social Behavior]
   790   C1273517:used [Finding]
   790   C1533574:Migration [Physiologic Function]
   790   C1881827:MIGRATION [Phenomenon or Process]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "on fibronectin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.301: Indeed, the migration and adhesion of both types of cells on fibronectin were efficiently blocked by a mAb to the 5 integrin. 

Phrase: "Indeed,"

Phrase: "the migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "adhesion of both types of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "on fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "efficiently"

Phrase: "blocked by a mAb"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "to the 5 integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.302: Thus, membrane-released L1 exerted an enhancing effect on the basal migration of CHO cells which involved the v5 integrin. 

Phrase: "Thus,"

Phrase: "membrane-released L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "an enhancing effect on the basal migration of CHO cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "the v5 integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.303: We reasoned that v5 could become directly engaged in migration or indirectly by transmitting signals which accelerated the existing migration machinery. 

Phrase: "We"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that v5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "could"

Phrase: "become"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "engaged in migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0425152:Engaged [Finding]
   790   C0600210:Migration [Social Behavior]
   790   C1533574:Migration [Physiologic Function]
   790   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "or"

Phrase: "indirectly by transmitting signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332289:transmitting [Functional Concept]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "which"

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "the existing migration machinery."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.304: The first option appeared less likely, as several studies have shown that v5 only participates in migration when cells receive additional signals like PMA or growth factors (Klemke et al., 1994; Filardo et al., 1996). 

Phrase: "The first option"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1518601:Option [Functional Concept]
   861   C1550456:option [Idea or Concept]
   789 E C1518600:Optional [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "less likely,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332148:Likely [Qualitative Concept]
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "as"

Phrase: "several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that v5 only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "participates in migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600210:Migration [Social Behavior]
   790   C1533574:Migration [Physiologic Function]
   790   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "additional signals like PMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "or"

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(Klemke et al.,"

Phrase: "1994"

Phrase: "; Filardo et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.305: A direct role of v5 in migration was also not consistent with the complete blocking of the 5-specific mAb. 

Phrase: "A direct role of v5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "not consistent with the complete"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "blocking of the 5-specific mAb."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0205369:Specific [Qualitative Concept]
   753   C0233660:Blocking [Mental or Behavioral Dysfunction]
   753   C0332206:Blocking [Functional Concept]
   753   C1552740:specific [Intellectual Product]
   719 E C0028778:Block [Pathologic Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.306: In addition, the mAb to v5 blocked partially the 6 integrinmediated migration on laminin, which is RGD independent. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the mAb to v5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "partially"

Phrase: "the 6 integrinmediated migration on laminin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "RGD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2699006:RGD [Intellectual Product]

Phrase: "independent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085862:Independent [Idea or Concept]
  1000   C1299583:Independent [Finding]
Processing 00000000.tx.307: We observed that soluble L1, either in a native form or as an ectodomain Fc protein, could stimulate migration of CHO cells, and that this could also be blocked by the mAb to v5. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that soluble L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "either in a native form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0302891:Native [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "or as an ectodomain Fc protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2983605:FC [Activity]

Phrase: "could"

Phrase: "stimulate"

Phrase: "migration of CHO cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1622501:cells migration [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "blocked by the mAb"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "to v5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]
Processing 00000000.tx.308: The stimulation of migration required the presence of RGDs in L1, consistent with the involvement of an integrin in the signaling pathway. 

Phrase: "The stimulation of migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "the presence of RGDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "consistent with the involvement of an integrin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the signaling pathway."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0037083:signaling pathway [Cell Function]
  1000   C0086982:Signaling Pathway [Molecular Function]
   983 E C0037080:Signal Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.309: Moreover, the inhibition of CHO-L1 migration by BB-3103 was fully restored by the addition of soluble L1. 

Phrase: "Moreover,"

Phrase: "the inhibition of CHO-L1 migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by BB-3103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "was"

Phrase: "fully"

Phrase: "restored by the addition of soluble L1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   748   C1749467:soluble [Cell Component]
   748   C1883712:Addition [Functional Concept]
   748   C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.310: Collectively, these data supported the notion that soluble L1 was driving cell migration by binding to v5, and that inhibition of L1 cleavage interrupted this autocrine/paracrine loop. 

Phrase: "Collectively,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "the notion"

Phrase: "that soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "was"

Phrase: "driving cell migration by binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1622501:Migration, Cell [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to v5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "that inhibition of L1 cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "interrupted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443239:Interrupted [Qualitative Concept]
  1000   C1512900:Interrupted [Temporal Concept]

Phrase: "this autocrine/paracrine loop."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
Processing 00000000.tx.311: The results in the CHO system were further corroborated by the analysis of SKOV3 cells differing in expression levels of L1. 

Phrase: "The results in the CHO system"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "corroborated by the analysis of SKOV3 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "differing in expression levels of L1."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   767   C0446432:L1 level [Body Location or Region]
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   753   C0441918:L1 [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.312: Cell variants with a higher level of L1 migrated better than cells with lower level on both fibronectin and laminin as substrate. 

Phrase: "Cell variants with a higher level of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:variants [Qualitative Concept]

Phrase: "migrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:Migrated [Functional Concept]

Phrase: "better than cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332272:Better [Qualitative Concept]

Phrase: "with lower level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "on both fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "laminin as substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.313: As shown for fibronectin, the addition of soluble L1 could restore the defect of SKOV3lo cells. 

Phrase: "As"

Phrase: "shown for fibronectin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1547282:Show [Intellectual Product]

Phrase: "the addition of soluble L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "could"

Phrase: "restore"

Phrase: "the defect of SKOV3lo cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.314: Thus, the amounts of L1 at the cell surface and released by the cells appeared to be an important factor in determining the rate of cell migration. 

Phrase: "Thus,"

Phrase: "the amounts of L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "at the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "released by the cells"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an important factor in determining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "the rate of cell migration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.315: The results obtained with L1/L-selectin mutants deserve a further notion. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained with L1/L-selectin mutants"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   790   C1335808:L-SELECTIN [Gene or Genome]
   753   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441918:L1 [Finding]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C1179698:L1 [Body Location or Region]
   753   C1301820:Obtained [Functional Concept]
   753   C1325391:selectin [Molecular Function]
   753   C1416177:L1 [Gene or Genome]
   719 E C1706701:Obtain [Activity]

Phrase: "deserve"

Phrase: "a further notion."
Processing 00000000.tx.316: Whereas it is conceivable that CHO-5 (L-selectin/L1) cells did not migrate because the L-selectin ectodomain could not stimulate, the situation with CHO-62 cells (L1/L-selectin) is less clear. 

Phrase: "Whereas"

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that CHO-5"

Phrase: "(L-selectin/L1) cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "migrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrate [Functional Concept]

Phrase: "because"

Phrase: "the L-selectin ectodomain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   734   C1335808:L-SELECTIN [Gene or Genome]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stimulate"

Phrase: ","

Phrase: "the situation with CHO-62 cells"

Phrase: "(L1/L-selectin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C1335808:L-SELECTIN [Gene or Genome]
   827   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1325391:selectin [Molecular Function]

Phrase: ")"

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.317: We observed that these cells released significantly more L1 into the medium than CHO-L1 cells, yet did not show haptotactic migration. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "significantly more L1 into the medium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441918:L1 [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]

Phrase: "than CHO-L1 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "yet"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "haptotactic migration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.318: Additional experiments showed that the conditioned medium of CHO-62 cells was able to stimulate vigorous migration of CHO cells, suggesting that the ectodomain was functionally active (unpublished data). 

Phrase: "Additional experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the conditioned medium of CHO-62 cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Medium [Intellectual Product]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "stimulate"

Phrase: "vigorous migration of CHO cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:cells migration [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ectodomain"

Phrase: "was"

Phrase: "functionally active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.319: However, in CHO-62, the L1 distribution was different compared with CHO-L1 cells. 

Phrase: "However,"

Phrase: "in CHO-62,"

Phrase: "the L1 distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with CHO-L1 cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.320: In addition to surface expression, L1 was localized in a region close to the nucleus. 

Phrase: "In addition to surface expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0205148:Surface [Spatial Concept]

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "was"

Phrase: "localized in a region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C0392752:Localized [Spatial Concept]

Phrase: "close to the nucleus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C0587267:Close [Functional Concept]
Processing 00000000.tx.321: Moreover, the cells were altered in morphology. 

Phrase: "Moreover,"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "altered in morphology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332437:Morphology [Qualitative Concept]
   790   C0392747:Altered [Functional Concept]
   790   C0543482:morphology [Spatial Concept]
   790   C0700329:Morphology, NOS [Finding]
   790   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.322: It is quite possible that secondary effects like changes in cytoskeletal organization are responsible for the reduced haptotactic migration of CHO-62 cells compared with L1-CHO wildtype cells. 

Phrase: "It"

Phrase: "is"

Phrase: "quite possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that secondary effects like changes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in cytoskeletal organization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1511632:Cytoskeletal Organization [Cell Function]
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "are"

Phrase: "responsible for the reduced haptotactic migration of CHO-62 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1273518:Responsible [Finding]

Phrase: "compared with L1-CHO wildtype cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C0085080:CHO Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0441918:L1 [Finding]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]
   753   C1707455:Compared [Activity]
   753   C1883559:Wild Type [Organism Attribute]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.323: Another possibility could be that the L-selectin cyttail actively inhibited cell migration. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "that"

Phrase: "the L-selectin cyttail actively"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.324: Further analysis is needed to solve this issue. 

Phrase: "Further analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "solve"

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.325: Several previous studies have shown that soluble L1 can influence axon growth and cell migration. 

Phrase: "Several previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "influence"

Phrase: "axon growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749784:axon growth [Organ or Tissue Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.326: It is well established that immobilized, purified L1 or L1 presented on a cell monolayer can serve as substrate for neurite outgrowth. 

Phrase: "It"

Phrase: "is"

Phrase: "well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0443211:Established [Qualitative Concept]
   861   C1272684:Established [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that immobilized, purified L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]

Phrase: "or"

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "presented on a cell monolayer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0449450:Presented [Idea or Concept]
   760   C0872351:monolayer [Clinical Drug]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "can"

Phrase: "serve as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710236:Substrate [Manufactured Object]

Phrase: "for neurite outgrowth."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]
Processing 00000000.tx.327: Several studies have provided evidence that soluble L1 can stimulate neurite outgrowth of cerebellar neurons (Doherty et al., 1995) or explants from embryonic chick brain (Sugawa et al., 1997). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "stimulate"

Phrase: "neurite outgrowth of cerebellar neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C3158384:neurite outgrowth [Cell Function]
   760   C0085103:Neurite [Cell Component]

Phrase: "(Doherty et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: "or"

Phrase: "explants from embryonic chick brain"

Phrase: "(Sugawa et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.328: Indeed, soluble L1 has been suggested as a potential pharmaceutical for the promotion of nerve regeneration (Sugawa et al., 1997). 

Phrase: "Indeed,"

Phrase: "soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "suggested as a potential pharmaceutical"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   760   C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   760   C3245505:Potential [Qualitative Concept]
   726   C1705535:Suggest [Idea or Concept]

Phrase: "for the promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of nerve regeneration"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027756:Nerve Regeneration [Cell Function]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C0034963:Regeneration [Organ or Tissue Function]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "(Sugawa et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.329: In most cases, the growth- and migration-promoting effects of L1 have been attributed to L1 homophilic binding. 

Phrase: "In most cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the growth-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "migration-promoting effects of L1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "attributed to L1 homophilic binding."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0243122:binding [Functional Concept]
   760   C0441918:L1 [Finding]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.330: However, Yip et al. 

Phrase: "However,"

Phrase: "Yip et al."
Processing 00000000.tx.331: (1998) have demonstrated that the RGD motif in L1 also contributes to neurite outgrowth by interacting with the v3 integrin (Yip et al., 1998). 

Phrase: "(1998"

Phrase: ")"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the RGD motif in L1 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052350:RGD Motif [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514562:Motif [Amino Acid Sequence]

Phrase: "contributes to neurite outgrowth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3158384:neurite outgrowth [Cell Function]
   770   C0085103:Neurite [Cell Component]
   770   C1880177:Contribute [Activity]

Phrase: "by interacting"

Phrase: "with the v3 integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(Yip et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.332: Interestingly, in this study both homophilic and integrin binding promoted outgrowth of dorsal root ganglion cells, whereas neural retinal cells responded only via homophilic binding (Yip et al., 1998). 

Phrase: "Interestingly,"

Phrase: "in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "both homophilic"

Phrase: "and"

Phrase: "integrin binding promoted outgrowth of dorsal root ganglion cells,"

Phrase: "whereas"

Phrase: "neural retinal cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   896   C0027882:Neural cell [Cell]
   884   C2338017:Retinal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "responded"

Phrase: "only via homophilic binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1720467:Only [Intellectual Product]

Phrase: "(Yip et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.333: Soluble L1 is also involved in the invasion and migration of malignant gliomas (Izumoto et al., 1996). 

Phrase: "Soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "involved in the invasion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1269955:Invasion [Finding]
   770   C1314939:Involved [Functional Concept]
   770   C2699153:Invasion [Pathologic Function]

Phrase: "and"

Phrase: "migration of malignant gliomas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "(Izumoto et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.334: It was shown that C6 glioma cells are stimulated to migrate by soluble L1 or L1 released from transfected fibroblasts (Izumoto et al., 1996). 

Phrase: "It"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that C6 glioma cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "migrate by soluble L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0232902:migrate [Functional Concept]
   770   C0441918:L1 [Finding]
   770   C1179698:L1 [Body Location or Region]
   770   C1416177:L1 [Gene or Genome]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "or"

Phrase: "L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "released from transfected fibroblasts"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0016030:Fibroblasts [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Izumoto et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.335: Another study from this group indicated that soluble L1, but not fibronectin or tenascin, stimulated the invasion and migration of C6 cells into cultured brain slices (Ohnishi et al., 1998). 

Phrase: "Another study from this group"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that soluble L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "but"

Phrase: "not fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "tenascin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0076088:Tenascin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336642:TENASCIN [Gene or Genome]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "the invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "and"

Phrase: "migration of C6 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1622501:cells migration [Cell Function]
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "into cultured brain slices"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1519355:Slice [Substance]

Phrase: "(Ohnishi et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.336: Antibody inhibition experiments suggested that homophilic binding of L1 was involved in stimulating glioma migration, but a contribution of RGD motifs and integrin binding was not tested (Izumoto et al., 1996). 

Phrase: "Antibody inhibition experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that homophilic binding of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "involved in stimulating glioma migration,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0017638:Glioma [Neoplastic Process]
   760   C0555198:[M]Glioma NOS [Neoplastic Process]
   760   C0600210:Migration [Social Behavior]
   760   C1314939:Involved [Functional Concept]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
   760   C1948023:Stimulating [Natural Phenomenon or Process]
   760   C2984291:Glioma [Functional Concept]

Phrase: "but"

Phrase: "a contribution of RGD motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "integrin binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149503:Integrin Binding [Molecular Function]
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(Izumoto et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.337: In our experiments, the enhanced migration of L1-CHO was blocked by v5-specific mAbs and by mAb 324 to mouse L1. 

Phrase: "In our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the enhanced migration of L1-CHO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "blocked by v5-specific mAbs"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0028778:Blocked [Pathologic Function]
   760   C0205369:Specific [Qualitative Concept]
   760   C0332206:Blocked [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   760   C2349105:V5+ [Element, Ion, or Isotope]
   760   C2983591:BLOCKED [Research Activity]
   726   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "and by mAb 324"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1515981:And [Idea or Concept]

Phrase: "to mouse L1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]
Processing 00000000.tx.338: The latter antibody was previously found to block 51-mediated binding of murine cells suggesting that the epitope recognized by this mAb partially overlaps with the Ig domain 6 (Ruppert et al., 1995). 

Phrase: "The latter antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "previously"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "51-mediated binding of murine cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitope [Immunologic Factor]

Phrase: "recognized by this mAb partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "overlaps with the Ig domain 6"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0185027:overlap [Therapeutic or Preventive Procedure]
   753   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C1948020:Overlap [Conceptual Entity]
   753   C3541296:IG [Idea or Concept]
   753   C3541951:Domain [Intellectual Product]

Phrase: "(Ruppert et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.339: Also, the migration of CHO cell stimulated by soluble L1 was inhibited by the v5-specific mAbs, and was not observed with soluble L1 devoid of RGDs. 

Phrase: "Also,"

Phrase: "the migration of CHO cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1622501:Migration, Cell [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "stimulated by soluble L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441918:L1 [Finding]
   770   C1179698:L1 [Body Location or Region]
   770   C1416177:L1 [Gene or Genome]
   770   C1749467:soluble [Cell Component]
   770   C1948023:Stimulated [Natural Phenomenon or Process]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "was"

Phrase: "inhibited by the v5-specific mAbs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205369:Specific [Qualitative Concept]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C2349105:V5+ [Element, Ion, or Isotope]
   719   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed with soluble L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441918:L1 [Finding]
   770   C1179698:L1 [Body Location or Region]
   770   C1416177:L1 [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "devoid of RGDs."
Processing 00000000.tx.340: This suggested that the triggering signal involved binding to integrins. 

Phrase: "This"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the triggering signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "binding to integrins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1149503:Integrin Binding [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
Processing 00000000.tx.341: We concluded that soluble L1 can stimulate cellular responses like cell migration by binding and signaling through integrins like v5. 

Phrase: "We"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "stimulate"

Phrase: "cellular responses like cell migration"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "by binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "signaling through integrins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0037083:Signaling [Cell Function]
   790   C3537152:signaling [Biologic Function]

Phrase: "like v5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349105:V5+ [Element, Ion, or Isotope]
Processing 00000000.tx.342: Recent work has provided evidence that protein ectodomain cleavage regulates the function of membrane-anchored growth factors and cytokines and is involved in signal transduction processes (Blobel, 2000). 

Phrase: "Recent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that protein ectodomain cleavage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0597304:Protein Cleavage [Molecular Function]
   901   C1157978:ectodomain cleavage [Molecular Function]
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "regulates"

Phrase: "the function of membrane-anchored growth factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0682568:membrane function [Body Part, Organ, or Organ Component]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "involved in signal transduction processes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0037083:Signal Transduction [Cell Function]
   760   C1160185:transduction [Organism Function]
   760   C1314939:Involved [Functional Concept]
   760   C1710082:Signal [Phenomenon or Process]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "(Blobel,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.343: The EGF receptormediated cell proliferation and migration of human mammary epithelial cells can be blocked with metalloproteinase inhibitors, demonstrating that relevant EGF receptor ligands need to be cleaved from the membrane to become activated (Dong et al., 1999). 

Phrase: "The EGF receptormediated cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferation [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "migration of human mammary epithelial cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C2611926:epithelial cell migration [Cell Function]
   783   C0237731:Human Migration [Social Behavior]
   783   C1622501:cells migration [Cell Function]
   753   C0600210:Migration [Social Behavior]
   753   C1533574:Migration [Physiologic Function]
   753   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "blocked with metalloproteinase inhibitors,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   816   C1152589:metalloproteinase inhibitor [Molecular Function]
   770   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0028778:Blocked [Pathologic Function]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C1999216:Inhibitor [Qualitative Concept]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "demonstrating"

Phrase: "that relevant EGF receptor ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   906   C1749409:EGF receptor ligand [Molecular Function]
   844   C1621296:receptor ligand [Molecular Function]
   812   C0023688:Ligands [Chemical]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cleaved from the membrane to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "become"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "(Dong et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.344: Also, the EGF receptor transactivation caused by G proteincoupled receptors requires metalloproteinase cleavage of the EGF-ligand heparin-binding EGF-like growth factor (Prenzel et al., 1999). 

Phrase: "Also,"

Phrase: "the EGF receptor transactivation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3158809:receptor transactivation [Physiologic Function]
   827   C0040624:Transactivation [Genetic Function]
   734   C0034802:Receptor, EGF [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "caused by G proteincoupled receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439267:g% [Quantitative Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "requires"

Phrase: "metalloproteinase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "of the EGF-ligand heparin-binding EGF-like growth factor"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   923   C0058402:Heparin-Binding EGF-Like Growth Factor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   923   C0166825:heparin-binding EGF-like growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1539630:HEPARIN-BINDING EGF-LIKE GROWTH FACTOR [Gene or Genome]
           HEPARIN-BINDING EGF
   875   C0599765:Heparin Binding Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1522455:Heparin Binding Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   836   C1522951:EGF binding [Molecular Function]
   822   C1517880:Ligand Binding [Molecular Function]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1148608:Heparin Binding [Molecular Function]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C0220844:growth [Physiologic Function]
   793   C0243122:binding [Functional Concept]
   793   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1521761:Factor [Functional Concept]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]

Phrase: "(Prenzel et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.345: Earlier work has implicated ectodomain shedding as an important element for EGF receptor signaling in development (Peschon et al., 1998). 

Phrase: "Earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "implicated ectodomain shedding as an important element"

Phrase: "for EGF receptor signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1514762:Receptor Signaling [Molecular Function]
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
   734   C0034802:Receptor, EGF [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "in development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "(Peschon et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.346: Mice lacking TACE/ADAM17 have phenotypes that resemble those seen in TGF- and EGF receptor deficient animals (Peschon et al., 1998). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "TACE/ADAM17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0529196:ADAM-17 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1412186:ADAM17 [Gene or Genome]
   861   C1706640:ADAM 17 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031437:Phenotypes [Organism Attribute]
   966 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "that"

Phrase: "resemble"

Phrase: "those"

Phrase: "seen in TGF-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205397:Seen [Qualitative Concept]
   790   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "EGF receptor deficient animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "(Peschon et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.347: Thus, the membrane-anchored form of TGF- has to be released by proteolysis before it can fulfill its function as EGF receptor ligand. 

Phrase: "Thus,"

Phrase: "the membrane-anchored form of TGF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "released by proteolysis"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0391871:Released [Functional Concept]
   790   C0597304:Proteolysis [Molecular Function]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]
   718 E C1947941:proteolytic [Enzyme]

Phrase: "before"

Phrase: "it"

Phrase: "can"

Phrase: "fulfill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "its function as EGF receptor ligand."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0920644:function receptor [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.348: ADAM mediated cleavage is also involved in Notch signaling, which is important in regulating cell fate during development (Artavanis-Tsakonas et al., 1999). 

Phrase: "ADAM"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "also"

Phrase: "involved in Notch signaling,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037083:Signaling [Cell Function]
   770   C1235660:Notch [Body Space or Junction]
   770   C1314939:Involved [Functional Concept]
   770   C3537152:signaling [Biologic Function]

Phrase: "which"

Phrase: "is"

Phrase: "important in"

Phrase: "regulating"

Phrase: "cell fate during development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1540661:cell fate [Cell Function]
   770   C1539479:FATE [Gene or Genome]

Phrase: "(Artavanis-Tsakonas et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.349: The extracellular domain of Notch can be cleaved by ADAM10 or ADAM17 (Brou et al., 2000; Mumm et al., 2000). 

Phrase: "The extracellular domain of Notch"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1517050:Extracellular Domain [Spatial Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "cleaved by ADAM10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]
   790   C1412181:ADAM10 [Gene or Genome]
   790   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "ADAM17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0529196:ADAM-17 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412186:ADAM17 [Gene or Genome]
  1000   C1706640:ADAM 17 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Brou et al.,"

Phrase: "2000"

Phrase: "; Mumm et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.350: The cytoplasmic domain then enters the nucleus and, in cooperation with a transcription factor, activates the Notch-dependent genetic program (Artavanis-Tsakonas et al., 1999). 

Phrase: "The cytoplasmic domain then"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1511625:Cytoplasmic Domain [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: ","

Phrase: "in cooperation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392337:cooperation [Social Behavior]

Phrase: "with a transcription factor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the Notch-dependent genetic program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "(Artavanis-Tsakonas et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.351: These examples support the notion that regulated proteolysis is an important element in cell signaling and in the cross-communication between different signaling systems (Prenzel et al., 1999; Blobel, 2000). 

Phrase: "These examples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707959:Example [Conceptual Entity]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that regulated proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "is"

Phrase: "an important element in cell signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0037083:Cell Signaling [Cell Function]
           Signaling
   804   C3537152:signaling [Biologic Function]

Phrase: "and in the cross-communication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0009452:Communication [Social Behavior]
   760   C1515981:And [Idea or Concept]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "between different signaling systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "(Prenzel et al.,"

Phrase: "1999"

Phrase: "; Blobel,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.352: Our results show that cleavage of a membrane-bound adhesion molecule can initiate integrin signaling via its RGD-containing ectodomain. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that cleavage of a membrane-bound adhesion molecule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "can"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "integrin signaling via its RGD-containing ectodomain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037083:Signaling [Cell Function]
   748   C3537152:signaling [Biologic Function]
Processing 00000000.tx.353: Many of the intracellular signaling cascades influenced by soluble growth factors and their receptors are also regulated by integrins (Giancotti and Ruoslahti, 1999). 

Phrase: "Many of the intracellular signaling cascades"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   822   C1155494:intracellular signaling cascade [Molecular Function]
   773   C2611812:signaling cascade [Cell Function]
   753   C0037083:Signaling [Cell Function]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0439064:Many [Quantitative Concept]
   753   C0747726:many [Conceptual Entity]
   753   C3537152:signaling [Biologic Function]
   719   C1707310:Cascade [Manufactured Object]
   719 E C1710082:Signal [Phenomenon or Process]

Phrase: "influenced by soluble growth factors"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0814287:factors influence [Clinical Attribute]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "their receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "also"

Phrase: "regulated by integrins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "(Giancotti"

Phrase: "and"

Phrase: "Ruoslahti,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.354: In fact, growth factors and integrin-mediated signals often act synergistically on cell functions (Sieg et al., 2000). 

Phrase: "In fact,"

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "integrin-mediated signals often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically on cell functions"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0007613:cell functions [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0542341:Functions [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "(Sieg et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.355: Ectodomain cleavage of membrane molecules is accelerated under pathological conditions such as inflammation and apoptosis and by diverse stimuli (Hooper et al., 1997; Subramanian et al., 1997). 

Phrase: "Ectodomain cleavage of membrane molecules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1157978:ectodomain cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "is"

Phrase: "accelerated under pathological conditions"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C0521110:Accelerated [Functional Concept]
   770   C1521733:Pathological [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "such as inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and by diverse stimuli"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234402:Stimuli [Phenomenon or Process]
   770   C1515981:And [Idea or Concept]
   770   C1880371:Diverse [Qualitative Concept]

Phrase: "(Hooper et al.,"

Phrase: "1997"

Phrase: "; Subramanian et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.356: In addition to PMA and pervanadate, other agents that also induce shedding include calcium ionophores, chemotactic peptides, cytokines, and growth factors. 

Phrase: "In addition to PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "and"

Phrase: "pervanadate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "other agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "that also"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "shedding"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "calcium ionophores,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0444420:Calcium Ionophores [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0022022:Ionophores [Pharmacologic Substance]
   827 E C1517596:ionophore [Molecular Function]

Phrase: "chemotactic peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "growth factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.357: Recently, it was shown that in A549 cells integrin ligation could augment the shedding of the hepatocyte growth factor receptor Met (Nath et al., 2001). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in A549 cells integrin ligation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0023690:Ligation [Therapeutic or Preventive Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "the shedding"

Phrase: "of the hepatocyte growth factor receptor Met (Nath et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.358: Cells grown on collagen released significantly more Met than when cultivated on uncoated plastic and this induction involved activation of the erk signaling pathway (Nath et al., 2001). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grown on collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C1167364:collagen [Cell Component]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "significantly more"

Phrase: "Met than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1550543:Meet [Idea or Concept]

Phrase: "when"

Phrase: "cultivated on uncoated plastic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032167:Plastic [Substance]
   770   C1519767:Uncoated [Qualitative Concept]

Phrase: "and"

Phrase: "this induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "activation of the erk signaling pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "(Nath et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.359: Although we have not yet tested any influence of integrin engagement in our system, it seems reasonable to assume that shedding of L1 has to be maintained during cell migration. 

Phrase: "Although"

Phrase: "we"

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "any influence of integrin engagement"

Phrase: "in our system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "reasonable to"

Phrase: "assume"

Phrase: "that shedding of L1"

Phrase: "has"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "maintained during cell migration."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C1622501:Migration, Cell [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0600210:Migration [Social Behavior]
   770   C1269647:Cell [Cell]
   770   C1314677:Maintained [Functional Concept]
   770   C1533574:Migration [Physiologic Function]
   770   C1704653:Cell [Medical Device]
   770   C1881827:MIGRATION [Phenomenon or Process]
   770   C1948049:Cell [Spatial Concept]
   737 E C0024501:Maintain [Activity]
Processing 00000000.tx.360: Extracellular matrix components serving as substrate for cell migration might induce signals that lead to sustained cleavage. 

Phrase: "Extracellular matrix components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "serving as substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1519269:Serving [Quantitative Concept]
   790   C1710236:Substrate [Manufactured Object]

Phrase: "for cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "might"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "that lead to sustained cleavage."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.361: If indeed this is the case, it could explain our observation that the enhanced migration of L1-CHO cells was observed on diverse substrates like fibronectin, laminin, and vitronectin. 

Phrase: "If"

Phrase: "indeed"

Phrase: "this"

Phrase: "is"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "it"

Phrase: "could"

Phrase: "explain"

Phrase: "our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the enhanced migration of L1-CHO cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1622501:cells migration [Cell Function]
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "was"

Phrase: "observed on diverse substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441672:Observed [Functional Concept]
   770   C1880371:Diverse [Qualitative Concept]
   737   C1710236:Substrate [Manufactured Object]

Phrase: "like fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "vitronectin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]
Processing 00000000.tx.362: Indeed, in previous work we have observed a link between the rate of L1 shedding and cytoskeletal changes (Gutwein et al., 2000). 

Phrase: "Indeed,"

Phrase: "in previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "we"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a link between the rate of L1 shedding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1517892:Link [Intellectual Product]
   744   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "cytoskeletal changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "(Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.363: The cytoplasmic domain of L1 can associate with several kinases as well as with the membrane skeletal protein ankyrin (Kamiguchi and Lemmon, 1997). 

Phrase: "The cytoplasmic domain of L1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1511625:Cytoplasmic Domain [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "can"

Phrase: "associate with several kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]

Phrase: "as well as with the membrane skeletal protein ankyrin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   762   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0025255:Membrane [Tissue]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0037253:skeletal [Body System]
   742   C0051926:Ankyrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205170:Well [Qualitative Concept]
   742   C0521324:Skeletal [Spatial Concept]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]
   742   C3146287:Well [Manufactured Object]

Phrase: "(Kamiguchi"

Phrase: "and"

Phrase: "Lemmon,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.364: It is possible that for the regulated cleavage these interactions are indispensable. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that for the regulated cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1330957:cleavage [Cell Function]

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "indispensable."
Processing 00000000.tx.365: How then can the cleavage of L1 be enhanced in MCD treated cells? 

Phrase: "How then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "can"

Phrase: "the cleavage of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "be"

Phrase: "enhanced in MCD treated cells?"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C2349975:Enhanced [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.366: A recent study has shown that the cleavage of APP by the -secretase ADAM10 was augmented in MCD treated cells. 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "by the -secretase ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412181:ADAM10 [Gene or Genome]
   861   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "augmented in MCD treated cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   753   C0205217:Augmented [Quantitative Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.367: The increase in enzymatic activity of ADAM10 was correlated with enhanced membrane fluidity (Kojiro et al., 2001). 

Phrase: "The increase in enzymatic activity of ADAM10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "correlated with enhanced membrane fluidity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0025245:Membrane Fluidity [Molecular Function]
   760   C0025255:Membrane [Tissue]
   760   C0596579:fluidity [Quantitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   760   C1707520:Correlated [Qualitative Concept]
   760   C2349975:Enhanced [Activity]

Phrase: "(Kojiro et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.368: The results presented in this study provide first evidence that at least in cultured cell lines ADAM10 was involved in the cleavage of L1, as a dominant-negative form of ADAM10, that was shown before to suppress cleavage of APP (Lammich et al., 1999), also affected the release of L1. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in this study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that at least"

Phrase: "in cultured cell lines ADAM10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1412181:ADAM10 [Gene or Genome]
   812   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]
   723   C0007600:Cultured Cell Line [Cell]

Phrase: "was"

Phrase: "involved in the cleavage of L1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0010813:cleavage [Cell Function]
   753   C0441918:L1 [Finding]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1179698:L1 [Body Location or Region]
   753   C1314939:Involved [Functional Concept]
   753   C1330957:cleavage [Cell Function]
   753   C1416177:L1 [Gene or Genome]

Phrase: "as"

Phrase: "a dominant-negative form of ADAM10,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1513916:Negative [Finding]
   753   C1522492:Form [Functional Concept]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "before to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332152:Before [Temporal Concept]
   861   C1705850:Before [Intellectual Product]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "(Lammich et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the release of L1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.369: These data confirm and extend previous data showing that ADAM10 activity can be augmented by cholesterol efflux of the membrane. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ADAM10 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "augmented by cholesterol efflux of the membrane."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C2246761:cholesterol efflux [Cell Function]
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   748   C0025255:Membrane [Tissue]
   748   C0205217:Augmented [Quantitative Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.370: The exact molecular mechanism of this enhanced cleavage remains to be investigated. 

Phrase: "The exact molecular mechanism of this enhanced cleavage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.371: The similarity with the APP system supports the notion that ADAM10 is involved in L1 cleavage, very likely as the executing enzyme. 

Phrase: "The similarity with the APP system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similarity [Qualitative Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "involved in L1 cleavage,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0010813:cleavage [Cell Function]
   770   C0441918:L1 [Finding]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1179698:L1 [Body Location or Region]
   770   C1314939:Involved [Functional Concept]
   770   C1330957:cleavage [Cell Function]
   770   C1416177:L1 [Gene or Genome]

Phrase: "very likely as the executing enzyme."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0332148:Likely [Qualitative Concept]
   753   C0442824:Very [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]
   753   C1552093:executing [Intellectual Product]
   719 E C1705848:Execute [Activity]
   719 E C3245498:execute [Functional Concept]
Processing 00000000.tx.372: Direct biochemical evidence for the cleavage of L1 by ADAM10 is presently not available. 

Phrase: "Direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "biochemical evidence for the cleavage of L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "by ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "presently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750528:presently [Idea or Concept]

Phrase: "not available."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.373: It is possible that ADAM10 is inhibited by cholesterol itself or by a cholesterol-dependent associated protein not yet identified. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "inhibited by cholesterol"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "itself"

Phrase: "or by a cholesterol-dependent associated protein"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332281:Associated [Qualitative Concept]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.374: Perhaps depletion of cholesterol increases encounter rates between L1 and the metalloproteinase. 

Phrase: "Perhaps depletion of cholesterol increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0151718:cholesterol depletion [Pathologic Function]
   760   C0333668:Depletion [Functional Concept]

Phrase: "encounter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Encounter [Behavior]
  1000   C1512346:encounter [Health Care Activity]
  1000   C1947978:Encounter [Behavior]

Phrase: "rates between L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "the metalloproteinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.375: It remains to be seen whether other ectodomain cleavage processes are also sensitive to MCD treatment, or whether this is a particular feature of ADAM10. 

Phrase: "It"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "whether"

Phrase: "other ectodomain cleavage processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]
   734   C1157978:ectodomain cleavage [Molecular Function]

Phrase: "are"

Phrase: "also sensitive to MCD treatment,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1550474:sensitive [Idea or Concept]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "whether"

Phrase: "this"

Phrase: "is"

Phrase: "a particular feature of ADAM10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1521970:Feature [Qualitative Concept]
   760   C1706388:Feature [Conceptual Entity]
   760   C2346469:Feature [Qualitative Concept]
   760   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.376: A further important question is whether ADAM10 mediates L1 cleavage also during brain development. 

Phrase: "A further important question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "whether"

Phrase: "ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "L1 cleavage also during brain development."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
Processing 00000000.tx.377: We observed that cleavage of L1 in mouse brain was highest around birth. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that cleavage of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "in mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "highest around birth."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C1522410:Highest [Qualitative Concept]
   756 E C0205250:High [Qualitative Concept]
   756 E C1299351:High [Qualitative Concept]
   756 E C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]
Processing 00000000.tx.378: Indeed, a coordinated expression of APP and the -secretase ADAM10 was reported in mouse brain development (Marcinkiewicz and Seidah, 2000). 

Phrase: "Indeed,"

Phrase: "a coordinated expression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the -secretase ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412181:ADAM10 [Gene or Genome]
   861   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "reported in mouse brain development"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C1160340:brain development [Organ or Tissue Function]
   806   C1521713:Mouse Brain [Tissue]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1527148:Development [Functional Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(Marcinkiewicz"

Phrase: "and"

Phrase: "Seidah,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.379: The study of Nayeem et al. has provided the first evidence that in addition to metalloproteinase(s) the release of a large portion of the L1 ectodomain can be mediated by the plasmin/plasminogen proteolytic system (Nayeem et al., 1999). 

Phrase: "The study of Nayeem et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that in addition to metalloproteinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1883712:Addition [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "the release of a large portion of the L1 ectodomain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "mediated by the plasmin/plasminogen proteolytic system"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0449913:System [Functional Concept]
   748   C0597304:Proteolytic [Molecular Function]
   748   C1367553:PLASMINOGEN [Gene or Genome]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1947941:proteolytic [Enzyme]

Phrase: "(Nayeem et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.380: The activation of plasminogen to plasmin involves a cascade of inhibitors and activators and requires binding to the cell surface (Plow et al., 1995). 

Phrase: "The activation of plasminogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1622667:plasminogen activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "to plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "involves"

Phrase: "a cascade of inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707310:Cascade [Manufactured Object]

Phrase: "and"

Phrase: "activators"

Phrase: "and"

Phrase: "requires"

Phrase: "binding to the cell surface"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1624592:cell surface binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "(Plow et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.381: In the brain, plasminogen and its proteolytic fragment are abundant in the hippocampus (Chen and Strickland, 1997). 

Phrase: "In the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "plasminogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "and"

Phrase: "its proteolytic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "abundant in the hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "(Chen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.382: It has been known for a long time that growth cones and migrating neurons release plasmin-like proteases (Krystosek and Seeds, 1981). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "known for a long time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C0205309:Known [Qualitative Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "and"

Phrase: "migrating neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "plasmin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "like proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "(Krystosek"

Phrase: "and"

Phrase: "Seeds,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0036563:Seed [Plant]
  1000   C1705192:Seed [Laboratory Procedure]
  1000   C1882540:{Seed} [Quantitative Concept]
  1000   C2346495:Seed [Conceptual Entity]
   944 E C1519232:Seminal [Clinical Attribute]

Phrase: "1981"

Phrase: ")."
Processing 00000000.tx.383: Proteolysis is required during neurite outgrowth and neuronal migration is retarded in mice lacking the tissue-type plasminogen activator (tPA) gene (Seeds et al., 1999). 

Phrase: "Proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "is"

Phrase: "required during neurite outgrowth"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3158384:neurite outgrowth [Cell Function]
   770   C0085103:Neurite [Cell Component]
   770   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "neuronal migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1326504:neuronal migration [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "is"

Phrase: "retarded in mice"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0521111:Retarded [Qualitative Concept]
   718 E C0311403:Inhibited [Qualitative Concept]
   718 E C3463820:Inhibiting [Activity]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the tissue-type plasminogen activator (tPA) gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1367553:Plasminogen Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0032143:Tissue-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Tissue Plasminogen Activator
   722   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]

Phrase: "(Seeds et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.384: The proteolytic activation of plasminogen by the urokinase-type plasminogen activator, which is synthesized and secreted by many tumor cells, plays an important role in tumor cell migration and invasion into the surrounding tissue (Reuning et al., 1998). 

Phrase: "The proteolytic activation of plasminogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2249699:activation of proteolysis [Molecular Function]
   797   C1622667:plasminogen activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "by the urokinase-type plasminogen activator,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0042071:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Plasminogen Activator, Urokinase
           Urokinase
  1000   C1522670:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Urokinase Plasminogen Activator
           Urokinase
   923   C1335224:plasminogen activator, urokinase [Gene or Genome]
           UROKINASE
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "secreted by many tumor cells,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0431085:Tumor cells [Cell]
   773 E C0597032:Tumor Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0027651:Tumor [Neoplastic Process]
   760   C1327616:Secreted [Cell Function]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in tumor cell migration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "invasion into the surrounding tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1269955:Invasion [Finding]
   760   C2699153:Invasion [Pathologic Function]

Phrase: "(Reuning et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.385: We demonstrate here that the 150-kD fragment of L1 generated and released following plasmin cleavage can also promote cell migration as it contains the RGDs in the 6.Ig domain. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "here"

Phrase: "that"

Phrase: "the 150-kD fragment of L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "plasmin cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "can"

Phrase: "also"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "as"

Phrase: "it"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the RGDs in the 6.Ig domain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1335588:RGDS [Gene or Genome]
Processing 00000000.tx.386: This raises the possibility that L1-150 can substitute for the complete ectodomain of L1. 

Phrase: "This"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that L1-150"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "substitute for the complete ectodomain of L1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205197:Complete [Qualitative Concept]
   748   C0441918:L1 [Finding]
   748   C0725685:COMPLEAT [Food]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
Processing 00000000.tx.387: The generation of L1-150 is evidently dependent on the availability of plasminogen and a cellular source of plasminogen activators and may therefore be restricted. 

Phrase: "The generation of L1-150"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "is"

Phrase: "evidently dependent on the availability of plasminogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "a cellular source of plasminogen activators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "may"

Phrase: "therefore"

Phrase: "be"

Phrase: "restricted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]
Processing 00000000.tx.388: In contrast, as shown in this study the release of L1 via metalloproteinase-mediated cleavage appears to be more abundant, at least in cultured human tumor cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "as"

Phrase: "shown in this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the release of L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "via metalloproteinase-mediated cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more abundant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundant [Qualitative Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in cultured human tumor cells."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   923   C0041362:Tumor Cells, Cultured [Cell]
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   875   C0427861:Human cells [Laboratory or Test Result]
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.389: In summary, membrane-released L1 can promote cell migration in two ways. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "membrane-released L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441918:L1 [Finding]
   827   C1179698:L1 [Body Location or Region]
   827   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell migration in two ways."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1622501:Migration, Cell [Cell Function]
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.390: First, soluble L1 can be immobilized into the surrounding matrix by the specific binding to laminin (Montgomery et al., 1996) or the proteoglycan neurocan (Oleszewski et al., 2000). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "soluble L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "immobilized into the surrounding matrix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1282914:Surrounding [Spatial Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "by the specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "to laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Montgomery et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "or"

Phrase: "the proteoglycan neurocan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1413764:NEUROCAN [Gene or Genome]
   861   C2326566:Neurocan [Amino Acid, Peptide, or Protein]

Phrase: "(Oleszewski et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.391: As shown before, immobilized L1 can serve as a potent substrate for cell migration. 

Phrase: "As"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "before,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "immobilized L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "can"

Phrase: "serve as a potent substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]

Phrase: "for cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.392: Second, as presented in this publication, soluble L1 fragments can directly interact with cells and stimulate cell migration. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "as"

Phrase: "presented in this publication,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0034036:Publication [Intellectual Product,Manufactured Object]
   770   C0034037:Publication [Occupational Activity]
   770   C0449450:Presented [Idea or Concept]
   770   C1704324:Publication [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "soluble L1 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "interact with cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "stimulate"

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.393: The metalloproteinase-released ectodomain was able to stimulate migration through autocrine/paracrine binding to integrins. 

Phrase: "The metalloproteinase-released ectodomain"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "stimulate"

Phrase: "migration through autocrine/paracrine binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600210:Migration [Social Behavior]
   760   C1533574:Migration [Physiologic Function]
   760   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "to integrins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.394: This is reminiscent of recent studies on ephrins and deleted in colorectal cancer (DCC) showing that proteolytic cleavage plays a critical role in regulating cell movements. 

Phrase: "This"

Phrase: "is"

Phrase: "reminiscent of recent studies"

Phrase: "on ephrins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1136111:Ephrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1323366:ephrin [Molecular Function]

Phrase: "and"

Phrase: "deleted in colorectal cancer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0009402:Colorectal Cancer [Neoplastic Process]
   833   C1527249:Colo-rectal cancer [Neoplastic Process]
   833   C2984278:Colorectal cancer [Functional Concept]
   833   C3542412:Colorectal Cancer [Intellectual Product]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0555952:Colorectal [Spatial Concept]
   770   C0998265:Cancer [Eukaryote]
   770   C1306459:Cancer [Finding]
   770   C1880274:Deleted [Activity]

Phrase: "("

Phrase: "DCC"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0009402:Colorectal Cancer [Neoplastic Process]
   833   C1527249:Colo-rectal cancer [Neoplastic Process]
   833   C2984278:Colorectal cancer [Functional Concept]
   833   C3542412:Colorectal Cancer [Intellectual Product]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0555952:Colorectal [Spatial Concept]
   770   C0998265:Cancer [Eukaryote]
   770   C1306459:Cancer [Finding]
   770   C1880274:Deleted [Activity]

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that proteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "cell movements."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007608:cell movement [Cell Function]
  1000   C1621968:Cell Movement [Cell Function]
   861   C0026649:Movement [Organism Function]
Processing 00000000.tx.395: The ability of soluble L1 to stimulate cell migration could be relevant for migratory processes under many physiological and pathophysiological conditions.  

Phrase: "The ability of soluble L1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "could"

Phrase: "be"

Phrase: "relevant for migratory processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "under many physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathophysiological conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.396: Materials and methods Top Abstract Introduction Results Discussion Materials and methods References  Cells Human breast tumor cell lines AR, MDA-231, MDA-435, SKBr3, and the ovarian tumor cell lines SKOV3 and OAW42 were cultivated in DME supplemented with 10% FBS at 37C, 5% CO2, and 100% humidity. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cells Human breast tumor cell lines AR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   883   C1447749:androgen receptor, human [Amino Acid, Peptide, or Protein,Receptor]
           Androgen Receptor
   812   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0002844:Androgen [Hormone,Pharmacologic Substance]
   793   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C3536949:Androgen [Pharmacologic Substance]

Phrase: "MDA-231,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   861   C0026374:MDA [Geographic Area]

Phrase: "MDA-435,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000379:MDA [Organic Chemical,Pharmacologic Substance]
   861   C0026374:MDA [Geographic Area]

Phrase: "SKBr3,"

Phrase: "and"

Phrase: "the ovarian tumor cell lines SKOV3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0085983:Tumor Cell Lines [Cell]

Phrase: "and"

Phrase: "OAW42"

Phrase: "were"

Phrase: "cultivated in DME"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "at 37C,"

Phrase: "5% CO2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "100% humidity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0020167:Humidity [Natural Phenomenon or Process]
   861   C0869465:Humidity [Natural Phenomenon or Process]
   789 E C0205381:Humid [Qualitative Concept]
Processing 00000000.tx.397: All cell lines were obtained from the tumor bank of the German Cancer Research Center (Heidelberg, Germany). 

Phrase: "All cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from the tumor bank of the German Cancer Research Center"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   756   C0683939:research center [Manufactured Object,Organization]
   756   C1516225:Cancer Research [Research Activity]
   756   C1519671:Tumor Bank [Manufactured Object]
   754   C1513817:Cancer Center [Health Care Related Organization]
   738   C0006826:Cancer [Neoplastic Process]
   738   C0027651:Tumor [Neoplastic Process]
   738   C0035168:research [Research Activity]
   738   C0205099:Center [Spatial Concept]
   738   C0242481:Research [Research Activity]
   738   C0442598:Bank [Manufactured Object]
   738   C0872261:Bank [Manufactured Object]
   738   C0998265:Cancer [Eukaryote]
   738   C1301820:Obtained [Functional Concept]
   738   C1306459:Cancer [Finding]
   738   C1556085:German [Population Group]
   738   C1578706:Tumor [Intellectual Product]
   738   C3273930:Tumor [Finding]
   704 E C1706701:Obtain [Activity]

Phrase: "(Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.398: CHO cells stably transfected with human (hL1-CHO) or mouse L1 (mL1-CHO) were described before (Gutwein et al., 2000). 

Phrase: "CHO cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Human [Human]

Phrase: "(hL1-CHO)"

Phrase: "or"

Phrase: "mouse L1 (mL1-CHO)"

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "(Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.399: Ectodomain swapped fusion proteins between human L-selectin (CD69L) and mouse L1 were constructed using PCR. 

Phrase: "Ectodomain"

Phrase: "swapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1416521:SWAP [Gene or Genome]
   966   C1419999:SWAP [Gene or Genome]

Phrase: "fusion proteins between human L-selectin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   837   C2742135:selectin L protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(CD69L"

Phrase: ")"

Phrase: "and"

Phrase: "mouse L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]
Processing 00000000.tx.400: In brief, the L1 ectodomain (amino acids M1 to E1123) were amplified and fused to the transmembrane and cytoplasmic part of CD69L (amino acids P346 to Y385). 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "the L1 ectodomain"

Phrase: "(amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "M1 to E1123"

Phrase: ")"

Phrase: "were"

Phrase: "amplified"

Phrase: "and"

Phrase: "fused to the transmembrane"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0699952:Fused [Functional Concept]
   770   C1167322:transmembrane [Cell Component]
   770   C2752508:transmembrane [Cell Component]
   737 E C1414861:FUSE [Gene or Genome]
   737 E C1708111:Fuse [Manufactured Object]

Phrase: "and"

Phrase: "cytoplasmic part of CD69L"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1292711:Part of [Spatial Concept]
   833   C1820050:cytoplasmic part [Cell Component]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "(amino acids P346 to Y385"

Phrase: ")."
Processing 00000000.tx.401: The ectodomain of CD69L (amino acids M1 to L319) was amplified and fused to the COOH-terminal L1 fragment (amino acids I1090 to E1260). 

Phrase: "The ectodomain of CD69L"

Phrase: "(amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "M1 to L319"

Phrase: ")"

Phrase: "was"

Phrase: "amplified"

Phrase: "and"

Phrase: "fused to the COOH-terminal L1 fragment"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0205088:Terminal [Temporal Concept]
   748   C0332255:fragment [Functional Concept]
   748   C0441918:L1 [Finding]
   748   C0699952:Fused [Functional Concept]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1708096:Fragment [Qualitative Concept]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: "(amino acids I1090 to E1260"

Phrase: ")."
Processing 00000000.tx.402: The latter fragment comprises the 34 membrane-proximal amino acids, the transmembrane and the cytoplasmic part of mouse L1. 

Phrase: "The latter fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the 34 membrane-proximal amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "the transmembrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167322:transmembrane [Cell Component]
  1000   C2752508:transmembrane [Cell Component]

Phrase: "and"

Phrase: "the cytoplasmic part of mouse L1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1292711:Part of [Spatial Concept]
   790   C1820050:cytoplasmic part [Cell Component]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.403: Mouse L1 devoid of RGDs (D555E and D564E) was constructed by site-directed mutagenesis as described previously (Oleszewski et al., 1999). 

Phrase: "Mouse L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "devoid of RGDs"

Phrase: "(D555E"

Phrase: "and"

Phrase: "D564E"

Phrase: ")"

Phrase: "was"

Phrase: "constructed by site-directed mutagenesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C3146302:Mutagenesis [Laboratory Procedure]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
   726   C2827421:Construct [Classification]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.404: All cDNA constructs were cloned into pCDNA3 and confirmed by DNA sequencing. 

Phrase: "All cDNA constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "cloned into pCDNA3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009013:cloned [Cell]
   756 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "confirmed by DNA sequencing."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.405: Plasmid DNAs were transfected into CHO cells. 

Phrase: "Plasmid DNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "transfected into CHO cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.406: G418 resistant colonies were stained for L1 or CD69L followed by the respective secondary antibodies, and positive cells were selected by several rounds of FACS sorting (Beer et al., 1999). 

Phrase: "G418 resistant colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "stained for L1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0441918:L1 [Finding]
   790   C1179698:L1 [Body Location or Region]
   790   C1416177:L1 [Gene or Genome]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "CD69L"

Phrase: "followed by the respective secondary antibodies,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0439178:% positive cells [Quantitative Concept]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "selected by several rounds of FACS sorting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0237886:Sorting [Mental Process]
   748   C0700314:sorting [Cell Function]
   748   C1947906:Sorting [Activity]
   714   C0332490:Round [Spatial Concept]
   714   C1707391:Select [Activity]

Phrase: "(Beer et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.407: SKOV3 cells with high or low expression of L1 (SKOV3hi or SKOV3lo) were established by three rounds of FACS sorting using an antibody to L1 and regrowth of sorted cells. 

Phrase: "SKOV3 cells with high"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "low expression of L1 (SKOV3hi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "SKOV3lo"

Phrase: ")"

Phrase: "were"

Phrase: "established by three rounds of FACS sorting"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205449:Three [Quantitative Concept]
   748   C0237886:Sorting [Mental Process]
   748   C0443211:Established [Qualitative Concept]
   748   C0700314:sorting [Cell Function]
   748   C1272684:Established [Qualitative Concept]
   748   C1947906:Sorting [Activity]
   714   C0332490:Round [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody to L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "regrowth of sorted cells."
Processing 00000000.tx.408: A similar protocol was applied to OAW42 cells. 

Phrase: "A similar protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "applied to OAW42 cells."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0185125:Applied [Health Care Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1632850:Apply [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1879355:Apply [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.409: Cells were kept in DME and cultivated at 37C, 5% CO2, and at 100% humidity. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "kept in DME"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C0333118:Keep [Functional Concept]

Phrase: "and"

Phrase: "cultivated at 37C,"

Phrase: "5% CO2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "and at 100% humidity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020167:Humidity [Natural Phenomenon or Process]
   770   C0869465:Humidity [Natural Phenomenon or Process]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.410: Plasmids encoding bovine HA-tagged ADAM10 and a dominant-negative form of ADAM10 carrying a E384A substitution (Flag-tagged ADAM10 DN) were described previously (Lammich et al., 1999). 

Phrase: "Plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "bovine HA-tagged ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1412181:ADAM10 [Gene or Genome]
   812   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "a dominant-negative form of ADAM10"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1513916:Negative [Finding]
   753   C1522492:Form [Functional Concept]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a E384A substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "(Flag-tagged ADAM10 DN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1333964:DN [Disease or Syndrome]
   812   C1707618:DN [Intellectual Product]

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Lammich et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.411: Transient expression was achieved by transfection of AR cells with superfect (Stratagene). 

Phrase: "Transient expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "achieved by transfection of AR cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C1514760:Receptor Cell [Cell]
   748   C0002844:Androgen [Hormone,Pharmacologic Substance]
   748   C0007634:Cells [Cell]
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C3282337:Cells [Cell]
   748   C3536949:Androgen [Pharmacologic Substance]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "with superfect"

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.412: Analysis of shed L1 in the culture supernatants by ELISA was done 48 h later (see below). 

Phrase: "Analysis of shed L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in the culture supernatants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]
   827   C1550101:Supernatant [Body Substance]

Phrase: "by ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "was"

Phrase: "done"

Phrase: "48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205087:Late [Temporal Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.413: Chemicals and antibodies mAb 324 against the mouse L1 adhesion molecule, mAb UJ 127.11 against human L1, and mAb 79 against mouse CD24 were described before (Ebeling et al., 1996; Beer et al., 1999). 

Phrase: "Chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "and"

Phrase: "antibodies mAb 324 against the mouse L1 adhesion molecule,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   764   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0001511:Adhesion [Pathologic Function]
   742   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0175633:Adhesion [Natural Phenomenon or Process]
   742   C0441918:L1 [Finding]
   742   C0567416:Molecule [Substance]
   742   C1179698:L1 [Body Location or Region]
   742   C1416177:L1 [Gene or Genome]
   708 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "mAb UJ 127.11 against human L1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0086418:Human [Human]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "mAb 79 against mouse CD24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "(Ebeling et al.,"

Phrase: "1996"

Phrase: "; Beer et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.414: mAb DREG56 against human CD69L was obtained from E.C. 

Phrase: "mAb DREG56 against human CD69L"

Phrase: "was"

Phrase: "obtained from E.C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.415: Butcher (Stanford University, Stanford, CA). 

Phrase: "Butcher"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335755:BUTCHER [Professional or Occupational Group]
  1000   C1706208:Butcher [Activity]

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA)."
Processing 00000000.tx.416: The mAb to v5 (P1F6) was obtained from Chemicon, the mAb to human CD49e (SAM-1) was from Dianova, the human L1 mAb 5G3 was obtained from Becton Dickinson, and the mAb to CD49f (GoH3) was obtained from Beckman Coulter. 

Phrase: "The mAb to v5 (P1F6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "was"

Phrase: "obtained from Chemicon,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the mAb to human CD49e"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(SAM-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036002:SAM [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0279268:SAM [Therapeutic or Preventive Procedure]
   861   C1563296:SAM [Pathologic Function]

Phrase: ")"

Phrase: "was from Dianova,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "the human L1 mAb 5G3"

Phrase: "was"

Phrase: "obtained from Becton Dickinson,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0331782:Becton Dickinson [Health Care Related Organization]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "the mAb to CD49f"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(GoH3"

Phrase: ")"

Phrase: "was"

Phrase: "obtained from Beckman Coulter."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.417: Polyclonal antibodies to the human L1 cytoplasmic domain (pcytL1) were produced by immunizing a rabbit with a recombinant L1 cytoplasmic fragment expressed in bacteria. 

Phrase: "Polyclonal antibodies to the human L1 cytoplasmic domain"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   750   C0312620:Cytoplasmic antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(pcytL1"

Phrase: ")"

Phrase: "were"

Phrase: "produced by immunizing"

Phrase: "a rabbit with a recombinant L1 cytoplasmic fragment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034493:Rabbit [Mammal]

Phrase: "expressed in bacteria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0004611:Bacteria [Bacterium]
   790   C1510439:bacteria [Functional Concept]
   790   C2347473:% Bacteria [Quantitative Concept]
   718 E C0521009:Bacterial [Qualitative Concept]
Processing 00000000.tx.418: PMA, sodium vanadate, MCD, and laminin from pepsinized human placenta (laminin-10/11) were obtained from Sigma-Aldrich. 

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "sodium vanadate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   861   C0042305:Vanadate [Inorganic Chemical]

Phrase: "MCD,"

Phrase: "and"

Phrase: "laminin from pepsinized human placenta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(laminin-10/11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0767106:laminin-10 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Sigma-Aldrich."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1719918:Sigma [Intellectual Product]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.419: Vitronectin and bovine serum fibronectin were purchased from Life Technologies, and human plasmin and 2-antiplasmin were obtained from Calbiochem. 

Phrase: "Vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "and"

Phrase: "bovine serum fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purchased from Life Technologies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C0869011:purchased [Activity]

Phrase: "and"

Phrase: "human plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "2-antiplasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003410:Antiplasmin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Calbiochem."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.420: BB-3103 was a gift of British Biotech, and Ro 31-9790 was obtained from Roche. 

Phrase: "BB-3103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "was"

Phrase: "a gift of British Biotech,"

Phrase: "and"

Phrase: "Ro 31-9790"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0385836:Ro 31-9790 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0035826:RO [Geographic Area]
   827   C0450355:31 [Intellectual Product]
   827   C1413096:RO [Gene or Genome]
   827   C2987048:RO [Gene or Genome]

Phrase: "was"

Phrase: "obtained from Roche."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0331965:Roche [Health Care Related Organization]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.421: Immunfluorescence The surface staining of cells with saturating amounts of mAbs, either hybridoma supernatants or purified antibodies, and phenylephrine-conjugated goat antibodies to mouse Ig (Dianova) has been described elsewhere (Ebeling et al., 1996). 

Phrase: "Immunfluorescence"

Phrase: "The surface staining of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "with saturating amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of mAbs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "either hybridoma supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "or"

Phrase: "purified antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "phenylephrine-conjugated goat antibodies to mouse Ig (Dianova"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(Ebeling et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.422: Stained cells were analyzed with a FACScan (Becton Dickinson) or sorted using a FACS Vantage. 

Phrase: "Stained cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed with a FACScan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "(Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")"

Phrase: "or"

Phrase: "sorted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237886:sorted [Mental Process]
  1000   C0700314:sorted [Cell Function]
  1000   C1947906:Sorted [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a FACS Vantage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0471146:vantage [Health Care Related Organization]
Processing 00000000.tx.423: Where indicated, cells were grown on coverslips and fixed with 2% paraformaldehyde/PBS before fluorescent staining and confocal microscopy analysis as previously described (Krauss and Altevogt, 1999). 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on coverslips"

Phrase: "and"

Phrase: "fixed with 2% paraformaldehyde/PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C2827483:Fixed [Body Substance]

Phrase: "before fluorescent staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0303920:Fluorescent stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Fluorescent
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "confocal microscopy analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0242842:Microscopy, Confocal [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Krauss"

Phrase: "and"

Phrase: "Altevogt,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.424: Analysis of L1 shedding These assays were described previously (Gutwein et al., 2000). 

Phrase: "Analysis of L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "shedding"

Phrase: "These assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.425: In brief, 2 x 106 cells were plated in 6-cm tissue culture plates in 5 ml of complete medium. 

Phrase: "In brief, 2 x 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in 6-cm tissue culture plates"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0040284:Tissue culture [Laboratory Procedure]
   778   C0180454:culture plates [Medical Device]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1139930:plates [Medical Device]
           plate
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   714   C0005971:Plate [Medical Device]
   714   C3537155:Plate [Manufactured Object]

Phrase: "in 5 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of complete medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.426: After 24 h at 37C, the complete medium was replaced by 1.7 ml serum-free culture medium for the indicated length of time. 

Phrase: "After 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C,"

Phrase: "the complete medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced by 1.7 ml serum-free culture medium"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   764   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   764   C1299987:Replaced by [Functional Concept]
           replaced
   762   C0128666:ML 7 [Organic Chemical]
   742   C0009458:Medium [Intellectual Product]
   742   C0010453:Culture [Idea or Concept]
   742   C0220814:culture [Functional Concept]
   742   C0229671:Serum [Body Substance]
   742   C0332296:free [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0439526:/mL [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C0559956:Replaced [Functional Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1705217:Medium [Substance]
   742   C1880497:Free [Qualitative Concept]
   742   C1996904:Free [Qualitative Concept]
   742   C2242979:Culture [Laboratory Procedure]
   742   C3244283:medium [Intellectual Product]
   708 E C1554078:Replace [Idea or Concept]

Phrase: "for the indicated length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "of time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.427: Cells remained firmly attached to the plastic surface. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "remained"

Phrase: "firmly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880776:Firmly [Qualitative Concept]

Phrase: "attached to the plastic surface."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0032167:Plastic [Substance]
   760   C0205148:Surface [Spatial Concept]
   760   C0231441:Attached [Finding]
   726 E C1314972:ATTACH [Intellectual Product]
Processing 00000000.tx.428: Where indicated, PMA (50 ng/ml) or pervanadate (200 mmolar) were included in the medium. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "(50 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(200 mmolar"

Phrase: ")"

Phrase: "were"

Phrase: "included in the medium."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0332257:included [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.429: A stock solution of pervanadate was freshly prepared by mixing a solution of H2O2 and sodium vanadate (Gutwein et al., 2000). 

Phrase: "A stock solution of pervanadate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "freshly"

Phrase: "prepared by mixing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205430:mixing [Functional Concept]
   756 E C1421951:MIX [Gene or Genome]
   756   C1521827:Prepare [Functional Concept]
   756 E C1720722:Mix [Qualitative Concept]

Phrase: "a solution of H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "sodium vanadate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   861   C0042305:Vanadate [Inorganic Chemical]

Phrase: "(Gutwein et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.430: MCD treatment (10 mM final concentration) for 30 min at 37C was done as described before (Krauss and Altevogt, 1999). 

Phrase: "MCD treatment"

Phrase: "(10 mM final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C"

Phrase: "was"

Phrase: "done"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "(Krauss"

Phrase: "and"

Phrase: "Altevogt,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.431: BB-3103 inhibitor was added 30 min before the addition of PMA or pervanadate or before MCD treatment. 

Phrase: "BB-3103 inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "30 min before the addition of PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0456693:/30 min [Temporal Concept]
   778   C1442458:30 min [Temporal Concept]
   748   C0702093:/min [Temporal Concept]

Phrase: "or"

Phrase: "pervanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0172341:pervanadate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or before MCD treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0010558:cyclodextrin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.432: Aliquots of the medium were TCA precipitated or immunoprecipitated with mAb to L1 and analyzed for the presence of L1 by Western blotting. 

Phrase: "Aliquots of the medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041405:TCA [Geographic Area]
  1000   C0085758:TCA [Congenital Abnormality]
  1000   C1415587:TCA [Gene or Genome]
  1000   C3536819:TCA [Pharmacologic Substance]

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "or"

Phrase: "immunoprecipitated with mAb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "to L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441918:L1 [Finding]
  1000   C1179698:L1 [Body Location or Region]
  1000   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "analyzed for the presence of L1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0441918:L1 [Finding]
   753   C0936012:Analyzed [Research Activity]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]

Phrase: "by Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.433: Alternatively, cells were removed from the tissue culture plastic surface by PBS/5 mM EDTA treatment for 5 min. 

Phrase: "Alternatively,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "removed from the tissue culture plastic surface"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0040284:Tissue culture [Laboratory Procedure]
   774   C1180156:Tissue surface [Body Location or Region]
   748   C0010453:Culture [Idea or Concept]
   748   C0032167:Plastic [Substance]
   748   C0040300:Tissue [Tissue]
   748   C0205148:Surface [Spatial Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0849355:Removed [Qualitative Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   714 E C1883720:Remove [Activity]
   714 E C3244314:remove [Functional Concept]

Phrase: "by PBS/5 mM EDTA treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.434: Shedding was analyzed by resuspending the cells in serum-free medium in 1.5 ml microfuge tubes at 37C for 1 h in the presence or absence of inducers and inhibitors. 

Phrase: "Shedding"

Phrase: "was"

Phrase: "analyzed by resuspending"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "the cells in serum-free medium"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0007634:THE CELL [Cell]
           Cells
   767   C1183428:Free cell [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in 1.5 ml microfuge tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0175730:tubes [Medical Device]
   804   C1547937:Tubes [Intellectual Product]
   804   C1704474:Tubes [Quantitative Concept]
   771 E C1561954:tube [Conceptual Entity]
   771 E C1704730:TUBE [Medical Device]

Phrase: "at 37C"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of inducers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "and"

Phrase: "inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.435: BB-3103 was used at 7 mM final concentration. 

Phrase: "BB-3103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0666068:BB 3103 [Organic Chemical,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "was"

Phrase: "used at 7 mM final concentration."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0086045:Concentration [Mental Process]
   753   C0205088:Final [Temporal Concept]
   753   C1273517:used [Finding]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1546485:Final [Idea or Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.436: In some experiments Ro 31-9790 at a final concentration of 30 mM was used with essentially similar results. 

Phrase: "In some experiments Ro 31-9790"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0385836:Ro 31-9790 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0035826:RO [Geographic Area]
   812   C0450355:31 [Intellectual Product]
   812   C0681814:Experiments [Research Activity]
   812   C1413096:RO [Gene or Genome]
   812   C2987048:RO [Gene or Genome]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "at a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 30 mM"

Phrase: "was"

Phrase: "used with essentially similar results."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C1273517:used [Finding]
   760   C2348205:Similar [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726 E C1947944:Use [Intellectual Product]
   726   C2825142:Result [Finding]
Processing 00000000.tx.437: Cell pellets and culture medium were separated by 10 min centrifugation in an Eppendorf centrifuge at 13,000 x g. 

Phrase: "Cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "separated by 10 min centrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0456692:/10 min [Temporal Concept]
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "in an Eppendorf centrifuge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0179834:centrifuge [Medical Device]

Phrase: "at 13,000 x g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.438: Culture supernatants from analyzed cells were TCA precipitated and redissolved in twofold-concentrated, nonreducing SDS-sample buffer. 

Phrase: "Culture supernatants from analyzed cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0007585:cells culture [Laboratory Procedure]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041405:TCA [Geographic Area]
  1000   C0085758:TCA [Congenital Abnormality]
  1000   C1415587:TCA [Gene or Genome]
  1000   C3536819:TCA [Pharmacologic Substance]

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "redissolved in twofold-concentrated, nonreducing SDS-sample buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0370003:Sample [Substance]
   744   C1880165:Concentrated [Biomedical or Dental Material]
   744   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.439: Cell pellets were lysed in lysis buffer (20 mM Tris/HCl, pH 8.0, containing 1% Triton X-100, 150 mM NaCl, 1 mM PMSF), cleared by centrifugation, and mixed with twofold-concentrated reducing SDS sample buffer. 

Phrase: "Cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "lysed in lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
           lysed
   770   C1536403:lysis [Cell Function]

Phrase: "(20 mM Tris/HCl,"

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM PMSF"

Phrase: ")"

Phrase: ","

Phrase: "cleared by centrifugation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521097:Cleared by [Functional Concept]
           cleared
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "mixed with twofold-concentrated reducing SDS sample buffer."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0205430:Mixed [Functional Concept]
   744   C0370003:Sample [Substance]
   744   C0392756:Reducing [Qualitative Concept]
   744   C1880165:Concentrated [Biomedical or Dental Material]
   744   C2347026:Sample [Conceptual Entity]
   744   C3160715:Mixed [Finding]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.440: Mouse brains of different developmental stages were homogenized in 1% Triton X-100/TBS/1mM orthovanadate, 1mM NaF/protease inhibitors (leupeptin, pepstatin, aprotinin 10 mg/ml each, 10 mM EDTA, 2 mM 1,10 phenanthroline) at 4C. 

Phrase: "Mouse brains of different developmental stages"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C1521713:Mouse Brain [Tissue]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   731   C1160340:brain development [Organ or Tissue Function]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "homogenized in 1% Triton X-100/TBS/1mM orthovanadate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   764   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   742   C0029366:Orthovanadate [Inorganic Chemical]
   742   C0242759:Triton [Geographic Area]
   742   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   742   C1532188:Tbsp [Quantitative Concept]

Phrase: "1mM NaF/protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   827 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   812   C1947941:Protease [Enzyme]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aprotinin 10 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "each,"

Phrase: "10 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "2 mM 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1418486:MM-1 [Gene or Genome]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "10 phenanthroline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: ")"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.441: The protein content of cell lysates was determined using the Biorad protein assay kit, and 20 mg protein was analyzed by SDS-PAGE and blotting. 

Phrase: "The protein content of cell lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Biorad protein assay kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "20 mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotting."
Processing 00000000.tx.442: Plasmin treatment of cell cultures 2 x 106 adherent AR cells in serum-free medium were treated with plasmin (0.6 U/ml) or plasmin plus 2-antiplasmin (1.2 U/ml) to neutralize plasmin activity. 

Phrase: "Plasmin treatment of cell cultures 2 x 106 adherent AR cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   736   C0039798:treatment [Functional Concept]
   736   C0087111:Treatment [Therapeutic or Preventive Procedure]
   736   C1522326:Treatment [Functional Concept]
   736   C1533734:Treatment [Therapeutic or Preventive Procedure]
   736   C1705169:Treatment [Conceptual Entity]
   736   C3538994:TREATMENT [Research Activity]

Phrase: "in serum-free medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0009458:Medium [Intellectual Product]
   827   C0229671:Serum [Body Substance]
   827   C0332296:free [Functional Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1705217:Medium [Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "treated with plasmin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(0.6 U/ml)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439340:U/ml [Quantitative Concept]
   861   C1880521:U/mL [Quantitative Concept]
   861   C2945590:U/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "plasmin plus 2-antiplasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003410:Antiplasmin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(1.2 U/ml) to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   888   C2736788:1 U/mL [Quantitative Concept]
   840   C0439340:U/ml [Quantitative Concept]
   840   C0580272:1/2 [Intellectual Product]
   840   C1519043:1-2 [Research Activity]
   840   C1880521:U/mL [Quantitative Concept]
   840   C2945590:U/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]

Phrase: "neutralize"

Phrase: "plasmin activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150268:plasmin activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.443: Where indicated, Ro 31-9790 was included. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "Ro 31-9790"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0385836:Ro 31-9790 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0035826:RO [Geographic Area]
   827   C0450355:31 [Intellectual Product]
   827   C1413096:RO [Gene or Genome]
   827   C2987048:RO [Gene or Genome]

Phrase: "was"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.444: Cells were incubated for 6 h and supernatants were collected and protease inhibitors (Roche completeZ mini) were added to prevent further cleavage. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 6 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0444953:H 6 [Intellectual Product]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Roche completeZ mini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0445542:Mini [Organism Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "further cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
Processing 00000000.tx.445: Aliquots of each supernatant were TCA precipitated and analyzed for the presence of L1 by Western blotting. 

Phrase: "Aliquots of each supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "TCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041405:TCA [Geographic Area]
  1000   C0085758:TCA [Congenital Abnormality]
  1000   C1415587:TCA [Gene or Genome]
  1000   C3536819:TCA [Pharmacologic Substance]

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "analyzed for the presence of L1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0441918:L1 [Finding]
   753   C0936012:Analyzed [Research Activity]
   753   C1179698:L1 [Body Location or Region]
   753   C1416177:L1 [Gene or Genome]

Phrase: "by Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.446: For mAb 5G3 blots, samples were prepared by heating at 80C in nonreducing sample buffer as described (Nayeem et al., 1999). 

Phrase: "For mAb 5G3 blots,"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared by heating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0018851:Heating [Environmental Effect of Humans]
   756   C1521827:Prepare [Functional Concept]

Phrase: "at 80C"

Phrase: "in nonreducing sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Nayeem et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.447: Supernatants were also tested for the stimulation of CHO haptotactic migration (see below). 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "also"

Phrase: "tested for the stimulation of CHO haptotactic migration"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   750   C0201780:Stimulation test [Laboratory Procedure]
   744   C0392366:tested [Intellectual Product]
   744   C0600210:Migration [Social Behavior]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1533574:Migration [Physiologic Function]
   744   C1881827:MIGRATION [Phenomenon or Process]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   711 E C0022885:Test [Laboratory Procedure]
   711 E C0039593:Test [Functional Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.448: Recombinant proteins Fusion proteins containing the Fc portion of human IgG1 and the ectodomain of mouse L1 or human L1 have been described in previous publications (Oleszewski et al., 1999). 

Phrase: "Recombinant proteins Fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034857:Recombinant Fusion Proteins [Amino Acid, Peptide, or Protein]
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Fc portion of human IgG1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "the ectodomain of mouse L1"

Phrase: "or"

Phrase: "human L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "described in previous publications"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0034036:Publications [Intellectual Product,Manufactured Object]
   770   C0205156:Previous [Temporal Concept]
   770   C1552607:previous [Temporal Concept]
   770   C1552738:described [Idea or Concept]
   737 E C0034037:Publication [Occupational Activity]
   737 E C1704324:Publication [Intellectual Product]

Phrase: "(Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.449: The mouse L1Fc mut III protein in which both RGDs in the 6.Ig-like domain are mutated to RGE has also been described (Oleszewski et al., 1999). 

Phrase: "The mouse L1Fc mut III protein in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2945616:iii protein [Amino Acid, Peptide, or Protein]
   767   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "both RGDs in the 6.Ig-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1335588:RGDS [Gene or Genome]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "mutated to RGE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.450: The production and characterization of SART-1-Fc will be reported in a separate publication (unpublished data). 

Phrase: "The production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "characterization of SART-1-Fc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "will"

Phrase: "be"

Phrase: "reported in a separate publication"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C0443299:Separate [Spatial Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1704324:Publication [Intellectual Product]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.451: Plasmid-DNA was transfected into COS-7 cells and supernatants containing the Fc fusion protein were collected. 

Phrase: "Plasmid-DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "transfected into COS-7 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Fc fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.452: Fc-fusion proteins were purified by protein A Sepharose chromatography and analyzed and quantified using a human Fc-specific capture ELISA with purified human IgG as standard (Oleszewski et al., 1999). 

Phrase: "Fc-fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "purified by protein A Sepharose chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0075172:protein A-sepharose [Carbohydrate]
   790   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   790   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Sepharose [Carbohydrate]
   753   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a human Fc-specific capture ELISA with purified human IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0014441:ELISA [Laboratory Procedure]

Phrase: "as standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]

Phrase: "(Oleszewski et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.453: ELISA for the detection of soluble human L1 For the detection of soluble L1, 96-well flexible microtiter plates (Falcon 3912; Becton Dickinson) were coated with 1 mg/ml of capturing antibody (anti-L1 mAb 5G3) overnight. 

Phrase: "ELISA for the detection of soluble human L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014441:ELISA [Laboratory Procedure]

Phrase: "For the detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of soluble L1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "96-well flexible microtiter plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C1709027:Microtiter Plate [Research Device]
   804   C1139930:plates [Medical Device]
   771 E C0005971:Plate [Medical Device]
   771 E C3537155:Plate [Manufactured Object]

Phrase: "(Falcon 3912"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325579:Falcon, NOS [Bird]

Phrase: "; Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")"

Phrase: "were"

Phrase: "coated with 1 mg/ml of capturing antibody"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0439294:mg ml [Quantitative Concept]
   767   C0487172:Mg Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0439269:mg% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1522408:Coated [Qualitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   711 E C0453946:Coat [Manufactured Object]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(anti-L1 mAb 5G3"

Phrase: ")"

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.454: Wells were blocked with 3% BSA/PBS for 45 min and then incubated for 1 h with tissue culture supernatants containing soluble L1. 

Phrase: "Wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "blocked with 3% BSA/PBS"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "for 45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with tissue culture supernatants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1550101:Supernatant [Body Substance]
   734   C0040284:Tissue culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "soluble L1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]
Processing 00000000.tx.455: After five washes with BSA/PBS, the wells were incubated for 1 h with biotin-conjugated mAb UJ127.11 followed by streptavidin-conjugated peroxidase (Dianova) using BMP as substrate. 

Phrase: "After five washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "with BSA/PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with biotin-conjugated mAb UJ127.11"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   804   C0522529:Conjugated [Spatial Concept]
   804   C2700256:Biotin [Laboratory Procedure]
   733 E C1160466:conjugation [Cell Function]

Phrase: "followed by streptavidin-conjugated peroxidase"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   760   C0522529:Conjugated [Spatial Concept]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "(Dianova"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BMP as substrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0279266:BMP [Therapeutic or Preventive Procedure]
Processing 00000000.tx.456: The color reaction was stopped by the addition of 10 mM H2SO4 and analyzed at 450 nm using an ELISA reader. 

Phrase: "The color reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0853041:color reaction [Disease or Syndrome]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 10 mM H2SO4"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C1272691:stopped [Qualitative Concept]
   744   C1883712:Addition [Functional Concept]
   711 E C1947925:Stop [Activity]
   711 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "analyzed at 450 nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ELISA reader."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.457: Human L1Fc protein served as an internal standard for the assay. 

Phrase: "Human L1Fc protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "served as an internal standard"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205102:Internal [Spatial Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C2828392:Standard [Intellectual Product]

Phrase: "for the assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.458: Biochemical analysis Samples were separated by SDS-PAGE under nonreducing conditions and transferred to an Immobilon membrane using semi-dry blotting. 

Phrase: "Biochemical analysis Samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1303103:analysis sample [Laboratory Procedure]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "under nonreducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "transferred to an Immobilon membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "semi-dry blotting."
Processing 00000000.tx.459: After blocking with 5% skim milk in TBS, the blots were developed with the respective primary antibody (mAbs UJ127.11, 5G3 or pcytL1) followed by peroxidase conjugated secondary antibody and ECL detection. 

Phrase: "After"

Phrase: "blocking with 5% skim milk"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   806   C0349375:Skim milk [Food]
   760   C0026131:Milk [Body Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "the blots"

Phrase: "were"

Phrase: "developed with the respective primary antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "(mAbs UJ127.11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "5G3"

Phrase: "or"

Phrase: "pcytL1"

Phrase: ")"

Phrase: "followed by peroxidase"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]

Phrase: "secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "ECL detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.460: Transmigration assays For the haptotactic cell migration assay, fibronectin, vitronectin, laminin, or BSA (each at 10 mg/ml) were coated for 90 min on the backside of Transwell chambers (Costar, 6.5 mm diam, 5-mm pore size). 

Phrase: "Transmigration assays For the haptotactic cell migration assay,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1513300:Cell Migration Assays [Laboratory Procedure]
           Migration Assays
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]

Phrase: "fibronectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vitronectin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "BSA ("

Phrase: "each at 10 mg/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439269:mg% [Quantitative Concept]
   770   C1457900:Each [Quantitative Concept]
   770   C1960952:mg % [Quantitative Concept]
   770   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "coated for 90 min"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "on the backside"

Phrase: "of Transwell chambers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0179874:chambers [Medical Device]
   827 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "(Costar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140299:COSTAR [Intellectual Product]

Phrase: "6.5 mm diam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1301886:Diam [Quantitative Concept]

Phrase: "5-mm pore size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456389:size [Spatial Concept]
   812   C1325742:Pore [Cell Component]

Phrase: ")."
Processing 00000000.tx.461: Cells (105 or as otherwise indicated) in RPMI 1640 medium containing 0.5% BSA were seeded into the upper chamber and allowed to transmigrate to the lower compartment for 16 h at 37C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(105"

Phrase: "or"

Phrase: "as"

Phrase: "otherwise"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ")"

Phrase: "in RPMI 1640 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% BSA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "were"

Phrase: "seeded into the upper chamber"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   760   C1282910:Upper [Spatial Concept]
   726   C0036563:Seed [Plant]
   726   C1705192:Seed [Laboratory Procedure]
   726   C1882540:{Seed} [Quantitative Concept]
   726   C2346495:Seed [Conceptual Entity]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transmigrate to the lower compartment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441994:Lower [Spatial Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.462: For mAb blocking the cells were preincubated at 10 mg/ml with the respective mAb for 30 min at 37C before onset of the assay. 

Phrase: "For mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated at 10 mg/ml"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0439294:mg ml [Quantitative Concept]
   760   C0439269:mg% [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "with the respective mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C"

Phrase: "before onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of the assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.463: To quantify transmigrated cells, the inner chamber was removed and cleaned carefully with a cotton swab to remove the non-migrated cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "transmigrated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the inner chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "cleaned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947930:Cleaned [Activity]

Phrase: "carefully with a cotton swab to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0010196:Cotton [Plant]
   753   C0183753:Swab [Substance]
   753   C0330523:cotton [Plant]
   753   C0330524:cotton [Plant]
   753   C0563454:Swab [Diagnostic Procedure]
   753   C1095832:Cotton [Substance]
   753   C1261188:Swab [Medical Device]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the non-migrated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.464: Migrated cells adherent to the bottom of the membrane were stained with crystal violet solution. 

Phrase: "Migrated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "adherent to the bottom of the membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0334154:Adherent [Functional Concept]

Phrase: "were"

Phrase: "stained with crystal violet solution."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   827   C0017440:Crystal violet stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Crystal Violet
   760   C0037633:Solution [Substance]
   760   C0330463:Violet [Plant]
   760   C0427896:Crystal [Body Substance]
   760   C0444626:Crystal [Chemical Viewed Structurally]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C0678580:violet [Natural Phenomenon or Process]
   760   C1533132:Crystal [Body Substance]
   760   C1704641:Crystal [Manufactured Object]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.465: The membranes were extensively washed in water and the remaining stain was eluted with 10% acidic acid. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "extensively"

Phrase: "washed in water"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1548982:Washed [Idea or Concept]
   790   C1550678:Water [Inorganic Chemical]
   756 E C0441648:Wash [Activity]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "the remaining stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "eluted with 10% acidic acid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001128:Acidic [Chemical]
Processing 00000000.tx.466: The eluted dye was measured at 595 nm in an ELISA reader. 

Phrase: "The eluted dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "measured at 595 nm"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in an ELISA reader."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.467: Each determination was done in quadruplicate and the data are given as mean values  SEM.  

Phrase: "Each determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "done in quadruplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205175:Quadruplicate [Quantitative Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]

Phrase: "and"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "given as mean values  SEM."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0042295:Values [Qualitative Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1550718:given [Idea or Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   760   C3244317:given [Intellectual Product]
   726 E C1522609:Value [Quantitative Concept]
   726 E C1947971:Give [Functional Concept]
Processing 00000000.tx.468: Footnotes  S. 

Phrase: "Footnotes  S."
Processing 00000000.tx.469: Mechtersheimer and P. 

Phrase: "Mechtersheimer"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.470: Gutwein contributed equally to this work. 

Phrase: "Gutwein"

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.471: * Abbreviations used in this paper: ADAM, a disintegrin and metalloproteinase; 

Phrase: "* Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "ADAM,"

Phrase: "a disintegrin and metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.472: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.473: AR, androgen receptor; 

Phrase: "AR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "androgen receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.474: FN, fibronectin; 

Phrase: "FN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.475: MCD, methyl--cyclodextrin; 

Phrase: "MCD,"

Phrase: "methyl--cyclodextrin"

Phrase: ";"
Processing 00000000.tx.476: RGD, Arg-Gly-Asp.  

Phrase: "RGD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052350:RGD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2699006:RGD [Intellectual Product]

Phrase: "Arg-Gly-Asp."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052350:Arg-Gly-Asp [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0206293:Asp [Reptile]
   827   C3541260:ASP [Gene or Genome]
Processing 00000000.tx.477: Acknowledgments  We gratefully acknowledge the excellent technical assistance of Christine Schlsser and Daniel Straub and Klaus Hexel for help with FACS sorting. 

Phrase: "Acknowledgments"

Phrase: "We gratefully"

Phrase: "acknowledge"

Phrase: "the excellent technical assistance of Christine Schlsser"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018896:Assistance [Social Behavior]
   748   C0449851:Technical [Functional Concept]

Phrase: "and"

Phrase: "Daniel Straub"

Phrase: "and"

Phrase: "Klaus Hexel for"

Phrase: "help with FACS sorting."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018896:Help [Social Behavior]
   770   C0237886:Sorting [Mental Process]
   770   C0700314:sorting [Cell Function]
   770   C1552861:help [Idea or Concept]
   770   C1947906:Sorting [Activity]
Processing 00000000.tx.478: This work was supported by a grant from the German-Israeli Cooperation in Cancer Research (P. Gutwein and P. Altevogt), a grant from MINERVA (N. Agmon-Levin), and by a guest scientist stipend from DKFZ (M. Fogel). 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a grant"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "from the German-Israeli Cooperation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0392337:cooperation [Social Behavior]

Phrase: "in Cancer Research"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1516225:Cancer Research [Research Activity]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "(P. Gutwein"

Phrase: "and"

Phrase: "P. Altevogt"

Phrase: ")"

Phrase: ","

Phrase: "a grant from MINERVA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018173:Grant [Quantitative Concept]
   770   C1548284:Grant [Idea or Concept]

Phrase: "(N. Agmon-Levin"

Phrase: ")"

Phrase: ","

Phrase: "and by a guest scientist stipend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0402112:Scientist [Professional or Occupational Group]
   753   C1515981:And [Idea or Concept]

Phrase: "from DKFZ"

Phrase: "(M. Fogel"

Phrase: ")."
Processing 00000000.tx.479: V. 

Phrase: "V."
Processing 00000000.tx.480: Lemmon was supported by a grant from the National Eye Institute (EY05285). 

Phrase: "Lemmon"

Phrase: "was"

Phrase: "supported by a grant"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "from the National Eye Institute"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C1955969:National Eye Institute [Health Care Related Organization]
   827   C0015392:Eye [Body Part, Organ, or Organ Component]
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]
   827   C1280202:Eye [Body Part, Organ, or Organ Component]
   827   C3245503:national [Intellectual Product]
   771 E C0029144:optic [Occupation or Discipline]
   771 E C0042789:Ocular [Organism Function]
   771 E C1299003:Ocular [Spatial Concept]
   734 E C0014236:Ophthalmia [Disease or Syndrome]
   734 E C0700042:Oculus [Body Location or Region]

Phrase: "(EY05285"

Phrase: ")."
Processing 00000000.tx.481: Submitted: 29 January 2001 Revised: 2 October 2001 Accepted: 2 October 2001  References Top Abstract Introduction Results Discussion Materials and methods References  Artavanis-Tsakonas, S., M.D. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "29 January 2001"

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: ":"

Phrase: "2 October 2001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "2 October 2001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Artavanis-Tsakonas,"

Phrase: "S."

Phrase: ","

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.482: Rand, and R.J. 

Phrase: "Rand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555436:Rand [Quantitative Concept]

Phrase: "and"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.483: Lake. 

Phrase: "Lake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337049:Lake [Geographic Area]
  1000   C1036400:Lake [Amphibian]
Processing 00000000.tx.484: 1999. 

Phrase: "1999."
Processing 00000000.tx.485: Notch signaling: cell fate control and signal integration in development. 

Phrase: "Notch signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: ":"

Phrase: "cell fate control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1326017:Cell Fate Control [Cell Function]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C1540661:cell fate [Cell Function]

Phrase: "and"

Phrase: "signal integration in development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1158478:Integration [Genetic Function]
   770   C1705422:Integration [Machine Activity]
Processing 00000000.tx.486: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.487: 284:770776.[Abstract/Free FullText] Beer, S., M. 

Phrase: "284"

Phrase: ":"

Phrase: "770776."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beer [Food]

Phrase: "S."

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: Oleszewski, P. 

Phrase: "Oleszewski,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.489: Gutwein, C. 

Phrase: "Gutwein,"

Phrase: "C."
Processing 00000000.tx.490: Geiger, and P. 

Phrase: "Geiger,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.491: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.492: 1999. 

Phrase: "1999."
Processing 00000000.tx.493: Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule. 

Phrase: "Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.494: J. 

Phrase: "J."
Processing 00000000.tx.495: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.496: 112:26672675.[Abstract/Free FullText] Black, R.A., and J.M. 

Phrase: "112"

Phrase: ":"

Phrase: "26672675."

Phrase: "[Abstract/Free FullText"

Phrase: "] Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "and"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.497: White. 

Phrase: "White."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]
Processing 00000000.tx.498: 1998. 

Phrase: "1998."
Processing 00000000.tx.499: ADAMs: focus on the protease domain. 

Phrase: "ADAMs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: ":"

Phrase: "focus on the protease domain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205234:Focus [Spatial Concept]
   760   C1285542:focus [Functional Concept]
Processing 00000000.tx.500: Curr. 

Phrase: "Curr."
Processing 00000000.tx.501: Opin. 

Phrase: "Opin."
Processing 00000000.tx.502: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.503: 10:654659.[Medline] Blobel, C.P. 

Phrase: "10"

Phrase: ":"

Phrase: "654659."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blobel,"

Phrase: "C.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.504: 2000. 

Phrase: "2000."
Processing 00000000.tx.505: Remarkable roles of proteolysis on and beyond the cell surface. 

Phrase: "Remarkable roles of proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "on"

Phrase: "and beyond the cell surface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.506: Curr. 

Phrase: "Curr."
Processing 00000000.tx.507: Opin. 

Phrase: "Opin."
Processing 00000000.tx.508: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.509: 12:606612.[Medline] Brou, C., F. 

Phrase: "12"

Phrase: ":"

Phrase: "606612."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brou,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.510: Logeat, N. 

Phrase: "Logeat,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.511: Gupta, C. 

Phrase: "Gupta,"

Phrase: "C."
Processing 00000000.tx.512: Bessia, O. 

Phrase: "Bessia,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.513: LeBail, J.R. 

Phrase: "LeBail,"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.514: Doedens, A. 

Phrase: "Doedens,"

Phrase: "A."
Processing 00000000.tx.515: Cumano, P. 

Phrase: "Cumano,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.516: Roux, R.A. 

Phrase: "Roux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.517: Black, and A. 

Phrase: "Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.518: Israel. 

Phrase: "Israel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]
Processing 00000000.tx.519: 2000. 

Phrase: "2000."
Processing 00000000.tx.520: A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. 

Phrase: "A novel proteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "involved in Notch signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037083:Signaling [Cell Function]
   770   C1235660:Notch [Body Space or Junction]
   770   C1314939:Involved [Functional Concept]
   770   C3537152:signaling [Biologic Function]

Phrase: ":"

Phrase: "the role of the disintegrin-metalloprotease TACE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.521: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.522: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.523: 5:207216.[Medline] Brmmendorf, T., S. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "207216."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brmmendorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.524: Kenwrick, and F.G. 

Phrase: "Kenwrick,"

Phrase: "and"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.525: Rathjen. 

Phrase: "Rathjen."
Processing 00000000.tx.526: 1998. 

Phrase: "1998."
Processing 00000000.tx.527: Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. 

Phrase: "Neural cell recognition molecule L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441918:L1 [Finding]
   804   C1179698:L1 [Body Location or Region]
   804   C1416177:L1 [Gene or Genome]

Phrase: ":"

Phrase: "from cell biology"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "to human hereditary brain malformations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0266449:Brain malformations [Congenital Abnormality]
   812   C0000768:malformations [Congenital Abnormality]
   812   C0243070:malformations [Functional Concept]
Processing 00000000.tx.528: Curr. 

Phrase: "Curr."
Processing 00000000.tx.529: Opin. 

Phrase: "Opin."
Processing 00000000.tx.530: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.531: 8:8797.[Medline] Chen, Z.L., and S. 

Phrase: "8"

Phrase: ":"

Phrase: "8797."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z."

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.532: Strickland. 

Phrase: "Strickland."
Processing 00000000.tx.533: 1997. 

Phrase: "1997."
Processing 00000000.tx.534: Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. 

Phrase: "Neuronal death in the hippocampus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2754100:neuron death [Cell Function]
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]

Phrase: "is"

Phrase: "promoted by plasmin-catalyzed degradation of laminin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   714   C0033414:Promote [Activity]
Processing 00000000.tx.535: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.536: 91:917925.[Medline] De Angelis, E., J. 

Phrase: "91"

Phrase: ":"

Phrase: "917925."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Angelis,"

Phrase: "E.,"

Phrase: "J."
Processing 00000000.tx.537: MacFarlane, J.S. 

Phrase: "MacFarlane,"

Phrase: "J.S."
Processing 00000000.tx.538: Du, G. 

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.539: Yeo, R. 

Phrase: "Yeo,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.540: Hicks, F.G. 

Phrase: "Hicks,"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.541: Rathjen, S. 

Phrase: "Rathjen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.542: Kenwrick, and T. 

Phrase: "Kenwrick,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.543: Brummendorf. 

Phrase: "Brummendorf."
Processing 00000000.tx.544: 1999. 

Phrase: "1999."
Processing 00000000.tx.545: Pathological missense mutations of neural cell adhesion molecule L1 affect homophilic and heterophilic binding activities. 

Phrase: "Pathological missense mutations of neural cell adhesion molecule L1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0599155:Mutations, Missense [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "homophilic"

Phrase: "and"

Phrase: "heterophilic binding activities."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C2266866:Binding Activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.546: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.547: 18:47444753.[Abstract/Free FullText] Debiec, H., E.I. 

Phrase: "18"

Phrase: ":"

Phrase: "47444753."

Phrase: "[Abstract/Free FullText"

Phrase: "] Debiec,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "E.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.548: Christensen, and P.M. 

Phrase: "Christensen,"

Phrase: "and"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.549: Ronco. 

Phrase: "Ronco."
Processing 00000000.tx.550: 1998. 

Phrase: "1998."
Processing 00000000.tx.551: The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. 

Phrase: "The cell adhesion molecule L1"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0950625:Cell Adhesion Molecule L1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0441918:L1 [Finding]
   812   C0567416:Molecule [Substance]
   812   C1179698:L1 [Body Location or Region]
   812   C1269647:Cell [Cell]
   812   C1416177:L1 [Gene or Genome]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "developmentally"

Phrase: "regulated in the renal epithelium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1328945:renal epithelium [Body Part, Organ, or Organ Component]
   760   C0014609:Epithelium [Tissue]
   760   C0022646:Renal [Body Part, Organ, or Organ Component]
   760   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "is"

Phrase: "involved in kidney branching morphogenesis."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C1622374:branching morphogenesis [Organism Function]
   797   C2753220:kidney morphogenesis [Organ or Tissue Function]
   760   C0022646:Kidney [Body Part, Organ, or Organ Component]
   760   C0026559:Morphogenesis [Organism Function]
   760   C0205384:Branching [Spatial Concept]
   760   C0227665:kidney [Body Part, Organ, or Organ Component]
   760   C1278978:Kidney [Body Part, Organ, or Organ Component]
   760   C1314939:Involved [Functional Concept]
   760   C1514845:KIDNEY [Tissue]
   726 E C1253959:Branch [Body Part, Organ, or Organ Component]
   726 E C1881507:Branch [Chemical Viewed Structurally]
   726 E C2700383:Branch [Plant]
   726 E C2826234:BRANCH [Intellectual Product]
Processing 00000000.tx.552: J. 

Phrase: "J."
Processing 00000000.tx.553: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.554: 143:20672079.[Abstract/Free FullText] Doherty, P., E. 

Phrase: "143"

Phrase: ":"

Phrase: "20672079."

Phrase: "[Abstract/Free FullText"

Phrase: "] Doherty,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "E."
Processing 00000000.tx.555: Williams, and F.S. 

Phrase: "Williams,"

Phrase: "and"

Phrase: "F.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.556: Walsh. 

Phrase: "Walsh."
Processing 00000000.tx.557: 1995. 

Phrase: "1995."
Processing 00000000.tx.558: A soluble chimeric form of the L1 glycoprotein stimulates neurite outgrowth. 

Phrase: "A soluble chimeric form of the L1 glycoprotein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "stimulates"

Phrase: "neurite outgrowth."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]
Processing 00000000.tx.559: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.560: 14:5766.[Medline] Doherty, P., G. 

Phrase: "14"

Phrase: ":"

Phrase: "5766."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Doherty,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.561: Williams, and E.J. 

Phrase: "Williams,"

Phrase: "and"

Phrase: "E.J."
Processing 00000000.tx.562: Williams. 

Phrase: "Williams."
Processing 00000000.tx.563: 2000. 

Phrase: "2000."
Processing 00000000.tx.564: CAMs and axonal growth: a critical evaluation of the role of calcium and the MAPK cascade. 

Phrase: "CAMs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007578:CAMs [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "axonal growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   964   C1749784:axon growth [Organ or Tissue Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: ":"

Phrase: "a critical evaluation of the role of calcium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0220825:Evaluation [Functional Concept]
   744   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "the MAPK cascade."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752319:MAPK cascade [Molecular Function]
   861   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.565: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.566: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.567: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.568: 16:283295.[Medline] Dong, J., L.K. 

Phrase: "16"

Phrase: ":"

Phrase: "283295."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dong,"

Phrase: "J.,"

Phrase: "L.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.569: Opresko, P.J. 

Phrase: "Opresko,"

Phrase: "P.J."
Processing 00000000.tx.570: Dempsey, D.A. 

Phrase: "Dempsey,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.571: Lauffenburger, R.J. 

Phrase: "Lauffenburger,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.572: Coffey, and H.S. 

Phrase: "Coffey,"

Phrase: "and"

Phrase: "H.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.573: Wiley. 

Phrase: "Wiley."
Processing 00000000.tx.574: 1999. 

Phrase: "1999."
Processing 00000000.tx.575: Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. 

Phrase: "Metalloprotease-mediated ligand release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "regulates"

Phrase: "autocrine signaling through the epidermal growth factor receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0525010:Autocrine Signaling [Cell Function]
   767   C1514762:Receptor Signaling [Molecular Function]
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]
Processing 00000000.tx.576: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.577: Natl. 

Phrase: "Natl."
Processing 00000000.tx.578: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.579: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.580: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.581: 96:62356240.[Abstract/Free FullText] Ebeling, O., A. 

Phrase: "96"

Phrase: ":"

Phrase: "62356240."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ebeling,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.582: Duczmal, S. 

Phrase: "Duczmal,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.583: Aigner, C. 

Phrase: "Aigner,"

Phrase: "C."
Processing 00000000.tx.584: Geiger, S. 

Phrase: "Geiger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.585: Schllhammer, J.T. 

Phrase: "Schllhammer,"

Phrase: "J.T."
Processing 00000000.tx.586: Kemshead, P. 

Phrase: "Kemshead,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.587: Mller, A.R. 

Phrase: "Mller,"

Phrase: "A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.588: Schwartz, and P. 

Phrase: "Schwartz,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.589: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.590: 1996. 

Phrase: "1996."
Processing 00000000.tx.591: L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. 

Phrase: "L1 adhesion molecule on human lymphocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "monocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026473:Monocytes [Cell]

Phrase: ":"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "involvement in binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involvement [Functional Concept]

Phrase: "to alpha v beta 3 integrin."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   911   C0253930:alpha(V) Integrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   911   C1416486:INTEGRIN, ALPHA-3 [Gene or Genome]
   911   C1416494:INTEGRIN, ALPHA-V [Gene or Genome]
   884   C0245726:beta 3 integrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1416498:INTEGRIN, BETA-3 [Gene or Genome]
   840   C1414290:BETA-3 [Gene or Genome]
   804   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0330390:Beta [Plant]
   804   C0439095:Alpha [Intellectual Product]
   804   C0439096:Beta [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2004068:Beta [Qualitative Concept]
   804   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.592: Eur. 

Phrase: "Eur."
Processing 00000000.tx.593: J. 

Phrase: "J."
Processing 00000000.tx.594: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.595: 26:25082516.[Medline] Felding-Habermann, B., S. 

Phrase: "26"

Phrase: ":"

Phrase: "25082516."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Felding-Habermann,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.596: Silletti, F. 

Phrase: "Silletti,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.597: Mei, C.H. 

Phrase: "Mei,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.598: Siu, P.M. 

Phrase: "Siu,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.599: Yip, P.C. 

Phrase: "Yip,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.600: Brooks, D.A. 

Phrase: "Brooks,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.601: Cheresh, T.E. 

Phrase: "Cheresh,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.602: O'Toole, M.H. 

Phrase: "O'Toole,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "M."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.603: Ginsberg, and A.M. 

Phrase: "Ginsberg,"

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.604: Montgomery. 

Phrase: "Montgomery."
Processing 00000000.tx.605: 1997. 

Phrase: "1997."
Processing 00000000.tx.606: A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins. 

Phrase: "A single immunoglobulin-like domain of the human neural cell adhesion molecule L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   766   C1512665:Immunoglobulin-Like Domain [Amino Acid Sequence]
           Immunoglobulin Domain
   735   C1880389:Domain [Functional Concept]
   735   C1883221:Domain [Conceptual Entity]
   735   C3541951:Domain [Intellectual Product]
   713   C0599845:molecular domain [Molecular Function]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "adhesion by multiple vascular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "platelet integrins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.607: J. 

Phrase: "J."
Processing 00000000.tx.608: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.609: 139:15671581.[Abstract/Free FullText] Fidler, I.J. 

Phrase: "139"

Phrase: ":"

Phrase: "15671581."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fidler,"

Phrase: "I.J."
Processing 00000000.tx.610: 1990. 

Phrase: "1990."
Processing 00000000.tx.611: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. 

Phrase: "Critical factors in the biology of human cancer metastasis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1552291:Human Factors [Intellectual Product]
   762   C1552302:Human Factors [Intellectual Product]
   726   C0005515:Biologic Factors [Biologically Active Substance]
   708   C1521761:Factor [Functional Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "twenty-eighth G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.612: Clowes memorial award lecture. 

Phrase: "Clowes memorial award lecture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0376683:lecture [Intellectual Product]
Processing 00000000.tx.613: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.614: 50:61306138.[Abstract] Filardo, E.J., S.L. 

Phrase: "50"

Phrase: ":"

Phrase: "61306138."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Filardo,"

Phrase: "E.J.,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.615: Deming, and D.A. 

Phrase: "Deming,"

Phrase: "and"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.616: Cheresh. 

Phrase: "Cheresh."
Processing 00000000.tx.617: 1996. 

Phrase: "1996."
Processing 00000000.tx.618: Regulation of cell migration by the integrin beta subunit ectodomain. 

Phrase: "Regulation of cell migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1155915:regulation of cell migration [Cell Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by the integrin beta subunit ectodomain."
Processing 00000000.tx.619: J. 

Phrase: "J."
Processing 00000000.tx.620: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.621: 109:16151622.[Abstract/Free FullText] Galko, M.J., and M. 

Phrase: "109"

Phrase: ":"

Phrase: "16151622."

Phrase: "[Abstract/Free FullText"

Phrase: "] Galko,"

Phrase: "M."

Phrase: "J.,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.622: Tessier-Lavigne. 

Phrase: "Tessier-Lavigne."
Processing 00000000.tx.623: 2000. 

Phrase: "2000."
Processing 00000000.tx.624: Function of an axonal chemoattractant modulated by metalloprotease activity. 

Phrase: "Function of an axonal chemoattractant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0234573:Axon function [Cell Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "modulated by metalloprotease activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1150224:metalloprotease activity [Molecular Function]
   770   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0443264:Modulated [Spatial Concept]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.625: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.626: 289:13651367.[Abstract/Free FullText] Gechtman, Z., J.L. 

Phrase: "289"

Phrase: ":"

Phrase: "13651367."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gechtman,"

Phrase: "Z.,"

Phrase: "J.L."
Processing 00000000.tx.627: Alonso, G. 

Phrase: "Alonso,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.628: Raab, D.E. 

Phrase: "Raab,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.629: Ingber, and M. 

Phrase: "Ingber,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.630: Klagsbrun. 

Phrase: "Klagsbrun."
Processing 00000000.tx.631: 1999. 

Phrase: "1999."
Processing 00000000.tx.632: The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. 

Phrase: "The shedding of membrane-anchored heparin-"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "epidermal-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014520:Epidermal [Tissue]
  1000   C0221920:Epidermal [Spatial Concept]
   884 E C3496194:Epidermis [Cell]

Phrase: "like growth factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1521761:Factor [Functional Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2827422:Factor [Conceptual Entity]
   861   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "regulated by the Raf/mitogen-activated protein kinase cascade"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   849   C0752319:mitogen-activated protein kinase cascade [Molecular Function]
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1155502:protein kinase cascade [Molecular Function]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1425569:RAF [Gene or Genome]
   742   C1706586:RAF [Gene or Genome]
   742   C1707310:Cascade [Manufactured Object]
   742   C1879547:Activated [Activity]
   720   C1449849:raf Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   708 E C1515877:Activate [Functional Concept]

Phrase: "and by cell adhesion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007577:Cell Adhesion [Cell Function]
   770   C0001511:Adhesion [Pathologic Function]
   770   C0007634:Cell [Cell]
   770   C0175633:Adhesion [Natural Phenomenon or Process]
   770   C1269647:Cell [Cell]
   770   C1515981:And [Idea or Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "spreading."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332261:Spreading [Qualitative Concept]
   966 E C1947932:Spread [Activity]
Processing 00000000.tx.633: J. 

Phrase: "J."
Processing 00000000.tx.634: Biol. 

Phrase: "Biol."
Processing 00000000.tx.635: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.636: 274:2882828835.[Abstract/Free FullText] Giancotti, F.G., and E. 

Phrase: "274"

Phrase: ":"

Phrase: "2882828835."

Phrase: "[Abstract/Free FullText"

Phrase: "] Giancotti,"

Phrase: "F.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.637: Ruoslahti. 

Phrase: "Ruoslahti."
Processing 00000000.tx.638: 1999. 

Phrase: "1999."
Processing 00000000.tx.639: Integrin signaling. 

Phrase: "Integrin signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.640: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.641: 285:10281032.[Abstract/Free FullText] Gutwein, P., M. 

Phrase: "285"

Phrase: ":"

Phrase: "10281032."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gutwein,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.642: Oleszewski, S. 

Phrase: "Oleszewski,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.643: Mechtersheimer, N. 

Phrase: "Mechtersheimer,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.644: Agmon-Levin, K. 

Phrase: "Agmon-Levin,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.645: Krauss, and P. 

Phrase: "Krauss,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.646: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.647: 2000. 

Phrase: "2000."
Processing 00000000.tx.648: Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. 

Phrase: "Role of Src kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the ADAM-mediated release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of L1 adhesion molecule"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "from human tumor cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.649: J. 

Phrase: "J."
Processing 00000000.tx.650: Biol. 

Phrase: "Biol."
Processing 00000000.tx.651: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.652: 275:1549015497.[Abstract/Free FullText] Hattori, M., M. 

Phrase: "275"

Phrase: ":"

Phrase: "1549015497."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hattori,"

Phrase: "M."

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.653: Osterfield, and J.G. 

Phrase: "Osterfield,"

Phrase: "and"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.654: Flanagan. 

Phrase: "Flanagan."
Processing 00000000.tx.655: 2000. 

Phrase: "2000."
Processing 00000000.tx.656: Regulated cleavage of a contact-mediated axon repellent. 

Phrase: "Regulated cleavage of a contact-mediated axon repellent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]
Processing 00000000.tx.657: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.658: 289:13601365.[Abstract/Free FullText] Hortsch, M. 

Phrase: "289"

Phrase: ":"

Phrase: "13601365."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hortsch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: 1996. 

Phrase: "1996."
Processing 00000000.tx.660: The L1 family of neural cell adhesion molecules: old proteins performing new tricks. 

Phrase: "The L1 family of neural cell adhesion molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Family [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "old proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "new tricks."
Processing 00000000.tx.661: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.662: 17:587593.[Medline] Hooper, N.M., E.H. 

Phrase: "17"

Phrase: ":"

Phrase: "587593."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hooper,"

Phrase: "N.M.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.663: Karran, and A.J. 

Phrase: "Karran,"

Phrase: "and"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.664: Turner. 

Phrase: "Turner."
Processing 00000000.tx.665: 1997. 

Phrase: "1997."
Processing 00000000.tx.666: Membrane protein secretases. 

Phrase: "Membrane protein secretases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.667: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.668: J. 

Phrase: "J."
Processing 00000000.tx.669: 321:265279.[Medline] Hynes, R.O. 

Phrase: "321"

Phrase: ":"

Phrase: "265279."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hynes,"

Phrase: "R.O."
Processing 00000000.tx.670: 1992. 

Phrase: "1992."
Processing 00000000.tx.671: Integrins: versatility, modulation, and signaling in cell adhesion. 

Phrase: "Integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: ":"

Phrase: "versatility,"

Phrase: "modulation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "signaling in cell adhesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.672: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.673: 69:1125.[Medline] Izumi, Y., M. 

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "1125."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Izumi,"

Phrase: "Y.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.674: Hirata, H. 

Phrase: "Hirata,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.675: Hasuwa, R. 

Phrase: "Hasuwa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.676: Iwamoto, T. 

Phrase: "Iwamoto,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.677: Umata, K. 

Phrase: "Umata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.678: Miyado, Y. 

Phrase: "Miyado,"

Phrase: "Y."
Processing 00000000.tx.679: Tamai, T. 

Phrase: "Tamai,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.680: Kurisaki, F.A. 

Phrase: "Kurisaki,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.681: Sehara, S. 

Phrase: "Sehara,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.682: Ohno, and E. 

Phrase: "Ohno,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.683: Mekada. 

Phrase: "Mekada."
Processing 00000000.tx.684: 1998. 

Phrase: "1998."
Processing 00000000.tx.685: A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. 

Phrase: "A metalloprotease-disintegrin,"

Phrase: "MDC9/meltrin-gamma/ADAM9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412207:ADAM9 [Gene or Genome]

Phrase: "and"

Phrase: "PKCdelta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2261577:PKCdelta [Molecular Function]

Phrase: "are"

Phrase: "involved in TPA-induced ectodomain shedding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0032143:T-PA [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1314939:Involved [Functional Concept]

Phrase: "of membrane-anchored heparin-binding EGF-like growth factor."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   923   C0058402:Heparin-Binding EGF-Like Growth Factor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   923   C0166825:heparin-binding EGF-like growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1539630:HEPARIN-BINDING EGF-LIKE GROWTH FACTOR [Gene or Genome]
           HEPARIN-BINDING EGF
   875   C0599765:Heparin Binding Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1522455:Heparin Binding Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1148608:Heparin Binding [Molecular Function]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C0220844:growth [Physiologic Function]
   793   C0243122:binding [Functional Concept]
   793   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]
   793   C1521761:Factor [Functional Concept]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
Processing 00000000.tx.686: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.687: 17:72607272.[Abstract/Free FullText] Izumoto, S., T. 

Phrase: "17"

Phrase: ":"

Phrase: "72607272."

Phrase: "[Abstract/Free FullText"

Phrase: "] Izumoto,"

Phrase: "S."

Phrase: ","

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.688: Ohnishi, N. 

Phrase: "Ohnishi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.689: Arita, S. 

Phrase: "Arita,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2811087:Arita [Eukaryote]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.690: Hiraga, T. 

Phrase: "Hiraga,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.691: Taki, and T. 

Phrase: "Taki,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.692: Hayakawa. 

Phrase: "Hayakawa."
Processing 00000000.tx.693: 1996. 

Phrase: "1996."
Processing 00000000.tx.694: Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. 

Phrase: "Gene expression of neural cell adhesion molecule L1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   822   C1332870:Cell Adhesion Molecule Gene [Gene or Genome]
   770   C0017262:Gene Expression [Genetic Function]
   767   C1861886:CELL Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   703   C0950625:Neural Cell Adhesion Molecule L1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1416769:NEURAL CELL ADHESION MOLECULE L1 [Gene or Genome]

Phrase: "in malignant gliomas"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0555198:Malignant Gliomas [Neoplastic Process]
       E   [M]Glioma NOS
   861   C0017638:[M]Gliomas [Neoplastic Process]
   827 E C2984291:Glioma [Functional Concept]

Phrase: "and"

Phrase: "biological significance of L1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "in glioma invasion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1269955:Invasion [Finding]
   861   C2699153:Invasion [Pathologic Function]
Processing 00000000.tx.695: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.696: 56:14401444.[Abstract] Kamiguchi, H., and V. 

Phrase: "56"

Phrase: ":"

Phrase: "14401444."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kamiguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.697: Lemmon. 

Phrase: "Lemmon."
Processing 00000000.tx.698: 1997. 

Phrase: "1997."
Processing 00000000.tx.699: Neural cell adhesion molecule L1: signaling pathways and growth cone motility. 

Phrase: "Neural cell adhesion molecule L1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0950625:Neural Cell Adhesion Molecule L1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cell Adhesion Molecule L1
           Neural Adhesion Molecule L1
  1000   C1416769:NEURAL CELL ADHESION MOLECULE L1 [Gene or Genome]
   804   C0441918:L1 [Finding]
   804   C1179698:L1 [Body Location or Region]
   804   C1416177:L1 [Gene or Genome]
   771   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   771   C1413393:neural cell adhesion molecule [Gene or Genome]
   722   C1413564:neural adhesion molecule [Gene or Genome]
   717   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0037080:Signal Pathways [Molecular Function]
   983   C0037083:signaling pathway [Cell Function]
   983   C0086982:Signaling Pathway [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "growth cone motility."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0007608:Motility [Cell Function]
   827   C0678835:Motility [Laboratory or Test Result]
   827   C1510470:Motility [Organism Function]
   755 E C1979933:Motile [Finding]
   734   C0596632:growth cone [Cell Component]
Processing 00000000.tx.700: J. 

Phrase: "J."
Processing 00000000.tx.701: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.702: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.703: 49:18.[Medline] Katayama, M., A. 

Phrase: "49"

Phrase: ":"

Phrase: "18."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katayama,"

Phrase: "M."

Phrase: ","

Phrase: "A."
Processing 00000000.tx.704: Iwamatsu, H. 

Phrase: "Iwamatsu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.705: Masutani, K. 

Phrase: "Masutani,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.706: Furuke, K. 

Phrase: "Furuke,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.707: Takeda, H. 

Phrase: "Takeda,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.708: Wada, T. 

Phrase: "Wada,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.709: Masuda, and K. 

Phrase: "Masuda,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.710: Ishii. 

Phrase: "Ishii."
Processing 00000000.tx.711: 1997. 

Phrase: "1997."
Processing 00000000.tx.712: Expression of neural cell adhesion molecule L1 in human lung cancer cell lines. 

Phrase: "Expression of neural cell adhesion molecule L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   731   C0950625:Neural Cell Adhesion Molecule L1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1416769:NEURAL CELL ADHESION MOLECULE L1 [Gene or Genome]

Phrase: "in human lung cancer cell lines."
Meta Candidates (Total=23; Excluded=5; Pruned=0; Remaining=18)
   894   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   840   C0007600:Cell lines [Cell]
   840   C0242379:Lung Cancer [Neoplastic Process]
   840   C0334227:Cancer Cell [Cell]
   840   C0684249:LUNG CANCER [Neoplastic Process]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0007634:Cell [Cell]
   804   C0024109:Lung [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C0205132:lines [Spatial Concept]
   804   C0819757:LUNG [Tissue]
   804   C0998265:Cancer [Eukaryote]
   804   C1269647:Cell [Cell]
   804   C1278908:Lung [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
   748 E C2707265:Pulmonary [Clinical Attribute]
   748 E C2709248:Pulmonary [Qualitative Concept]
   711 E C0032285:Pneumonia [Disease or Syndrome]
Processing 00000000.tx.713: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.714: Struct. 

Phrase: "Struct."
Processing 00000000.tx.715: Funct. 

Phrase: "Funct."
Processing 00000000.tx.716: 22:511516.[Medline] Klemke, R.L., M. 

Phrase: "22"

Phrase: ":"

Phrase: "511516."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klemke,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.717: Yebra, E.M. 

Phrase: "Yebra,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.718: Bayna, and D.A. 

Phrase: "Bayna,"

Phrase: "and"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.719: Cheresh. 

Phrase: "Cheresh."
Processing 00000000.tx.720: 1994. 

Phrase: "1994."
Processing 00000000.tx.721: Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin. 

Phrase: "Receptor tyrosine kinase signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1514762:Receptor Signaling [Molecular Function]
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
   756   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "required for integrin alpha v beta 5-directed cell motility"
Meta Candidates (Total=28; Excluded=2; Pruned=0; Remaining=26)
   833   C0083026:Integrin Alpha-V/Beta-5 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
           Alpha-V/Beta-5
   782   C0253930:Integrin alpha V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C0249042:Integrin Beta-5 [Amino Acid, Peptide, or Protein,Receptor]
   777 E C1416494:INTEGRIN, ALPHA-V [Gene or Genome]
   777   C1416501:INTEGRIN, BETA-5 [Gene or Genome]
   777   C1531430:Integrin Alpha 5 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   775 E C1416488:INTEGRIN, ALPHA-5 [Gene or Genome]
   760   C0007608:cell motility [Cell Function]
           Motility
   760   C1540127:beta-5 [Gene or Genome]
   760   C3280555:BETA-5 [Gene or Genome]
   757   C0030280:Alpha cell [Cell]
   757   C0030281:Beta cell [Cell]
   739   C0007634:Cell [Cell]
   739   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   739   C0330390:Beta [Plant]
   739   C0439095:Alpha [Intellectual Product]
   739   C0439096:Beta [Intellectual Product]
   739   C0678835:Motility [Laboratory or Test Result]
   739   C1269647:Cell [Cell]
   739   C1510470:Motility [Organism Function]
   739   C1514873:Required [Functional Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   739   C2003941:Alpha [Intellectual Product]
   739   C2004068:Beta [Qualitative Concept]
   739   C2350010:Alpha [Qualitative Concept]

Phrase: "but"

Phrase: "not adhesion on vitronectin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.722: J. 

Phrase: "J."
Processing 00000000.tx.723: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.724: 127:859866.[Abstract] Kowitz, A., G. 

Phrase: "127"

Phrase: ":"

Phrase: "859866."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kowitz,"

Phrase: "A.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.725: Kadmon, M. 

Phrase: "Kadmon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.726: Eckert, V. 

Phrase: "Eckert,"

Phrase: "V."
Processing 00000000.tx.727: Schirrmacher, M. 

Phrase: "Schirrmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.728: Schachner, and P. 

Phrase: "Schachner,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.729: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.730: 1992. 

Phrase: "1992."
Processing 00000000.tx.731: Expression and function of the neural cell adhesion molecule L1 in mouse leukocytes. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "function of the neural cell adhesion molecule L1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0007613:Cell Function [Cell Function]
   767   C0700630:neural function [Physiologic Function]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
   731   C1148560:molecular function [Molecular Function]
   703   C0950625:Neural Cell Adhesion Molecule L1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1416769:NEURAL CELL ADHESION MOLECULE L1 [Gene or Genome]

Phrase: "in mouse leukocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1522639:Mouse Leukocyte [Cell]
   861   C0023516:Leukocytes [Cell]
Processing 00000000.tx.732: Eur. 

Phrase: "Eur."
Processing 00000000.tx.733: J. 

Phrase: "J."
Processing 00000000.tx.734: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.735: 22:11991205.[Medline] Kojiro, E., G. 

Phrase: "22"

Phrase: ":"

Phrase: "11991205."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kojiro,"

Phrase: "E.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.736: Gimpl, S. 

Phrase: "Gimpl,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.737: Lammich, W. 

Phrase: "Lammich,"

Phrase: "W."
Processing 00000000.tx.738: Marz, and F. 

Phrase: "Marz,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.739: Fahrenholz. 

Phrase: "Fahrenholz."
Processing 00000000.tx.740: 2001. 

Phrase: "2001."
Processing 00000000.tx.741: Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. 

Phrase: "Low cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860920:Low cholesterol [Finding]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "stimulates"

Phrase: "the nonamyloidogenic pathway by its effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "on the alpha-secretase ADAM 10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412181:ADAM10 [Gene or Genome]
   861   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.742: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.743: Natl. 

Phrase: "Natl."
Processing 00000000.tx.744: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.745: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.746: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.747: 98:58155820.[Abstract/Free FullText] Krauss, K., and P. 

Phrase: "98"

Phrase: ":"

Phrase: "58155820."

Phrase: "[Abstract/Free FullText"

Phrase: "] Krauss,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.748: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.749: 1999. 

Phrase: "1999."
Processing 00000000.tx.750: Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts. 

Phrase: "Integrin leukocyte function-associated antigen-1-mediated cell binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   891   C1149503:Integrin Binding [Molecular Function]
   842   C1148575:antigen binding [Molecular Function]
   791   C0243122:binding [Functional Concept]
   791   C1145667:Binding [Activity]
   791   C1167622:Binding [Molecular Function]
   707   C0079717:Leukocyte Function Associated Antigen-1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "can"

Phrase: "be"

Phrase: "activated by clustering of membrane rafts."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   773   C1167250:membrane raft [Cell Component]
   753   C0009085:Clustering [Research Activity]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C1879547:Activated [Activity]
   719   C0336849:Raft [Manufactured Object]
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.751: J. 

Phrase: "J."
Processing 00000000.tx.752: Biol. 

Phrase: "Biol."
Processing 00000000.tx.753: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.754: 274:3692136927.[Abstract/Free FullText] Krger, A., R. 

Phrase: "274"

Phrase: ":"

Phrase: "3692136927."

Phrase: "[Abstract/Free FullText"

Phrase: "] Krger,"

Phrase: "A.,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.755: Soeltl, I. 

Phrase: "Soeltl,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.756: Sopov, C. 

Phrase: "Sopov,"

Phrase: "C."
Processing 00000000.tx.757: Kopitz, M. 

Phrase: "Kopitz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.758: Arlt, V. 

Phrase: "Arlt,"

Phrase: "V."
Processing 00000000.tx.759: Magdolen, N. 

Phrase: "Magdolen,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.760: Harbeck, B. 

Phrase: "Harbeck,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.761: Gansbacher, and M. 

Phrase: "Gansbacher,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.762: Schmitt. 

Phrase: "Schmitt."
Processing 00000000.tx.763: 2001. 

Phrase: "2001."
Processing 00000000.tx.764: Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. 

Phrase: "Hydroxamate-type matrix metalloproteinase inhibitor batimastat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0215791:batimastat [Organic Chemical,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "liver metastasis."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0494165:Liver Metastasis [Neoplastic Process]
   861   C0027627:Metastasis [Neoplastic Process]
   861   C2939420:metastasis [Neoplastic Process]
   789 E C0036525:Metastatic [Functional Concept]
   789 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.765: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.766: 61:12721275.[Abstract/Free FullText] Krystosek, A., and N.W. 

Phrase: "61"

Phrase: ":"

Phrase: "12721275."

Phrase: "[Abstract/Free FullText"

Phrase: "] Krystosek,"

Phrase: "A.,"

Phrase: "and"

Phrase: "N.W."
Processing 00000000.tx.767: Seeds. 

Phrase: "Seeds."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0036563:Seed [Plant]
  1000   C1705192:Seed [Laboratory Procedure]
  1000   C1882540:{Seed} [Quantitative Concept]
  1000   C2346495:Seed [Conceptual Entity]
   944 E C1519232:Seminal [Clinical Attribute]
Processing 00000000.tx.768: 1981. 

Phrase: "1981."
Processing 00000000.tx.769: Plasminogen activator release at the neuronal growth cone. 

Phrase: "Plasminogen activator release at the neuronal growth cone."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.770: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.771: 213:15321534.[Medline] Lammich, S., E. 

Phrase: "213"

Phrase: ":"

Phrase: "15321534."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "E."
Processing 00000000.tx.772: Kojro, R. 

Phrase: "Kojro,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.773: Postina, S. 

Phrase: "Postina,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.774: Gilbert, R. 

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.775: Pfeiffer, M. 

Phrase: "Pfeiffer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.776: Jasionowski, C. 

Phrase: "Jasionowski,"

Phrase: "C."
Processing 00000000.tx.777: Haass, and F. 

Phrase: "Haass,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.778: Fahrenholz. 

Phrase: "Fahrenholz."
Processing 00000000.tx.779: 1999. 

Phrase: "1999."
Processing 00000000.tx.780: Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. 

Phrase: "Constitutive"

Phrase: "and"

Phrase: "regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597304:Protein Cleavage [Molecular Function]
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "by a disintegrin metalloprotease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.781: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.782: Natl. 

Phrase: "Natl."
Processing 00000000.tx.783: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.784: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.785: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.786: 96:39223927.[Abstract/Free FullText] Liljelund, P., P. 

Phrase: "96"

Phrase: ":"

Phrase: "39223927."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liljelund,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.787: Ghosh, and A.N. van den Pol. 

Phrase: "Ghosh,"

Phrase: "and"

Phrase: "A.N. van den Pol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0017360:POL [Gene or Genome]
   804   C0032356:POL [Geographic Area]
   804   C0178587:DEN [Quantitative Concept]
   804   C0557775:Van [Manufactured Object]
Processing 00000000.tx.788: 1994. 

Phrase: "1994."
Processing 00000000.tx.789: Expression of the neural axon adhesion molecule L1 in the developing and adult rat brain. 

Phrase: "Expression of the neural axon adhesion molecule L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the developing"

Phrase: "and"

Phrase: "adult rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.790: J. 

Phrase: "J."
Processing 00000000.tx.791: Biol. 

Phrase: "Biol."
Processing 00000000.tx.792: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.793: 269:3288632895.[Abstract/Free FullText] Linnemann, D., A. 

Phrase: "269"

Phrase: ":"

Phrase: "3288632895."

Phrase: "[Abstract/Free FullText"

Phrase: "] Linnemann,"

Phrase: "D."

Phrase: ","

Phrase: "A."
Processing 00000000.tx.794: Raz, and E. 

Phrase: "Raz,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.795: Bock. 

Phrase: "Bock."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678387:bock [Food]
Processing 00000000.tx.796: 1989. 

Phrase: "1989."
Processing 00000000.tx.797: Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity. 

Phrase: "Differential expression of cell adhesion molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "of K1735 melanoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C1513095:Melanoma Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "differing in metastatic capacity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036525:Metastatic [Functional Concept]
   770   C1516240:Capacity [Quantitative Concept]
   770   C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.798: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.799: J. 

Phrase: "J."
Processing 00000000.tx.800: Cancer. 

Phrase: "Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.801: 43:709712.[Medline] Marcinkiewicz, M., and N.G. 

Phrase: "43"

Phrase: ":"

Phrase: "709712."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marcinkiewicz,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "N.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.802: Seidah. 

Phrase: "Seidah."
Processing 00000000.tx.803: 2000. 

Phrase: "2000."
Processing 00000000.tx.804: Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. 

Phrase: "Coordinated expression of beta-amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the putative beta-secretase BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412727:BACE [Gene or Genome]

Phrase: "and"

Phrase: "alpha-secretase ADAM10 in mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1412181:ADAM10 [Gene or Genome]
   760   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "human brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.805: J. 

Phrase: "J."
Processing 00000000.tx.806: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.807: 75:21332143.[Medline] Montgomery, A.M., J.C. 

Phrase: "75"

Phrase: ":"

Phrase: "21332143."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Montgomery,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "J.C."
Processing 00000000.tx.808: Becker, C.H. 

Phrase: "Becker,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.809: Siu, V.P. 

Phrase: "Siu,"

Phrase: "V.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1535597:v p [Therapeutic or Preventive Procedure]
Processing 00000000.tx.810: Lemmon, D.A. 

Phrase: "Lemmon,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.811: Cheresh, J.D. 

Phrase: "Cheresh,"

Phrase: "J.D."
Processing 00000000.tx.812: Pancook, X. 

Phrase: "Pancook,"

Phrase: "X."
Processing 00000000.tx.813: Zhao, and R.A. 

Phrase: "Zhao,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.814: Reisfeld. 

Phrase: "Reisfeld."
Processing 00000000.tx.815: 1996. 

Phrase: "1996."
Processing 00000000.tx.816: Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin v3. 

Phrase: "Human neural cell adhesion molecule L1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0950625:Neural Cell Adhesion Molecule L1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cell Adhesion Molecule L1
           Neural Adhesion Molecule L1
   947   C1416769:NEURAL CELL ADHESION MOLECULE L1 [Gene or Genome]
   799   C0441918:L1 [Finding]
   799   C1179698:L1 [Body Location or Region]
   799   C1416177:L1 [Gene or Genome]
   734   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1413393:neural cell adhesion molecule [Gene or Genome]
   700   C1413564:neural adhesion molecule [Gene or Genome]

Phrase: "and"

Phrase: "rat homologue NILE"

Phrase: "are"

Phrase: "ligands for integrin v3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1749428:integrin ligand [Molecular Function]
   770   C0023688:Ligands [Chemical]
Processing 00000000.tx.817: J. 

Phrase: "J."
Processing 00000000.tx.818: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.819: 132:475485.[Abstract] Mumm, J.S., E.H. 

Phrase: "132"

Phrase: ":"

Phrase: "475485."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mumm,"

Phrase: "J.S.,"

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.820: Schroeter, M.T. 

Phrase: "Schroeter,"

Phrase: "M.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.821: Saxena, A. 

Phrase: "Saxena,"

Phrase: "A."
Processing 00000000.tx.822: Griesemer, X. 

Phrase: "Griesemer,"

Phrase: "X."
Processing 00000000.tx.823: Tian, D.J. 

Phrase: "Tian,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.824: Pan, W.J. 

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "W.J."
Processing 00000000.tx.825: Ray, and R. 

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.826: Kopan. 

Phrase: "Kopan."
Processing 00000000.tx.827: 2000. 

Phrase: "2000."
Processing 00000000.tx.828: A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. 

Phrase: "A ligand-induced extracellular cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]

Phrase: "regulates"

Phrase: "gamma-secretase-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like proteolytic activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of Notch1."
Processing 00000000.tx.829: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.830: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.831: 5:197206.[Medline] Nath, D., N.J. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "197206."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nath,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538040:NATH [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "N.J."
Processing 00000000.tx.832: Williamson, R. 

Phrase: "Williamson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.833: Jarvis, and G. 

Phrase: "Jarvis,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.834: Murphy. 

Phrase: "Murphy."
Processing 00000000.tx.835: 2001. 

Phrase: "2001."
Processing 00000000.tx.836: Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase. 

Phrase: "Shedding of c-"

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "is"

Phrase: "regulated by crosstalk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010357:Crosstalk [Molecular Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C2986468:Cross-talk [Cell Function]

Phrase: "between a G-protein coupled receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682972:G Protein-Coupled Receptor [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1948027:Coupled [Functional Concept]
   779 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "the EGF receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034802:Receptor, EGF [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "is"

Phrase: "mediated by a TIMP-3 sensitive metalloproteinase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0210492:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C1527365:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0332324:Sensitive [Functional Concept]
   748   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.837: J. 

Phrase: "J."
Processing 00000000.tx.838: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.839: 114:12131220.[Abstract/Free FullText] Nayeem, N., S. 

Phrase: "114"

Phrase: ":"

Phrase: "12131220."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nayeem,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.840: Silletti, X. 

Phrase: "Silletti,"

Phrase: "X."
Processing 00000000.tx.841: Yang, V.P. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "V.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1535597:v p [Therapeutic or Preventive Procedure]
Processing 00000000.tx.842: Lemmon, R.A. 

Phrase: "Lemmon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.843: Reisfeld, W.B. 

Phrase: "Reisfeld,"

Phrase: "W.B."
Processing 00000000.tx.844: Stallcup, and A.M. 

Phrase: "Stallcup,"

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.845: Montgomery. 

Phrase: "Montgomery."
Processing 00000000.tx.846: 1999. 

Phrase: "1999."
Processing 00000000.tx.847: A potential role for the plasmin(ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1. 

Phrase: "A potential role for the plasmin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(ogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722236:Ogen [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "system in the posttranslational cleavage of the neural cell adhesion molecule L1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0449913:System [Functional Concept]
   736   C1553451:System [Manufactured Object]
   736   C1704459:System [Medical Device]
   725   C0027882:nervous system cell [Cell]
Processing 00000000.tx.848: J. 

Phrase: "J."
Processing 00000000.tx.849: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.850: 112:47394749.[Abstract/Free FullText] Ohnishi, T., H. 

Phrase: "112"

Phrase: ":"

Phrase: "47394749."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ohnishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.851: Matsumura, S. 

Phrase: "Matsumura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.852: Izumoto, S. 

Phrase: "Izumoto,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.853: Hiraga, and T. 

Phrase: "Hiraga,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.854: Hayakawa. 

Phrase: "Hayakawa."
Processing 00000000.tx.855: 1998. 

Phrase: "1998."
Processing 00000000.tx.856: A novel model of glioma cell invasion using organotypic brain slice culture. 

Phrase: "A novel model of glioma cell invasion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "organotypic brain slice culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.857: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.858: 58:29352940.[Abstract] Oleszewski, M., S. 

Phrase: "58"

Phrase: ":"

Phrase: "29352940."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Oleszewski,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.859: Beer, S. 

Phrase: "Beer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beer [Food]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.860: Katich, C. 

Phrase: "Katich,"

Phrase: "C."
Processing 00000000.tx.861: Geiger, Y. 

Phrase: "Geiger,"

Phrase: "Y."
Processing 00000000.tx.862: Zeller, U. 

Phrase: "Zeller,"

Phrase: "U."
Processing 00000000.tx.863: Rauch, and P. 

Phrase: "Rauch,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.864: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.865: 1999. 

Phrase: "1999."
Processing 00000000.tx.866: Integrin and neurocan binding to L1 involves distinct Ig domains. 

Phrase: "Integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "neurocan binding to L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "involves"

Phrase: "distinct Ig domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.867: J. 

Phrase: "J."
Processing 00000000.tx.868: Biol. 

Phrase: "Biol."
Processing 00000000.tx.869: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.870: 274:2460224610.[Abstract/Free FullText] Oleszewski, M., P. 

Phrase: "274"

Phrase: ":"

Phrase: "2460224610."

Phrase: "[Abstract/Free FullText"

Phrase: "] Oleszewski,"

Phrase: "M."

Phrase: ","

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.871: Gutwein, W. von der Lieth, U. 

Phrase: "Gutwein,"

Phrase: "W. von der Lieth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "U."
Processing 00000000.tx.872: Rauch, and P. 

Phrase: "Rauch,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.873: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.874: 2000. 

Phrase: "2000."
Processing 00000000.tx.875: Characterization of the L1-neurocan-binding site. 

Phrase: "Characterization of the L1-neurocan-binding site."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]
Processing 00000000.tx.876: Implications for L1-L1 homophilic binding. 

Phrase: "Implications for L1-L1 homophilic binding."
Processing 00000000.tx.877: J. 

Phrase: "J."
Processing 00000000.tx.878: Biol Chem. 

Phrase: "Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.879: 275:3447834485.[Abstract/Free FullText] Pancook, J.D., R.A. 

Phrase: "275"

Phrase: ":"

Phrase: "3447834485."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pancook,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.880: Reisfeld, N. 

Phrase: "Reisfeld,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.881: Varki, A. 

Phrase: "Varki,"

Phrase: "A."
Processing 00000000.tx.882: Vitiello, R.I. 

Phrase: "Vitiello,"

Phrase: "R.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.883: Fox, and A.M. 

Phrase: "Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016633:Fox [Mammal]
   928 E C0049564:FOXY [Organic Chemical]

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.884: Montgomery. 

Phrase: "Montgomery."
Processing 00000000.tx.885: 1997. 

Phrase: "1997."
Processing 00000000.tx.886: Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "regulation of the neural cell adhesion molecule L1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C1154398:regulation of cell adhesion [Cell Function]
   767   C0598959:neural regulation [Organ or Tissue Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   703   C0950625:Neural Cell Adhesion Molecule L1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1416769:NEURAL CELL ADHESION MOLECULE L1 [Gene or Genome]

Phrase: "on human cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "of myelomonocytic"

Phrase: "and"

Phrase: "lymphoid origin."
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   861   C0079946:origin [Classification]
   861   C0439659:Origin [Temporal Concept]
   861   C1550512:origin [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   789 E C0205313:Original [Idea or Concept]
   789 E C2347409:Original [Occupational Activity]
   777 E C0005615:Birth [Organism Function]
   777 E C0035150:Reproduction [Organism Function]
   777 E C1550722:birth [Idea or Concept]
   777 E C3245487:birth [Intellectual Product]
   761 E C0454729:Natal [Geographic Area]
   761 E C0559522:Genital [Body System]
   761 E C0598240:originality [Mental Process]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]
Processing 00000000.tx.887: J. 

Phrase: "J."
Processing 00000000.tx.888: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.889: 158:44134421.[Abstract] Patel, K., F. 

Phrase: "158"

Phrase: ":"

Phrase: "44134421."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Patel,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.890: Kiely, E. 

Phrase: "Kiely,"

Phrase: "E."
Processing 00000000.tx.891: Phimister, G. 

Phrase: "Phimister,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.892: Melino, F. 

Phrase: "Melino,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.893: Rathjen, and J.T. 

Phrase: "Rathjen,"

Phrase: "and"

Phrase: "J.T."
Processing 00000000.tx.894: Kemshead. 

Phrase: "Kemshead."
Processing 00000000.tx.895: 1991. 

Phrase: "1991."
Processing 00000000.tx.896: The 200/220 kD antigen recognized by monoclonal antibody (MAb) UJ127.11 on neural tissues and tumors is the human L1 adhesion molecule. 

Phrase: "The 200/220 kD antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003320:Antigen [Immunologic Factor]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "recognized by monoclonal antibody (MAb) UJ127.11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "on neural tissues"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027757:neural tissues [Tissue]
   983 E C1762608:Neural tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "is"

Phrase: "the human L1 adhesion molecule."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.897: Hybridoma. 

Phrase: "Hybridoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020204:Hybridoma [Cell]
Processing 00000000.tx.898: 10:481491.[Medline] Peschon, J.J., J.L. 

Phrase: "10"

Phrase: ":"

Phrase: "481491."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Peschon,"

Phrase: "J.J.,"

Phrase: "J.L."
Processing 00000000.tx.899: Slack, P. 

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.900: Reddy, K.L. 

Phrase: "Reddy,"

Phrase: "K.L."
Processing 00000000.tx.901: Stocking, S.W. 

Phrase: "Stocking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0453908:Stocking [Manufactured Object]

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.902: Sunnarborg, D.C. 

Phrase: "Sunnarborg,"

Phrase: "D.C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.903: Lee, W.E. 

Phrase: "Lee,"

Phrase: "W.E."
Processing 00000000.tx.904: Russell, B.J. 

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "B.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.905: Castner, R.S. 

Phrase: "Castner,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.906: Johnson, J.N. 

Phrase: "Johnson,"

Phrase: "J.N."
Processing 00000000.tx.907: Fitzner, R.W. 

Phrase: "Fitzner,"

Phrase: "R.W."
Processing 00000000.tx.908: Boyce, and N. 

Phrase: "Boyce,"

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.909: Nelson, et al.1998. 

Phrase: "Nelson,"

Phrase: "et al.1998."
Processing 00000000.tx.910: An essential role for ectodomain shedding in mammalian development. 

Phrase: "An essential role for ectodomain shedding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in mammalian development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.911: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.912: 282:12811284.[Abstract/Free FullText] Plow, E.F., T. 

Phrase: "282"

Phrase: ":"

Phrase: "12811284."

Phrase: "[Abstract/Free FullText"

Phrase: "] Plow,"

Phrase: "E.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.913: Herren, A. 

Phrase: "Herren,"

Phrase: "A."
Processing 00000000.tx.914: Redlitz, L.A. 

Phrase: "Redlitz,"

Phrase: "L.A."
Processing 00000000.tx.915: Miles, and P.J. 

Phrase: "Miles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0331865:Miles [Quantitative Concept]
   966 E C2347127:mile [Quantitative Concept]
   966 E C2348616:mile [Quantitative Concept]

Phrase: "and"

Phrase: "P.J."
Processing 00000000.tx.916: Hoover. 

Phrase: "Hoover."
Processing 00000000.tx.917: 1995. 

Phrase: "1995."
Processing 00000000.tx.918: The cell biology of the plasminogen system. 

Phrase: "The cell biology of the plasminogen system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   748   C0005532:Biology [Biomedical Occupation or Discipline]
Processing 00000000.tx.919: Faseb J. 

Phrase: "Faseb J."
Processing 00000000.tx.920: 9:939945.[Abstract/Free FullText] Prenzel, N., E. 

Phrase: "9"

Phrase: ":"

Phrase: "939945."

Phrase: "[Abstract/Free FullText"

Phrase: "] Prenzel,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "E."
Processing 00000000.tx.921: Zwick, H. 

Phrase: "Zwick,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.922: Daub, M. 

Phrase: "Daub,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.923: Leserer, R. 

Phrase: "Leserer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.924: Abraham, C. 

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.925: Wallasch, and A. 

Phrase: "Wallasch,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.926: Ullrich. 

Phrase: "Ullrich."
Processing 00000000.tx.927: 1999. 

Phrase: "1999."
Processing 00000000.tx.928: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. 

Phrase: "EGF receptor transactivation by G-protein-coupled receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3158809:receptor transactivation [Physiologic Function]
   744   C0040624:Transactivation [Genetic Function]

Phrase: "requires"

Phrase: "metalloproteinase cleavage of proHB-EGF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
Processing 00000000.tx.929: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.930: 402:884888.[Medline] Reid, R.A., and J.J. 

Phrase: "402"

Phrase: ":"

Phrase: "884888."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reid,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "and"

Phrase: "J.J."
Processing 00000000.tx.931: Hemperly. 

Phrase: "Hemperly."
Processing 00000000.tx.932: 1992. 

Phrase: "1992."
Processing 00000000.tx.933: Variants of human L1 cell adhesion molecule arise through alternate splicing of RNA. 

Phrase: "Variants of human L1 cell adhesion molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "arise through alternate splicing of RNA."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0002345:Alternate Splicing [Genetic Function]
   783   C0035687:RNA Splicing [Genetic Function]
           Splicing
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332270:alternate [Functional Concept]
   753   C1523987:Alternate [Conceptual Entity]
   753   C2610186:splicing [Genetic Function]
Processing 00000000.tx.934: J. 

Phrase: "J."
Processing 00000000.tx.935: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.936: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.937: 3:127135.[Medline] Reuning, U., V. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "127135."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reuning,"

Phrase: "U.,"

Phrase: "V."
Processing 00000000.tx.938: Magdolen, O. 

Phrase: "Magdolen,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.939: Wilhelm, K. 

Phrase: "Wilhelm,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.940: Fischer, V. 

Phrase: "Fischer,"

Phrase: "V."
Processing 00000000.tx.941: Lutz, H. 

Phrase: "Lutz,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.942: Graeff, and M. 

Phrase: "Graeff,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.943: Schmitt. 

Phrase: "Schmitt."
Processing 00000000.tx.944: 1998. 

Phrase: "1998."
Processing 00000000.tx.945: Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis. 

Phrase: "Multifunctional potential of the plasminogen activation system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "in tumor invasion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1269955:Tumor invasion [Finding]
           Invasion
   861   C2699153:Invasion [Pathologic Function]

Phrase: "and"

Phrase: "metastasis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.946: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.947: J. 

Phrase: "J."
Processing 00000000.tx.948: Oncol. 

Phrase: "Oncol."
Processing 00000000.tx.949: 13:893906.[Medline] Ruppert, M., S. 

Phrase: "13"

Phrase: ":"

Phrase: "893906."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ruppert,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.950: Aigner, M. 

Phrase: "Aigner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.951: Hubbe, H. 

Phrase: "Hubbe,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.952: Yagita, and P. 

Phrase: "Yagita,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.953: Altevogt. 

Phrase: "Altevogt."
Processing 00000000.tx.954: 1995. 

Phrase: "1995."
Processing 00000000.tx.955: The L1 adhesion molecule is a cellular ligand for VLA-5. 

Phrase: "The L1 adhesion molecule"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "a cellular ligand for VLA-5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023688:Ligand [Chemical]
Processing 00000000.tx.956: J. 

Phrase: "J."
Processing 00000000.tx.957: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.958: 131:18811891.[Abstract] Sadoul, K., R. 

Phrase: "131"

Phrase: ":"

Phrase: "18811891."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sadoul,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.959: Sadoul, A. 

Phrase: "Sadoul,"

Phrase: "A."
Processing 00000000.tx.960: Faissner, and M. 

Phrase: "Faissner,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.961: Schachner. 

Phrase: "Schachner."
Processing 00000000.tx.962: 1988. 

Phrase: "1988."
Processing 00000000.tx.963: Biochemical characterization of different molecular forms of the neural cell adhesion molecule L1. 

Phrase: "Biochemical characterization of different molecular forms of the neural cell adhesion molecule L1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1880022:Characterization [Activity]
Processing 00000000.tx.964: J. 

Phrase: "J."
Processing 00000000.tx.965: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.966: 50:510521.[Medline] Schachner, M. 

Phrase: "50"

Phrase: ":"

Phrase: "510521."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schachner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.967: 1997. 

Phrase: "1997."
Processing 00000000.tx.968: Neural recognition molecules and synaptic plasticity. 

Phrase: "Neural recognition molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "synaptic plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]
Processing 00000000.tx.969: Curr. 

Phrase: "Curr."
Processing 00000000.tx.970: Opin. 

Phrase: "Opin."
Processing 00000000.tx.971: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.972: 9:627634.[Medline] Schlndorff, J., and C.P. 

Phrase: "9"

Phrase: ":"

Phrase: "627634."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schlndorff,"

Phrase: "J.,"

Phrase: "and"

Phrase: "C.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.973: Blobel. 

Phrase: "Blobel."
Processing 00000000.tx.974: 1999. 

Phrase: "1999."
Processing 00000000.tx.975: Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. 

Phrase: "Metalloprotease-disintegrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0174807:Disintegrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "modular proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "capable of promoting cell-cell interactions"

Phrase: "and"

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "signals by protein-ectodomain shedding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.976: J. 

Phrase: "J."
Processing 00000000.tx.977: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.978: 112:36033617.[Abstract/Free FullText] Schwartz, M.A., and S.J. 

Phrase: "112"

Phrase: ":"

Phrase: "36033617."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schwartz,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and S.J."
Processing 00000000.tx.979: Shattil. 

Phrase: "Shattil."
Processing 00000000.tx.980: 2000. 

Phrase: "2000."
Processing 00000000.tx.981: Signaling networks linking integrins and rho family GTPases. 

Phrase: "Signaling networks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1882071:networks [Conceptual Entity]
   827 E C1513822:Network [Professional or Occupational Group]
   827 E C1705739:Network [Manufactured Object]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "rho family GTPases."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0174045:rho GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0015576:Family [Family Group]
   827   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.982: Trends Biochem. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.983: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.984: 25:388391.[Medline] Seeds, N.W., M.E. 

Phrase: "25"

Phrase: ":"

Phrase: "388391."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seeds,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0036563:Seed [Plant]
  1000   C1705192:Seed [Laboratory Procedure]
  1000   C1882540:{Seed} [Quantitative Concept]
  1000   C2346495:Seed [Conceptual Entity]
   944 E C1519232:Seminal [Clinical Attribute]

Phrase: "N.W.,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.985: Basham, and S.P. 

Phrase: "Basham,"

Phrase: "and S.P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.986: Haffke. 

Phrase: "Haffke."
Processing 00000000.tx.987: 1999. 

Phrase: "1999."
Processing 00000000.tx.988: Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. 

Phrase: "Neuronal migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1326504:neuronal migration [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "is"

Phrase: "retarded in mice"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C0521111:Retarded [Qualitative Concept]
   718 E C0311403:Inhibited [Qualitative Concept]
   718 E C3463820:Inhibiting [Activity]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the tissue plasminogen activator gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1367553:Plasminogen Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
Processing 00000000.tx.989: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.990: Natl. 

Phrase: "Natl."
Processing 00000000.tx.991: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.992: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.993: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.994: 96:1411814123.[Abstract/Free FullText] Sieg, D.J., C.R. 

Phrase: "96"

Phrase: ":"

Phrase: "1411814123."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sieg,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "C.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.995: Hauck, D. 

Phrase: "Hauck,"

Phrase: "D."
Processing 00000000.tx.996: Ilic, C.K. 

Phrase: "Ilic,"

Phrase: "C.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.997: Klingbeil, E. 

Phrase: "Klingbeil,"

Phrase: "E."
Processing 00000000.tx.998: Schaefer, C.H. 

Phrase: "Schaefer,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.999: Damsky, and D.D. 

Phrase: "Damsky,"

Phrase: "and"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.1000: Schlaepfer. 

Phrase: "Schlaepfer."
Processing 00000000.tx.1001: 2000. 

Phrase: "2000."
Processing 00000000.tx.1002: FAK integrates growth-factor and integrin signals to promote cell migration. 

Phrase: "FAK"

Phrase: "integrates"

Phrase: "growth-factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1521761:Factor [Functional Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2827422:Factor [Conceptual Entity]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell migration."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]
Processing 00000000.tx.1003: Nat. 

Phrase: "Nat."
Processing 00000000.tx.1004: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.1005: 2:249256.[Medline] Silletti, S., F. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "249256."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Silletti,"

Phrase: "S."

Phrase: ","

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.1006: Mei, D. 

Phrase: "Mei,"

Phrase: "D."
Processing 00000000.tx.1007: Sheppard, and A.M. 

Phrase: "Sheppard,"

Phrase: "and"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1008: Montgomery. 

Phrase: "Montgomery."
Processing 00000000.tx.1009: 2000. 

Phrase: "2000."
Processing 00000000.tx.1010: Plasmin-sensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment. 

Phrase: "Plasmin-sensitive dibasic sequences in the third fibronectin-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0162326:Sequences [Nucleotide Sequence]
   711 E C0004793:Sequence [Nucleotide Sequence]
   711 E C0162327:Sequence [Nucleotide Sequence]
   711 E C1519249:Sequence [Functional Concept]

Phrase: "like domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "of L1-cell adhesion molecule (CAM)"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0950625:L1 Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416769:L1 CELL ADHESION MOLECULE [Gene or Genome]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   902   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: "facilitate"

Phrase: "homomultimerization"

Phrase: "and"

Phrase: "concomitant integrin recruitment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2949735:Recruitment [Activity]
Processing 00000000.tx.1011: J. 

Phrase: "J."
Processing 00000000.tx.1012: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.1013: 149:14851502.[Abstract/Free FullText] Subramanian, S.V., M.L. 

Phrase: "149"

Phrase: ":"

Phrase: "14851502."

Phrase: "[Abstract/Free FullText"

Phrase: "] Subramanian,"

Phrase: "S.V.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1018233:S. V [Bacterium]
   861   C2603362:S' [Clinical Attribute]

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1014: Fitzgerald, and M. 

Phrase: "Fitzgerald,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1015: Bernfield. 

Phrase: "Bernfield."
Processing 00000000.tx.1016: 1997. 

Phrase: "1997."
Processing 00000000.tx.1017: Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. 

Phrase: "Regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "shedding of syndecan-1"

Phrase: "and -"

Phrase: "4 ectodomains by thrombin"

Phrase: "and"

Phrase: "growth factor receptor activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514758:Receptor Activation [Cell Function]
   812   C1879547:Activation [Activity]
   756   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.1018: J. 

Phrase: "J."
Processing 00000000.tx.1019: Biol. 

Phrase: "Biol."
Processing 00000000.tx.1020: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.1021: 272:1471314720.[Abstract/Free FullText] Sugawa, M., K. 

Phrase: "272"

Phrase: ":"

Phrase: "1471314720."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sugawa,"

Phrase: "M."

Phrase: ","

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.1022: Ono, Y. 

Phrase: "Ono,"

Phrase: "Y."
Processing 00000000.tx.1023: Yasui, T. 

Phrase: "Yasui,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.1024: Kishi, and T. 

Phrase: "Kishi,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.1025: Tsumori. 

Phrase: "Tsumori."
Processing 00000000.tx.1026: 1997. 

Phrase: "1997."
Processing 00000000.tx.1027: Enhancement of neurite outgrowth by the soluble form of human L1 (neural cell adhesion molecule). 

Phrase: "Enhancement of neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "by the soluble form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of human L1 (neural cell adhesion molecule"
Meta Candidates (Total=24; Excluded=5; Pruned=0; Remaining=19)
   901   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C0950625:L1 Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1413393:neural cell adhesion molecule [Gene or Genome]
   901   C1416769:L1 CELL ADHESION MOLECULE [Gene or Genome]
   876   C0950624:L1 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor]
   867   C1413564:neural adhesion molecule [Gene or Genome]
   861   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   858   C0427861:human cell [Laboratory or Test Result]
   827   C0007577:Cell Adhesion [Cell Function]
   827   C0027882:Neural cell [Cell]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0007634:Cell [Cell]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0567416:Molecule [Substance]
   799   C0599851:Neural [Functional Concept]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   743 E C0027740:Nerve [Tissue]
   743 E C0027757:NERVE [Tissue]
   743 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   727 E C1521991:Molecular [Qualitative Concept]
   706 E C0027769:nervy [Sign or Symptom]

Phrase: ")."
Processing 00000000.tx.1028: Neuroreport. 

Phrase: "Neuroreport."
Processing 00000000.tx.1029: 8:31573162.[Medline] Tessier-Lavigne, M., and C.S. 

Phrase: "8"

Phrase: ":"

Phrase: "31573162."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tessier-Lavigne,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "C.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.1030: Goodman. 

Phrase: "Goodman."
Processing 00000000.tx.1031: 1996. 

Phrase: "1996."
Processing 00000000.tx.1032: The molecular biology of axon guidance. 

Phrase: "The molecular biology of axon guidance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]
   753   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.1033: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.1034: 274:11231133.[Abstract/Free FullText] Tokumaru, S., S. 

Phrase: "274"

Phrase: ":"

Phrase: "11231133."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tokumaru,"

Phrase: "S."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.1035: Higashiyama, T. 

Phrase: "Higashiyama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.1036: Endo, T. 

Phrase: "Endo, T."
Processing 00000000.tx.1037: Nakagawa, J.I. 

Phrase: "Nakagawa,"

Phrase: "J.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.1038: Miyagawa, K. 

Phrase: "Miyagawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.1039: Yamamori, Y. 

Phrase: "Yamamori,"

Phrase: "Y."
Processing 00000000.tx.1040: Hanakawa, H. 

Phrase: "Hanakawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.1041: Ohmoto, K. 

Phrase: "Ohmoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.1042: Yoshino, Y. 

Phrase: "Yoshino,"

Phrase: "Y."
Processing 00000000.tx.1043: Shirakata, Y. 

Phrase: "Shirakata,"

Phrase: "Y."
Processing 00000000.tx.1044: Matsuzawa, K. 

Phrase: "Matsuzawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.1045: Hashimoto, and N. 

Phrase: "Hashimoto,"

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.1046: Taniguchi. 

Phrase: "Taniguchi."
Processing 00000000.tx.1047: 2000. 

Phrase: "2000."
Processing 00000000.tx.1048: Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. 

Phrase: "Ectodomain shedding of epidermal growth factor receptor ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C1621321:receptor shedding [Molecular Function]

Phrase: "is"

Phrase: "required for keratinocyte migration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1656945:keratinocyte migration [Cell Function]
   770   C0022567:keratinocyte [Cell]
   770   C0600210:Migration [Social Behavior]
   770   C1514873:Required [Functional Concept]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "in cutaneous wound healing."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0043240:Wound Healing [Organism Function]
           Healing
   873   C0564444:skin wound [Injury or Poisoning]
   827   C0043250:Wound [Injury or Poisoning]
   827   C0205249:Healing [Functional Concept]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.1049: J. 

Phrase: "J."
Processing 00000000.tx.1050: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.1051: 151:209220.[Abstract/Free FullText] Turner, A.J., and N.M. 

Phrase: "151"

Phrase: ":"

Phrase: "209220."

Phrase: "[Abstract/Free FullText"

Phrase: "] Turner,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.1052: Hooper. 

Phrase: "Hooper."
Processing 00000000.tx.1053: 1999. 

Phrase: "1999."
Processing 00000000.tx.1054: Role for ADAM-family proteinases as membrane protein secretases. 

Phrase: "Role for ADAM-family proteinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0680074:family role [Social Behavior]
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "as membrane protein secretases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.1055: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.1056: Soc. 

Phrase: "Soc."
Processing 00000000.tx.1057: Trans. 

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.1058: 27:255259.[Medline] Yip, P.M., X. 

Phrase: "27"

Phrase: ":"

Phrase: "255259."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yip,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "X."
Processing 00000000.tx.1059: Zhao, A.M. 

Phrase: "Zhao,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1060: Montgomery, and C.H. 

Phrase: "Montgomery,"

Phrase: "and"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.1061: Siu. 

Phrase: "Siu."
Processing 00000000.tx.1062: 1998. 

Phrase: "1998."
Processing 00000000.tx.1063: The Arg-Gly-Asp motif in the cell adhesion molecule L1 promotes neurite outgrowth via interaction with the alphavbeta3 integrin. 

Phrase: "The Arg-Gly-Asp motif in the cell adhesion molecule L1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1514562:Motif [Amino Acid Sequence]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neurite outgrowth via interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C3158384:neurite outgrowth [Cell Function]
   770   C0085103:Neurite [Cell Component]

Phrase: "with the alphavbeta3 integrin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.1064: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.1065: Biol. 

Phrase: "Biol."
Processing 00000000.tx.1066: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.1067: 9:277290.[Abstract/Free FullText]

Phrase: "9"

Phrase: ":"

Phrase: "277290."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

